data_2kim_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kim _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 73.329999999999998 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 72.420000000000002 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 71.120000000000005 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 72.230000000000004 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 74.230000000000004 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 74.200000000000003 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 73.540000000000006 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 74.420000000000002 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 74.530000000000001 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 71.430000000000007 112.405 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 65.430000000000007 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 73.230000000000004 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 73.140000000000001 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 73.049999999999997 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 72.409999999999997 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 75.209999999999994 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 73.299999999999997 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 74.409999999999997 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.209999999999994 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 74.329999999999998 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.512 HD11 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HD11 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 71.219999999999999 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.447 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.501 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 70.219999999999999 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.503 HG23 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 73.019999999999996 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 54.210000000000001 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 74.109999999999999 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 75.310000000000002 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.099999999999994 111.752 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 52.130000000000003 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 74.239999999999995 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 65.109999999999999 109.822 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.239999999999995 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 73.120000000000005 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 74.109999999999999 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.815 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 73.019999999999996 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 75.140000000000001 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 75.200000000000003 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 73.540000000000006 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.437 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 55.32 112.516 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 2' ' ' ASP . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 75.239999999999995 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 72.120000000000005 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.499 HG21 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 72.219999999999999 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 73.519999999999996 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 73.219999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.43 111.604 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 37.799999999999997 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 72.129999999999995 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 73.239999999999995 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 73.129999999999995 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 71.219999999999999 111.289 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 75.430000000000007 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 73.0 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 65.420000000000002 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.439999999999998 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 75.510000000000005 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 73.230000000000004 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 64.420000000000002 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 74.230000000000004 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 75.420000000000002 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.439 HD13 HD23 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 75.209999999999994 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 75.109999999999999 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 73.450000000000003 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 12' ' ' ILE . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 64.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 73.409999999999997 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 62.140000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 74.319999999999993 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.472 HD12 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 74.299999999999997 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 72.450000000000003 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.473 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 75.049999999999997 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 71.420000000000002 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 64.040000000000006 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 54.439999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 73.120000000000005 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 75.0 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 74.450000000000003 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 75.400000000000006 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.420000000000002 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 61.450000000000003 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 71.329999999999998 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 73.040000000000006 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.310000000000002 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 17' ' ' LYS . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 73.5 111.332 175.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 74.329999999999998 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 74.329999999999998 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 73.430000000000007 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 74.340000000000003 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 75.019999999999996 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.472 HD21 HD12 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 75.120000000000005 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 75.040000000000006 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.499 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo . . . . . 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 72.219999999999999 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 74.209999999999994 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 74.140000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 73.040000000000006 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 24.2 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 73.430000000000007 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.755 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.579 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.409999999999997 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 74.510000000000005 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.66 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 75.329999999999998 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 71.549999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 63.32 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 74.209999999999994 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 73.239999999999995 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 70.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 72.450000000000003 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 75.209999999999994 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 73.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 73.219999999999999 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HD2' HD11 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.120000000000005 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' O ' HD21 ' A' ' 78' ' ' LEU . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.755 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 71.120000000000005 111.64 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 75.439999999999998 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 64.409999999999997 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.431 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 61.119999999999997 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 74.120000000000005 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.426 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 73.340000000000003 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.661 HD12 HD13 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 73.319999999999993 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 72.420000000000002 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.5 HG21 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 74.310000000000002 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 64.219999999999999 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 65.040000000000006 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 62.32 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.483 HD21 HD12 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 72.150000000000006 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 75.129999999999995 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 75.219999999999999 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.455 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.83 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.66 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo . . . . . 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.435 ' O ' HG21 ' A' ' 6' ' ' VAL . 15.3 t70 . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 61.140000000000001 112.269 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 71.450000000000003 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 75.439999999999998 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 63.5 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 74.230000000000004 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 75.310000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.450000000000003 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 73.319999999999993 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 72.409999999999997 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 74.129999999999995 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 63.100000000000001 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 63.25 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 75.030000000000001 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.420000000000002 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.439999999999998 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 75.420000000000002 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 73.510000000000005 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 37.539999999999999 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 73.5 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 75.120000000000005 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 61.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 73.099999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.209999999999994 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 4.8 p-10 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 63.25 111.556 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 71.340000000000003 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 74.510000000000005 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 60.109999999999999 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 72.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 75.319999999999993 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.548 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 75.140000000000001 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 75.120000000000005 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 73.420000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 73.409999999999997 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 44.409999999999997 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.68 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 54.049999999999997 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 65.549999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 62.520000000000003 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.511 HD23 HD13 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 74.319999999999993 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.5 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo . . . . . 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' HG21 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 74.349999999999994 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 72.219999999999999 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HB ' HD12 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 73.299999999999997 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 73.319999999999993 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 72.340000000000003 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 73.510000000000005 111.493 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.541 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.541 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 74.030000000000001 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 63.299999999999997 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 27' ' ' ALA . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 74.099999999999994 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 70.340000000000003 113.997 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 74.299999999999997 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 63.140000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD12 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 74.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.52 ' HB3' HD13 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 55.450000000000003 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.704 HD12 HD22 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.209999999999994 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.458 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 70.019999999999996 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 71.299999999999997 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 72.5 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 64.25 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 75.540000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.349999999999994 111.257 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 74.040000000000006 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 72.0 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 73.209999999999994 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 75.099999999999994 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 72.150000000000006 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 75.409999999999997 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 75.120000000000005 113.383 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 74.140000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 73.319999999999993 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 75.549999999999997 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG23 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 71.319999999999993 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.765 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 62.439999999999998 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 75.430000000000007 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 72.310000000000002 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD1' HG11 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 37.93 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 75.439999999999998 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 72.230000000000004 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 72.209999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 74.409999999999997 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 65.109999999999999 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 73.140000000000001 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 74.209999999999994 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 74.310000000000002 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 71.519999999999996 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 74.510000000000005 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 53.030000000000001 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 63.340000000000003 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 72.420000000000002 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 74.439999999999998 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 62.240000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 71.140000000000001 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 71.030000000000001 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 73.439999999999998 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.677 HD12 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 74.340000000000003 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 5.8 p-10 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 63.539999999999999 111.933 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 70.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 74.0 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 75.120000000000005 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 74.400000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 72.140000000000001 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 70.299999999999997 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 74.510000000000005 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 29.0 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 73.329999999999998 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 75.140000000000001 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 73.420000000000002 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.319999999999993 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 74.5 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.677 HD21 HD12 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.519999999999996 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 74.329999999999998 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 73.129999999999995 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.219999999999999 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 75.510000000000005 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.420000000000002 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 74.530000000000001 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 75.140000000000001 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 60.229999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 73.219999999999999 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 73.430000000000007 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 74.219999999999999 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 73.409999999999997 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 74.030000000000001 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 74.420000000000002 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 64.420000000000002 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 70.150000000000006 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 73.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 73.329999999999998 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 65.299999999999997 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 72.109999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 74.209999999999994 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.329999999999998 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 75.5 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 74.049999999999997 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.439999999999998 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 74.540000000000006 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.200000000000003 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 74.200000000000003 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 75.340000000000003 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 75.019999999999996 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 74.200000000000003 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 37.310000000000002 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 75.230000000000004 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 75.230000000000004 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 72.140000000000001 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 65.420000000000002 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 63.229999999999997 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 74.209999999999994 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 74.010000000000005 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.749 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 71.340000000000003 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 63.210000000000001 111.9 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 74.450000000000003 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 63.32 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 75.230000000000004 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 72.109999999999999 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.746 HD12 HD11 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 75.030000000000001 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 72.519999999999996 111.278 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 74.209999999999994 112.697 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 74.349999999999994 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.130000000000003 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 70.239999999999995 112.993 -178.035 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 75.239999999999995 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 75.030000000000001 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.409999999999997 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 75.049999999999997 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.140000000000001 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 74.109999999999999 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 71.340000000000003 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 73.409999999999997 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.531 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.524 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 74.430000000000007 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 75.340000000000003 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 73.510000000000005 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.409999999999997 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 74.040000000000006 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.507 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 72.010000000000005 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 65.409999999999997 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 73.239999999999995 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.51 HD11 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 74.439999999999998 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HD11 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 74.230000000000004 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.400000000000006 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.415 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 73.219999999999999 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 61' ' ' GLN . 1.9 p-10 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.510000000000005 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' HD21 ' A' ' 59' ' ' ASN . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 71.019999999999996 112.115 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 62.340000000000003 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.567 HG21 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 75.129999999999995 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 110.064 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.25 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 75.230000000000004 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 61.5 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.728 HD12 HD12 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.209999999999994 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 44.030000000000001 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.340000000000003 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 75.150000000000006 114.612 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.728 HD12 HD12 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 73.310000000000002 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 75.319999999999993 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 75.120000000000005 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.340000000000003 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.531 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo . . . . . 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 52.229999999999997 112.318 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' HG21 ' A' ' 6' ' ' VAL . 7.5 m-20 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 73.0 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 74.319999999999993 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 71.230000000000004 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.416 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 73.299999999999997 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 73.310000000000002 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 29' ' ' MET . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.409 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD12 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 61.240000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 75.299999999999997 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 75.409999999999997 110.592 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 72.530000000000001 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 75.349999999999994 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 74.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 74.439999999999998 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 74.150000000000006 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 71.239999999999995 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 75.299999999999997 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 72.040000000000006 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 51.539999999999999 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.484 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 74.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 74.409999999999997 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 71.340000000000003 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG21 HG23 ' A' ' 8' ' ' ILE . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 72.340000000000003 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 51.219999999999999 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 73.540000000000006 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 74.519999999999996 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 75.310000000000002 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 73.040000000000006 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.434 ' HB3' HD11 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 74.230000000000004 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.483 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 73.409999999999997 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 71.129999999999995 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 75.439999999999998 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 71.540000000000006 111.682 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 75.540000000000006 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 74.329999999999998 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 74.200000000000003 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 73.450000000000003 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 54.5 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 73.150000000000006 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 75.230000000000004 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 72.019999999999996 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 71.299999999999997 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 74.230000000000004 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 75.219999999999999 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 70.409999999999997 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 74.450000000000003 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 74.310000000000002 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 74.0 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 75.0 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.484 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 6' ' ' VAL . 16.0 t70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 73.530000000000001 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 75.430000000000007 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 74.120000000000005 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 75.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.5 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 72.230000000000004 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 72.409999999999997 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.210000000000001 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 72.230000000000004 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 73.319999999999993 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 42.140000000000001 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 75.099999999999994 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 73.400000000000006 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 61.130000000000003 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.510000000000005 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 60.340000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.515 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 63.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.140000000000001 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 73.209999999999994 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 74.5 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 72.430000000000007 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 75.0 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 62.030000000000001 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 70.200000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.432 ' HB3' HD11 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 74.109999999999999 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.468 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 74.439999999999998 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.519999999999996 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 75.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 71.239999999999995 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 73.310000000000002 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.549999999999997 111.557 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 73.019999999999996 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 71.219999999999999 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 75.409999999999997 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 63.25 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HG3' HG13 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 75.340000000000003 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 72.109999999999999 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 74.25 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 73.030000000000001 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 73.200000000000003 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 65.150000000000006 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 71.219999999999999 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 72.519999999999996 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.452 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 74.540000000000006 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 72.120000000000005 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 74.349999999999994 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 73.120000000000005 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 74.030000000000001 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 61.420000000000002 111.289 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 54.140000000000001 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 75.439999999999998 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 74.019999999999996 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.592 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 74.310000000000002 113.066 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 75.209999999999994 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.887 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 74.409999999999997 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 52.420000000000002 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 72.430000000000007 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 75.329999999999998 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 54.119999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.430000000000007 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 71.430000000000007 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 73.329999999999998 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 75.450000000000003 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.524 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 72.219999999999999 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 72.209999999999994 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 74.530000000000001 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 71.049999999999997 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 72.530000000000001 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.628 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 72.200000000000003 111.376 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.483 HD11 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 63.539999999999999 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.569 ' HZ3' HD12 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 73.439999999999998 113.117 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.887 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 74.109999999999999 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 74.530000000000001 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.578 HD11 HD22 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.511 HD21 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 72.140000000000001 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 73.209999999999994 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 73.310000000000002 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 71.030000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.728 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.430000000000007 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 75.209999999999994 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 64.030000000000001 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 72.120000000000005 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 72.420000000000002 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.643 HD13 HD12 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.519999999999996 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 74.299999999999997 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 74.450000000000003 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.408 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 74.340000000000003 112.74 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 75.120000000000005 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 75.310000000000002 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 72.209999999999994 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 73.230000000000004 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.622 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.622 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 75.0 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD23 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 64.209999999999994 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 75.319999999999993 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 74.450000000000003 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 61.200000000000003 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 73.430000000000007 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 65.120000000000005 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 70.010000000000005 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 64.409999999999997 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 74.0 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 74.540000000000006 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 73.349999999999994 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 73.430000000000007 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 65.310000000000002 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 74.400000000000006 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 61.329999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 75.019999999999996 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 74.450000000000003 111.437 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 71.400000000000006 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.65 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 62.130000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 71.329999999999998 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 74.540000000000006 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.68 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 75.049999999999997 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD11 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.439999999999998 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 75.329999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.340000000000003 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG23 HD13 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 72.439999999999998 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 41.109999999999999 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 74.530000000000001 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.527 HG23 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 75.310000000000002 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 73.299999999999997 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD22 HG23 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 64.5 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 74.439999999999998 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 74.299999999999997 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 73.450000000000003 111.744 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.471 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 64.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.445 HD12 HG11 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 61.020000000000003 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 75.230000000000004 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 65.420000000000002 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 73.239999999999995 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.57 HD13 HG23 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 74.540000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.503 HD23 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.450000000000003 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 71.120000000000005 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 72.400000000000006 112.594 178.046 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 65.049999999999997 111.198 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 74.319999999999993 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 61.109999999999999 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 71.099999999999994 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 74.510000000000005 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 73.540000000000006 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.239999999999995 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 73.540000000000006 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 73.219999999999999 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.25 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 75.040000000000006 111.435 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.519999999999996 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 71.200000000000003 114.675 -170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 71.129999999999995 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 64.109999999999999 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 72.239999999999995 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.119999999999997 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 65.310000000000002 111.925 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 HD21 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 74.040000000000006 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.349999999999994 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 78' ' ' LEU . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 75.219999999999999 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.519999999999996 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 65.140000000000001 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.667 HD13 HD23 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 75.049999999999997 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.4 HD21 ' HG2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 71.099999999999994 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HG2' HD21 ' A' ' 59' ' ' ASN . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 73.439999999999998 112.443 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.749 ' HZ1' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 72.519999999999996 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.5 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 65.239999999999995 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 75.120000000000005 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 73.230000000000004 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 75.420000000000002 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.582 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 74.540000000000006 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.518 HG21 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 74.040000000000006 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.586 HD11 HD11 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 75.450000000000003 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD23 HD13 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 74.540000000000006 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 74.150000000000006 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 75.329999999999998 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 74.349999999999994 111.378 174.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 6' ' ' VAL . 17.1 m-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 75.549999999999997 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 65.010000000000005 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 72.340000000000003 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 71.239999999999995 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HZ1' ' HG3' ' A' ' 81' ' ' GLU . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 75.140000000000001 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 74.099999999999994 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 71.310000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 74.340000000000003 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 72.310000000000002 110.899 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.691 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.540000000000006 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 74.109999999999999 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.409999999999997 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.540000000000006 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 74.239999999999995 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 73.120000000000005 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 75.349999999999994 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 72.120000000000005 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 74.340000000000003 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 75.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 HD21 HD12 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.597 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 74.120000000000005 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 75.049999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 61' ' ' GLN . 2.8 p-10 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' ' 59' ' ' ASN . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 74.319999999999993 111.865 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 70.219999999999999 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 75.25 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 75.109999999999999 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 74.299999999999997 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.574 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 71.239999999999995 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 74.420000000000002 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HG3' ' HZ1' ' A' ' 17' ' ' LYS . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 73.450000000000003 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 75.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.319999999999993 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 73.239999999999995 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 75.129999999999995 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 72.239999999999995 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 74.340000000000003 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HZ1' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 71.129999999999995 112.179 175.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.340000000000003 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.25 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 75.319999999999993 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 74.340000000000003 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.691 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 72.239999999999995 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 65.430000000000007 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 73.400000000000006 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 75.109999999999999 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.439999999999998 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 74.140000000000001 110.18 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 73.439999999999998 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.430000000000007 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 73.439999999999998 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 75.420000000000002 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HE1' HD13 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 74.540000000000006 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.530000000000001 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 73.140000000000001 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 75.340000000000003 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 74.230000000000004 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 75.329999999999998 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.340000000000003 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.403 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 75.129999999999995 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 63.299999999999997 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 74.140000000000001 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.420000000000002 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 63.329999999999998 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 74.010000000000005 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.498 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 72.129999999999995 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.502 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 73.420000000000002 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.437 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 71.400000000000006 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.613 HD12 HD23 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 65.349999999999994 112.591 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 71.230000000000004 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 74.349999999999994 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 75.129999999999995 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.521 HD12 HG13 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 74.25 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' OE1' HG22 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.543 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.340000000000003 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 73.519999999999996 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.55 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 73.25 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 65.420000000000002 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.735 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.405 HD11 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.613 HD23 HD12 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 75.040000000000006 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 72.219999999999999 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HZ2' ' HB3' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 74.019999999999996 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 64.510000000000005 111.844 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 65.519999999999996 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.406 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 71.530000000000001 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 72.329999999999998 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 75.420000000000002 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 72.129999999999995 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 64.540000000000006 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 73.25 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 73.409999999999997 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 73.010000000000005 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 75.519999999999996 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 71.299999999999997 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.444 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 65.140000000000001 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 73.129999999999995 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.429 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 74.140000000000001 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 72.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.420000000000002 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 72.310000000000002 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 73.530000000000001 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 72.140000000000001 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.430000000000007 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.492 HD11 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD11 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 74.150000000000006 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.441 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 64.409999999999997 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 74.230000000000004 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 72.120000000000005 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.521 HD12 HD23 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.485 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 74.25 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 73.010000000000005 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 73.019999999999996 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 64.200000000000003 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.420000000000002 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 74.219999999999999 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 62.200000000000003 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 74.400000000000006 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.611 HD12 HD13 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 75.319999999999993 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 71.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 74.540000000000006 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.611 HD13 HD12 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 73.140000000000001 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 74.010000000000005 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 75.439999999999998 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 75.019999999999996 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 73.230000000000004 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 72.129999999999995 111.341 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 75.219999999999999 112.826 177.695 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 72.430000000000007 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 74.319999999999993 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.219999999999999 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.442 ' O ' HG21 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 74.230000000000004 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 74.219999999999999 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.526 ' HB ' HD12 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 74.349999999999994 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 75.230000000000004 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 73.519999999999996 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.575 ' HG ' HD12 ' A' ' 26' ' ' ILE . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 71.030000000000001 111.269 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 75.0 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 72.150000000000006 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.575 HD12 ' HG ' ' A' ' 21' ' ' SER . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 74.420000000000002 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.422 ' HE2' HG13 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 74.349999999999994 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 74.430000000000007 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 74.010000000000005 112.987 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 60.5 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 65.150000000000006 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 74.549999999999997 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 73.519999999999996 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 74.25 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 65.439999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.430000000000007 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.329999999999998 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.516 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 70.299999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 74.219999999999999 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 72.519999999999996 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.634 HD12 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 72.329999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 73.319999999999993 111.856 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 74.140000000000001 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG22 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 71.140000000000001 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.687 ' HD2' HD13 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 72.519999999999996 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.687 HD13 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 63.329999999999998 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.658 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.427 ' OE1' HG22 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 75.430000000000007 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 74.519999999999996 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 75.319999999999993 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 74.049999999999997 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD23 HD12 ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 75.319999999999993 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 HD12 HD23 ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 71.319999999999993 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 73.299999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.634 HD12 HD12 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.617 HD22 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 75.349999999999994 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.200000000000003 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 75.340000000000003 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 73.239999999999995 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.409999999999997 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.340000000000003 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 73.109999999999999 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 53.539999999999999 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 71.430000000000007 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 75.120000000000005 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 65.040000000000006 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 74.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 72.319999999999993 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 75.420000000000002 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 64.150000000000006 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 64.030000000000001 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 74.420000000000002 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 74.230000000000004 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 74.340000000000003 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 74.209999999999994 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 72.400000000000006 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 65.319999999999993 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.584 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 72.310000000000002 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 71.310000000000002 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 73.439999999999998 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 65.409999999999997 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 73.349999999999994 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 63.409999999999997 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 75.219999999999999 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 75.519999999999996 112.952 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 71.430000000000007 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.430000000000007 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 75.329999999999998 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.479 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 74.219999999999999 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 74.120000000000005 112.085 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 75.230000000000004 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.310000000000002 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 74.219999999999999 111.401 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 75.120000000000005 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 53.420000000000002 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 63.439999999999998 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.420000000000002 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 75.420000000000002 111.546 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 75.129999999999995 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.621 HD11 HD13 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 73.239999999999995 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 74.540000000000006 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 74.439999999999998 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD23 HD13 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 72.209999999999994 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 63.049999999999997 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 72.439999999999998 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.420000000000002 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 74.140000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 75.329999999999998 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.456 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.340000000000003 111.373 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 73.340000000000003 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 73.040000000000006 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 74.530000000000001 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 70.530000000000001 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 75.219999999999999 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 74.319999999999993 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 74.319999999999993 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.230000000000004 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 71.439999999999998 111.544 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 73.239999999999995 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 74.329999999999998 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.478 ' HE1' ' HG2' ' A' ' 25' ' ' GLU . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 72.329999999999998 111.805 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 52.329999999999998 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 73.239999999999995 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 71.319999999999993 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 74.129999999999995 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 74.319999999999993 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.400000000000006 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 72.340000000000003 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 74.099999999999994 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 61.140000000000001 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.477 HD11 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 71.340000000000003 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.466 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 74.010000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.595 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 74.340000000000003 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.733 HD11 HD22 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 64.239999999999995 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 60.420000000000002 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 65.400000000000006 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 71.239999999999995 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 73.409999999999997 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 75.450000000000003 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.540000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 63.340000000000003 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 73.430000000000007 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.44 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.619 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 75.329999999999998 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.455 HD11 HD23 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 72.140000000000001 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 71.400000000000006 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 74.530000000000001 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 62.520000000000003 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 HD12 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 72.329999999999998 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.310000000000002 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.733 HD22 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 74.310000000000002 112.119 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.583 ' HD3' HE21 ' A' ' 99' ' ' GLN . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.540000000000006 111.598 175.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.583 HE21 ' HD3' ' A' ' 97' ' ' LYS . 85.9 mm-40 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.031 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 73.540000000000006 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 75.200000000000003 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 73.329999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 65.340000000000003 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.437 ' NE2' HD12 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 74.109999999999999 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.64 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 75.450000000000003 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 73.239999999999995 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 75.120000000000005 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 72.340000000000003 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 73.420000000000002 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 73.400000000000006 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 64.450000000000003 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 75.319999999999993 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 74.239999999999995 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 72.349999999999994 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 71.420000000000002 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 63.149999999999999 111.54 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 74.239999999999995 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.518 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 72.439999999999998 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 72.140000000000001 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.64 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 75.129999999999995 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD13 HD22 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.2 OUTLIER -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 64.140000000000001 111.956 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.349999999999994 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 75.219999999999999 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 73.209999999999994 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 55.409999999999997 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 71.310000000000002 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 71.209999999999994 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 63.549999999999997 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 74.409999999999997 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 73.409999999999997 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 61.32 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.682 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 72.420000000000002 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 54.5 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 73.519999999999996 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.593 HD22 HD13 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 75.5 112.198 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . 0.437 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo . . . . . 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.87 0.366 . . . . 75.430000000000007 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.59 154.12 36.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 73.329999999999998 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 72.420000000000002 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 71.120000000000005 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 72.230000000000004 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 74.230000000000004 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 74.200000000000003 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.501 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 73.540000000000006 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 74.420000000000002 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 74.530000000000001 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 71.430000000000007 112.405 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 65.430000000000007 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 73.230000000000004 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 73.140000000000001 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 73.049999999999997 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 72.409999999999997 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 75.209999999999994 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 73.299999999999997 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 74.409999999999997 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG13 HD11 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.209999999999994 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 74.329999999999998 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.512 HD11 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD2' HD11 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 71.219999999999999 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.447 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.501 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 70.219999999999999 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.503 HG23 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.753 HD12 HD23 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 73.019999999999996 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 54.210000000000001 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 74.109999999999999 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 75.310000000000002 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 72.099999999999994 111.752 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 52.130000000000003 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 74.239999999999995 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 65.109999999999999 109.822 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.239999999999995 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 73.120000000000005 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 74.109999999999999 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.815 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 73.019999999999996 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 75.140000000000001 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.815 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.753 HD23 HD12 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 75.200000000000003 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.459 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 73.540000000000006 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.437 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo -68.4 -21.02 41.42 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 101' ' ' LEU . 1.5 pt? -130.77 108.9 10.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.167 0.508 . . . . 75.329999999999998 111.293 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.529 -0.748 . . . . 74.120000000000005 111.415 178.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HE1' HG21 ' A' ' 6' ' ' VAL . 24.2 ptt? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.86 0.362 . . . . 74.109999999999999 111.681 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 -63.9 156.58 27.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 55.32 112.516 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 HG21 ' HE1' ' A' ' 1' ' ' MET . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 75.239999999999995 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 72.120000000000005 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.499 HG21 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 72.219999999999999 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 73.519999999999996 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 73.219999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 81' ' ' GLU . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.43 111.604 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 37.799999999999997 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 72.129999999999995 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 73.239999999999995 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 73.129999999999995 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 71.219999999999999 111.289 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 75.430000000000007 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 73.0 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 65.420000000000002 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.439999999999998 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 75.510000000000005 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 73.230000000000004 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 74.409999999999997 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 64.420000000000002 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 74.230000000000004 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 75.420000000000002 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.439 HD13 HD23 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 75.209999999999994 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 75.109999999999999 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 73.450000000000003 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HD2' HG21 ' A' ' 12' ' ' ILE . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 64.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 73.409999999999997 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 62.140000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 74.319999999999993 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.472 HD12 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 74.299999999999997 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 72.450000000000003 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.473 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 75.049999999999997 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 71.420000000000002 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 64.040000000000006 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 54.439999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 73.120000000000005 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 75.0 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 74.450000000000003 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 75.400000000000006 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.420000000000002 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 61.450000000000003 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 71.329999999999998 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 73.040000000000006 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.310000000000002 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 17' ' ' LYS . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 73.5 111.332 175.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 74.329999999999998 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 64.530000000000001 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 74.329999999999998 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 73.430000000000007 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.4 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 74.340000000000003 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 75.019999999999996 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.472 HD21 HD12 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 75.120000000000005 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 75.040000000000006 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.499 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo -73.77 -16.91 23.33 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.12 135.09 42.95 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.473 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.35 0 CA-C-O 119.292 -0.385 . . . . 71.019999999999996 112.027 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.535 0.207 . . . . 75.299999999999997 111.188 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.02 143.02 28.0 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 72.219999999999999 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 74.209999999999994 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 74.140000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 73.040000000000006 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 24.2 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 73.430000000000007 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.755 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.579 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.579 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.409999999999997 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 74.510000000000005 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.66 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 75.329999999999998 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 71.549999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 63.32 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 74.209999999999994 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 73.239999999999995 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 70.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 72.450000000000003 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 75.209999999999994 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 73.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 73.219999999999999 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HD2' HD11 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.120000000000005 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' O ' HD21 ' A' ' 78' ' ' LEU . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.755 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.483 HD12 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 71.120000000000005 111.64 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 75.439999999999998 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 64.409999999999997 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 61.119999999999997 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 74.120000000000005 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.426 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 73.340000000000003 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.661 HD12 HD13 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 73.319999999999993 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 72.420000000000002 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.5 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG21 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 74.310000000000002 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 64.219999999999999 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.661 HD13 HD12 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 65.040000000000006 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 62.32 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.483 HD21 HD12 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 72.150000000000006 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 75.129999999999995 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 75.219999999999999 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.455 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.83 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.66 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo -72.66 35.21 0.33 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 101' ' ' LEU . 1.9 pt? -144.96 128.21 16.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.324 0.583 . . . . 74.430000000000007 111.695 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.646 -0.692 . . . . 73.120000000000005 111.091 177.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 73.239999999999995 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.435 ' O ' HG21 ' A' ' 6' ' ' VAL . 15.3 t70 -66.48 138.96 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.430000000000007 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 61.140000000000001 112.269 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 71.450000000000003 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 75.439999999999998 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 63.5 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 74.230000000000004 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 75.310000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.450000000000003 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 73.319999999999993 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 72.409999999999997 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 74.129999999999995 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 63.100000000000001 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 63.25 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 75.030000000000001 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.420000000000002 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.439999999999998 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 75.420000000000002 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 73.510000000000005 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 37.539999999999999 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 73.5 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 75.120000000000005 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 61.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 73.099999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.444 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.209999999999994 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 4.8 p-10 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 63.25 111.556 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 71.340000000000003 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 74.510000000000005 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 60.109999999999999 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 72.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 75.319999999999993 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.548 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 75.140000000000001 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 75.120000000000005 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 73.420000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 73.409999999999997 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 44.409999999999997 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.68 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 54.049999999999997 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 65.549999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 62.520000000000003 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.511 HD23 HD13 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 74.319999999999993 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.5 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.299999999999997 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo -81.41 18.37 1.35 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.58 -49.74 6.32 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.342 -0.39 . . . . 74.319999999999993 111.912 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.25 1.105 0 N-CA-C 112.276 0.472 . . . . 74.549999999999997 112.276 -174.28 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HE2' ' HA ' ' A' ' 6' ' ' VAL . 24.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.763 0.316 . . . . 64.239999999999995 111.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.7 157.46 24.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 1' ' ' MET . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' HG21 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 74.349999999999994 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 72.219999999999999 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HB ' HD12 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 73.299999999999997 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 73.319999999999993 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 72.340000000000003 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 73.510000000000005 111.493 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.541 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 72.120000000000005 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.541 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 74.030000000000001 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 63.299999999999997 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 27' ' ' ALA . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 74.430000000000007 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 74.099999999999994 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 70.340000000000003 113.997 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 74.299999999999997 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 63.140000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD12 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 74.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.52 ' HB3' HD13 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 55.450000000000003 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.704 HD12 HD22 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.418 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.209999999999994 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.458 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 70.019999999999996 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 71.299999999999997 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 72.5 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 64.25 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 75.540000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.349999999999994 111.257 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 74.040000000000006 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 72.0 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 73.209999999999994 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 75.099999999999994 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 72.150000000000006 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 75.409999999999997 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.59 ' HB2' ' HG3' ' A' ' 102' ' ' GLU . 3.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo -82.49 -64.36 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 75.120000000000005 113.383 176.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -81.14 -22.62 38.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.213 0.449 . . . . 71.310000000000002 112.213 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 99' ' ' GLN . 7.4 pt-20 . . . . . 0 C--O 1.254 1.303 0 N-CA-C 111.707 0.262 . . . . 62.210000000000001 111.707 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.5 0.19 . . . . 75.420000000000002 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.35 143.17 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 74.019999999999996 111.64 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 74.140000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 73.319999999999993 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 75.549999999999997 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG23 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 71.319999999999993 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.765 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 62.439999999999998 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 75.430000000000007 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.462 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 72.310000000000002 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD1' HG11 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 37.93 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 75.439999999999998 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 72.230000000000004 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 72.209999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 74.409999999999997 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 65.109999999999999 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 73.140000000000001 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 74.209999999999994 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 74.310000000000002 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 71.519999999999996 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 74.510000000000005 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 53.030000000000001 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 63.340000000000003 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 72.420000000000002 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 74.439999999999998 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 62.240000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 71.140000000000001 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 71.030000000000001 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 73.439999999999998 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.677 HD12 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 74.340000000000003 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 5.8 p-10 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 63.539999999999999 111.933 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 70.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.412 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 74.0 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 75.120000000000005 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 74.400000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 72.140000000000001 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.611 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 70.299999999999997 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 74.510000000000005 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 29.0 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 73.329999999999998 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 75.140000000000001 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 73.420000000000002 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.319999999999993 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 74.5 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.677 HD21 HD12 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.519999999999996 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 74.329999999999998 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 73.129999999999995 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.219999999999999 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 75.510000000000005 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.14 -24.61 79.56 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 101' ' ' LEU . 5.4 mp -88.65 31.26 0.85 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.279 -0.873 . . . . 75.5 110.594 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 113.181 0.808 . . . . 63.420000000000002 113.181 -176.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.629 -0.137 . . . . 74.219999999999999 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -62.9 128.27 35.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.420000000000002 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 74.530000000000001 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 75.140000000000001 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 60.229999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 73.219999999999999 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 73.430000000000007 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 74.219999999999999 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 73.409999999999997 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 74.030000000000001 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 74.420000000000002 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 64.420000000000002 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 70.150000000000006 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.439 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 73.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 73.329999999999998 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 65.299999999999997 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 72.109999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 74.209999999999994 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.329999999999998 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 75.5 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 74.049999999999997 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.439999999999998 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 74.540000000000006 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD11 HD21 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.200000000000003 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 74.200000000000003 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.483 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 75.340000000000003 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 75.019999999999996 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 74.200000000000003 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 37.310000000000002 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 75.230000000000004 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 75.230000000000004 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 72.140000000000001 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 65.420000000000002 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 63.229999999999997 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 74.209999999999994 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' HB3' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 74.010000000000005 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.749 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 71.340000000000003 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.746 HD11 HD12 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 63.210000000000001 111.9 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 74.450000000000003 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 63.32 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 75.230000000000004 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 72.109999999999999 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.746 HD12 HD11 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 75.030000000000001 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 72.519999999999996 111.278 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 74.209999999999994 112.697 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 74.349999999999994 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.130000000000003 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.13 -22.96 72.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 70.239999999999995 112.993 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.63 -171.57 2.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.546 0.338 . . . . 74.340000000000003 110.721 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.153 0 N-CA-C 112.069 0.396 . . . . 74.209999999999994 112.069 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.81 0.338 . . . . 73.209999999999994 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.05 155.62 40.34 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 75.239999999999995 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 75.030000000000001 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.409999999999997 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 75.049999999999997 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.140000000000001 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 74.109999999999999 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 71.340000000000003 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 73.409999999999997 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB2' HG23 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.531 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.524 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 74.430000000000007 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 75.340000000000003 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 73.510000000000005 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.409999999999997 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 74.040000000000006 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.507 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 72.010000000000005 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 65.409999999999997 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 73.239999999999995 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.51 HD11 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 74.439999999999998 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HD2' HD11 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 74.230000000000004 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.400000000000006 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.415 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 73.219999999999999 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.455 HD21 ' HB2' ' A' ' 61' ' ' GLN . 1.9 p-10 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.510000000000005 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' HD21 ' A' ' 59' ' ' ASN . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 71.019999999999996 112.115 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 62.340000000000003 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.567 HG21 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 75.129999999999995 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 110.064 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.25 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 75.230000000000004 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 61.5 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.728 HD12 HD12 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 74.239999999999995 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.209999999999994 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 44.030000000000001 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 75.340000000000003 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 75.150000000000006 114.612 -172.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 75.439999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.728 HD12 HD12 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 73.310000000000002 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 75.319999999999993 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 75.120000000000005 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.340000000000003 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.531 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo -62.5 -29.13 78.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 52.229999999999997 112.318 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.73 92.51 8.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.957 -0.565 . . . . 74.439999999999998 110.639 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.812 -0.613 . . . . 72.219999999999999 111.256 178.328 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.769 0.319 . . . . 71.299999999999997 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' HG21 ' A' ' 6' ' ' VAL . 7.5 m-20 -83.41 173.5 11.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 73.0 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 74.319999999999993 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 71.230000000000004 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.416 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 73.299999999999997 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 73.310000000000002 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 29' ' ' MET . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 74.200000000000003 111.409 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.517 ' HB ' HD12 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 72.430000000000007 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 61.240000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 75.299999999999997 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 75.409999999999997 110.592 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 72.530000000000001 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 75.349999999999994 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 74.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 74.439999999999998 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 74.150000000000006 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 71.239999999999995 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 75.299999999999997 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 72.040000000000006 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 51.539999999999999 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.484 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 74.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 74.409999999999997 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 71.340000000000003 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.444 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG21 HG23 ' A' ' 8' ' ' ILE . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 72.340000000000003 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 51.219999999999999 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.501 HD12 HD21 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 73.540000000000006 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 74.519999999999996 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 75.310000000000002 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD12 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 73.040000000000006 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.434 ' HB3' HD11 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 74.230000000000004 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.483 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 73.409999999999997 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.508 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 71.129999999999995 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 75.439999999999998 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 71.540000000000006 111.682 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 75.540000000000006 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 74.329999999999998 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 74.200000000000003 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 73.450000000000003 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 54.5 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.705 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 73.150000000000006 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 74.310000000000002 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 75.230000000000004 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 72.019999999999996 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 71.299999999999997 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 74.230000000000004 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 75.219999999999999 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 70.409999999999997 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 75.219999999999999 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 74.450000000000003 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 74.310000000000002 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 74.0 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 75.0 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.484 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo -57.46 -48.23 18.31 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -113.38 102.0 9.92 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.069 -0.514 . . . . 73.439999999999998 109.837 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 119.061 -0.495 . . . . 74.340000000000003 112.272 -177.192 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.205 0.446 . . . . 75.349999999999994 112.205 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 6' ' ' VAL . 16.0 t70 -173.99 128.07 0.38 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 73.530000000000001 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 75.430000000000007 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 74.120000000000005 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 75.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.5 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 74.129999999999995 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 72.230000000000004 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 72.409999999999997 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG13 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.210000000000001 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 72.230000000000004 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 73.319999999999993 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 42.140000000000001 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 75.099999999999994 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 73.400000000000006 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 61.130000000000003 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.510000000000005 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 60.340000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.515 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 63.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.140000000000001 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 73.209999999999994 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 74.5 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 72.430000000000007 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 75.0 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 62.030000000000001 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 70.200000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.432 ' HB3' HD11 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 74.109999999999999 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.468 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 74.439999999999998 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.563 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.519999999999996 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 75.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 71.239999999999995 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 73.310000000000002 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.549999999999997 111.557 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 73.019999999999996 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 71.219999999999999 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 75.409999999999997 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 63.25 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' HG3' HG13 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.633 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 75.340000000000003 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 72.109999999999999 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 74.25 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 73.030000000000001 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 73.200000000000003 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 65.150000000000006 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 71.219999999999999 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.565 HD13 HD11 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 72.519999999999996 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.452 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.452 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 74.540000000000006 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 72.120000000000005 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 74.349999999999994 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.21 6.12 5.28 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.66 91.9 2.09 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.325 0.583 . . . . 74.120000000000005 111.784 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.363 -0.827 . . . . 71.420000000000002 112.138 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HG3' ' HB2' ' A' ' 5' ' ' LEU . 16.8 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.066 -0.346 . . . . 65.549999999999997 110.066 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 54.63 33.25 18.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 166.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 73.120000000000005 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 74.030000000000001 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 61.420000000000002 111.289 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 54.140000000000001 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 75.439999999999998 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 74.019999999999996 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 111.592 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 74.310000000000002 113.066 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 75.209999999999994 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.887 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 74.409999999999997 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 52.420000000000002 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 72.430000000000007 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 75.329999999999998 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 54.119999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.430000000000007 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 71.430000000000007 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 73.329999999999998 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 75.450000000000003 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.524 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 72.219999999999999 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 72.209999999999994 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 74.530000000000001 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 71.049999999999997 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 72.530000000000001 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.628 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 72.200000000000003 111.376 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.483 HD11 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 63.539999999999999 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.569 ' HZ3' HD12 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 73.439999999999998 113.117 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.887 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 74.109999999999999 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 74.530000000000001 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.578 HD11 HD22 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.511 HD21 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 72.140000000000001 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.511 ' HB2' HD21 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 73.209999999999994 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 73.310000000000002 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 71.030000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 73.349999999999994 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.728 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.430000000000007 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 75.209999999999994 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 64.030000000000001 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 72.120000000000005 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 72.420000000000002 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 72.230000000000004 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.643 HD13 HD12 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD22 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.519999999999996 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 74.299999999999997 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.4 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 74.450000000000003 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.408 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo -61.59 -42.42 33.11 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 74.340000000000003 112.74 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -131.47 -66.55 0.72 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.372 -0.376 . . . . 75.209999999999994 111.089 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.044 -0.503 . . . . 61.219999999999999 111.978 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.774 0.321 . . . . 75.319999999999993 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -65.47 150.74 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 75.120000000000005 112.208 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 75.310000000000002 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 72.209999999999994 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 73.230000000000004 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.622 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.622 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 75.0 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.564 HD12 HD23 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 64.209999999999994 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 75.319999999999993 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 74.450000000000003 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 61.200000000000003 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 73.430000000000007 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 65.120000000000005 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 70.010000000000005 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 64.409999999999997 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 74.0 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 74.540000000000006 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.406 ' HB2' HG22 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 73.349999999999994 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 73.430000000000007 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 65.310000000000002 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 74.400000000000006 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 61.329999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 75.019999999999996 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 74.450000000000003 111.437 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 73.129999999999995 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 71.400000000000006 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.65 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 62.130000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 75.420000000000002 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 71.329999999999998 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 74.510000000000005 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 74.540000000000006 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.68 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 75.049999999999997 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD11 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.439999999999998 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 75.329999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.340000000000003 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG23 HD13 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.538 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 72.439999999999998 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 41.109999999999999 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 74.530000000000001 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.527 HG23 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 75.310000000000002 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 73.299999999999997 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD22 HG23 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 64.5 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.567 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 74.439999999999998 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 74.299999999999997 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 73.450000000000003 111.744 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.471 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 64.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.445 HD12 HG11 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 61.020000000000003 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG22 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 75.230000000000004 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 65.420000000000002 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 73.239999999999995 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.57 HD13 HG23 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 74.540000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.503 HD23 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.450000000000003 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 71.120000000000005 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -25.22 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 72.400000000000006 112.594 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 pp -163.28 -175.56 4.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.132 -0.485 . . . . 74.109999999999999 110.922 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.306 0 CA-C-O 118.689 -0.672 . . . . 74.430000000000007 111.121 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.71 0.291 . . . . 71.209999999999994 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 109.65 1.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 65.049999999999997 111.198 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 74.319999999999993 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 61.109999999999999 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.568 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 71.099999999999994 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.505 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 74.510000000000005 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 73.540000000000006 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.239999999999995 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 73.540000000000006 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 73.219999999999999 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.25 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 75.040000000000006 111.435 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.519999999999996 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 71.200000000000003 114.675 -170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 71.129999999999995 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 64.109999999999999 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 72.239999999999995 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.119999999999997 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 65.310000000000002 111.925 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.432 HD11 HD21 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 74.040000000000006 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.349999999999994 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 72.099999999999994 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.438 ' O ' HD21 ' A' ' 78' ' ' LEU . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 75.219999999999999 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.519999999999996 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 65.140000000000001 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.667 HD13 HD23 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 75.049999999999997 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.4 HD21 ' HG2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 71.099999999999994 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HG2' HD21 ' A' ' 59' ' ' ASN . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 73.439999999999998 112.443 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.749 ' HZ1' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 72.519999999999996 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.5 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 65.239999999999995 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 75.120000000000005 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 73.230000000000004 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 75.420000000000002 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.582 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 74.540000000000006 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.518 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.518 HG21 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 74.040000000000006 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.582 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.586 HD11 HD11 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 75.450000000000003 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD23 HD13 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 74.540000000000006 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 74.150000000000006 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 75.329999999999998 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.86 -43.15 21.27 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 74.349999999999994 111.378 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 ' N ' HD21 ' A' ' 101' ' ' LEU . 2.3 pt? -145.05 154.04 42.08 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.549 -0.75 . . . . 75.420000000000002 109.798 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 113.129 0.789 . . . . 71.450000000000003 113.129 -173.009 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.738 0.304 . . . . 74.530000000000001 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 6' ' ' VAL . 17.1 m-20 -69.99 129.55 39.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 -175.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 75.549999999999997 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 65.010000000000005 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG13 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 72.340000000000003 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 71.239999999999995 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HZ1' ' HG3' ' A' ' 81' ' ' GLU . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 75.140000000000001 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 74.099999999999994 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 71.310000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 74.340000000000003 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 72.310000000000002 110.899 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.691 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.540000000000006 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 74.109999999999999 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.409999999999997 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.540000000000006 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 74.239999999999995 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 73.120000000000005 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 75.349999999999994 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD12 HD21 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 72.120000000000005 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 74.340000000000003 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 75.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 HD21 HD12 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.597 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 74.120000000000005 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.597 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 75.049999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 61' ' ' GLN . 2.8 p-10 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' HB2' HD22 ' A' ' 59' ' ' ASN . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 74.319999999999993 111.865 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 70.219999999999999 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HZ3' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 75.25 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 75.109999999999999 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 74.299999999999997 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.574 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 71.239999999999995 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 74.420000000000002 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HG3' ' HZ1' ' A' ' 17' ' ' LYS . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 73.450000000000003 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 75.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.319999999999993 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.605 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 73.239999999999995 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 75.129999999999995 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 72.239999999999995 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 74.340000000000003 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' HZ1' ' HB3' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 71.129999999999995 112.179 175.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.340000000000003 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.25 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 75.319999999999993 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 74.340000000000003 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.691 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo -66.39 -9.24 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.56 5.2 32.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.925 -0.579 . . . . 71.540000000000006 111.601 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.256 1.426 0 CA-C-O 118.984 -0.531 . . . . 72.349999999999994 111.226 175.129 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.886 0.374 . . . . 75.340000000000003 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -68.78 152.34 45.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 72.239999999999995 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 65.430000000000007 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 73.400000000000006 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 75.109999999999999 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.439999999999998 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 74.140000000000001 110.18 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 73.439999999999998 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.430000000000007 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 73.439999999999998 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 75.420000000000002 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HE1' HD13 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 74.540000000000006 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.530000000000001 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 73.140000000000001 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 75.340000000000003 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 74.230000000000004 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 75.329999999999998 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.340000000000003 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 72.439999999999998 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.403 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 75.129999999999995 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 63.299999999999997 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 74.140000000000001 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.420000000000002 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 63.329999999999998 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 74.010000000000005 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.498 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 72.129999999999995 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.502 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 73.420000000000002 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.437 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 71.400000000000006 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.613 HD12 HD23 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 65.349999999999994 112.591 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 71.230000000000004 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 74.349999999999994 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 75.129999999999995 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD12 HG13 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 74.25 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.437 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' OE1' HG22 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.543 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.726 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.340000000000003 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 73.519999999999996 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.55 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 73.25 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 65.420000000000002 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.735 ' HZ3' ' HB3' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.405 HD11 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.613 HD23 HD12 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 75.040000000000006 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 72.219999999999999 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.589 ' HZ2' ' HB3' ' A' ' 97' ' ' LYS . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo -92.94 174.5 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 101' ' ' LEU . 6.1 mp -80.14 79.13 6.74 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.239 0.542 . . . . 71.540000000000006 110.048 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.603 -0.713 . . . . 72.209999999999994 112.257 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HE1' HG21 ' A' ' 6' ' ' VAL . 51.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.558 0.218 . . . . 72.329999999999998 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.73 152.49 18.77 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 -175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 74.019999999999996 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG21 ' HE1' ' A' ' 1' ' ' MET . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 64.510000000000005 111.844 179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 65.519999999999996 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.406 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 71.530000000000001 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 72.329999999999998 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 75.420000000000002 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 72.129999999999995 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 64.540000000000006 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 73.25 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 73.409999999999997 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 73.010000000000005 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 75.519999999999996 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 71.299999999999997 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 65.140000000000001 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 73.129999999999995 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.429 HG22 HG23 ' A' ' 8' ' ' ILE . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 74.140000000000001 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 72.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.420000000000002 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 72.310000000000002 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 73.530000000000001 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 72.140000000000001 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.430000000000007 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.492 HD11 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HD11 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 74.150000000000006 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.441 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 64.409999999999997 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 74.230000000000004 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 72.120000000000005 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.521 HD12 HD23 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 74.299999999999997 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.485 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 74.25 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 73.010000000000005 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 73.019999999999996 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 64.200000000000003 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.420000000000002 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 74.219999999999999 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 62.200000000000003 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 74.400000000000006 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.611 HD12 HD13 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 75.319999999999993 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 71.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.918 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.918 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 74.540000000000006 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.611 HD13 HD12 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 73.140000000000001 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 74.010000000000005 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 75.439999999999998 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 75.019999999999996 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 73.230000000000004 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 72.129999999999995 111.341 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.44 -10.94 30.38 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 75.219999999999999 112.826 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.2 mt -97.41 -0.36 46.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.329 -0.396 . . . . 72.219999999999999 111.903 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 119.066 -0.492 . . . . 71.140000000000001 112.205 -177.419 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.782 0.325 . . . . 72.209999999999994 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.33 156.16 37.42 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 72.430000000000007 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 74.319999999999993 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.219999999999999 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.442 ' O ' HG21 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 74.230000000000004 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 74.219999999999999 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.526 ' HB ' HD12 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 74.349999999999994 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 75.230000000000004 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 73.519999999999996 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.575 ' HG ' HD12 ' A' ' 26' ' ' ILE . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 71.030000000000001 111.269 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 75.0 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 72.150000000000006 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.575 HD12 ' HG ' ' A' ' 21' ' ' SER . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 74.420000000000002 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.422 ' HE2' HG13 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 74.349999999999994 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 74.430000000000007 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 74.010000000000005 112.987 -175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 60.5 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 65.150000000000006 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 74.549999999999997 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 73.519999999999996 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 74.25 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 65.439999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.430000000000007 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 HD12 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.329999999999998 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD2' HD11 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.516 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 70.299999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 74.219999999999999 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 72.519999999999996 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.634 HD12 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 72.329999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 73.319999999999993 111.856 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 74.140000000000001 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG22 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 71.140000000000001 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.687 ' HD2' HD13 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 72.519999999999996 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.687 HD13 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 63.329999999999998 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.658 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.427 ' OE1' HG22 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 75.430000000000007 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 74.519999999999996 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 75.319999999999993 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 74.049999999999997 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD23 HD12 ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 75.319999999999993 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 HD12 HD23 ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 71.319999999999993 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' HG2' HG21 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 73.299999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.634 HD12 HD12 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.617 HD22 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 75.349999999999994 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.200000000000003 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo -79.57 -7.56 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.04 101.26 0.26 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.465 0.543 . . . . 73.219999999999999 112.465 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.396 -0.335 . . . . 73.140000000000001 111.406 174.792 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.868 0.366 . . . . 74.239999999999995 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.57 148.42 48.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 75.340000000000003 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 73.239999999999995 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.409999999999997 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.340000000000003 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 73.109999999999999 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 53.539999999999999 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 71.430000000000007 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 75.120000000000005 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 65.040000000000006 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 74.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 73.319999999999993 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 72.319999999999993 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 75.420000000000002 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 64.150000000000006 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 74.099999999999994 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 64.030000000000001 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 74.420000000000002 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 74.230000000000004 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 74.340000000000003 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 74.209999999999994 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 72.400000000000006 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 65.319999999999993 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.584 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 72.310000000000002 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 71.310000000000002 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 73.439999999999998 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 65.409999999999997 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 73.349999999999994 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 63.409999999999997 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 75.120000000000005 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 75.219999999999999 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 75.519999999999996 112.952 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 71.430000000000007 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.430000000000007 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 75.329999999999998 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.479 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 74.219999999999999 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 74.120000000000005 112.085 -178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 75.230000000000004 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.310000000000002 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 74.219999999999999 111.401 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 75.120000000000005 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 53.420000000000002 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HA ' HG22 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 63.439999999999998 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.420000000000002 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 75.420000000000002 111.546 175.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 75.129999999999995 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.621 HD11 HD13 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.41 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 73.239999999999995 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 74.540000000000006 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 74.439999999999998 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD23 HD13 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 72.209999999999994 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 63.049999999999997 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.448 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 72.439999999999998 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.420000000000002 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo -73.37 -49.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.21 97.98 5.7 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.847 0.314 . . . . 74.420000000000002 111.847 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 114.282 1.216 . . . . 72.239999999999995 114.282 176.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.543 0.211 . . . . 71.409999999999997 111.267 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.2 150.9 16.68 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.5 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 74.140000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 75.329999999999998 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.456 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.340000000000003 111.373 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 73.340000000000003 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 73.040000000000006 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.595 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 74.530000000000001 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 70.530000000000001 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 75.219999999999999 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 74.319999999999993 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 74.319999999999993 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.230000000000004 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 71.439999999999998 111.544 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 73.239999999999995 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 74.329999999999998 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 71.109999999999999 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.478 ' HE1' ' HG2' ' A' ' 25' ' ' GLU . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 72.329999999999998 111.805 178.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 52.329999999999998 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 73.239999999999995 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 71.319999999999993 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 74.129999999999995 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 74.319999999999993 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.400000000000006 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 74.340000000000003 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 72.340000000000003 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.451 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 74.099999999999994 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 61.140000000000001 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.477 HD11 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 71.340000000000003 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.477 ' HD2' HD11 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.466 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 74.010000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.595 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 74.340000000000003 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.733 HD11 HD22 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 64.239999999999995 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 60.420000000000002 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 65.400000000000006 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 71.239999999999995 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 73.409999999999997 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 75.450000000000003 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.540000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 63.340000000000003 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 73.430000000000007 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 73.530000000000001 111.44 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.619 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 75.329999999999998 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.455 HD11 HD23 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 72.140000000000001 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 71.400000000000006 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 74.530000000000001 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 62.520000000000003 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.65 HD11 HD12 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 72.329999999999998 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.310000000000002 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.733 HD22 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 74.310000000000002 112.119 178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.583 ' HD3' HE21 ' A' ' 99' ' ' GLN . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.540000000000006 111.598 175.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.583 HE21 ' HD3' ' A' ' 97' ' ' LYS . 85.9 mm-40 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 72.120000000000005 111.031 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 11.05 1.04 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.5 mt -94.57 -10.28 32.55 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.349 -0.387 . . . . 74.329999999999998 111.604 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 112.206 0.447 . . . . 72.439999999999998 112.206 -175.788 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HE2' HG22 ' A' ' 6' ' ' VAL . 27.5 ttt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.832 0.349 . . . . 74.120000000000005 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.36 153.47 35.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 111.187 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 73.439999999999998 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 73.540000000000006 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 HG22 ' HE2' ' A' ' 1' ' ' MET . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 75.200000000000003 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 73.329999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 65.340000000000003 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.518 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' NE2' HD12 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 74.109999999999999 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.64 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 75.450000000000003 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 73.239999999999995 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 75.120000000000005 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 72.340000000000003 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 73.420000000000002 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 73.400000000000006 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 64.450000000000003 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 75.319999999999993 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 74.239999999999995 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 72.349999999999994 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 71.420000000000002 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 63.149999999999999 111.54 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 74.239999999999995 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.546 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.546 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.518 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 72.439999999999998 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 72.140000000000001 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.64 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 75.129999999999995 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD13 HD22 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.2 OUTLIER -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 64.140000000000001 111.956 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.349999999999994 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 75.219999999999999 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 73.209999999999994 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 55.409999999999997 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 71.310000000000002 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 71.209999999999994 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 63.549999999999997 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.528 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 72.109999999999999 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 74.409999999999997 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 73.409999999999997 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 61.32 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.682 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 72.420000000000002 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 54.5 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 73.519999999999996 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.593 HD22 HD13 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 95' ' ' LYS . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 75.5 112.198 -178.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . 0.437 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.852 ' HG3' ' HB2' ' A' ' 102' ' ' GLU . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo -91.5 -16.07 1.34 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp -160.19 23.2 0.16 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.577 0.584 . . . . 74.120000000000005 112.577 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.852 ' HB2' ' HG3' ' A' ' 99' ' ' GLN . 30.2 mm-40 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.942 -0.551 . . . . 73.040000000000006 111.176 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 63.409999999999997 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 64.530000000000001 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 61.329999999999998 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 71.310000000000002 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 71.540000000000006 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 72.040000000000006 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HE1' HD12 ' A' ' 43' ' ' LEU . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 61.539999999999999 112.405 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 62.450000000000003 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 63.229999999999997 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 53.43 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 71.239999999999995 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 73.219999999999999 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 61.350000000000001 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD12 ' HE1' ' A' ' 23' ' ' TYR . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.109999999999999 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 72.319999999999993 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.63 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 61.329999999999998 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.46 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.523 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 53.340000000000003 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 72.120000000000005 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 51.219999999999999 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 71.030000000000001 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 65.109999999999999 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 60.439999999999998 111.752 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 42.32 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 70.540000000000006 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 61.329999999999998 109.822 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.63 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.030000000000001 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 70.219999999999999 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 72.400000000000006 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 72.239999999999995 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.576 HG23 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 64.549999999999997 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 73.430000000000007 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 72.409999999999997 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.447 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 74.519999999999996 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 34.200000000000003 112.516 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 2' ' ' ASP . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 54.340000000000003 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 63.420000000000002 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 71.150000000000006 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 71.519999999999996 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 71.329999999999998 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 54.149999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 26' ' ' ILE . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.340000000000003 111.604 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 24.32 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 65.120000000000005 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 41.310000000000002 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 71.310000000000002 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 15' ' ' ILE . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 65.319999999999993 111.289 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 61.549999999999997 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 53.340000000000003 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 64.230000000000004 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.0 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 74.420000000000002 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 52.509999999999998 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 71.439999999999998 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 62.140000000000001 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 73.409999999999997 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 70.230000000000004 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 74.319999999999993 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 62.119999999999997 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 45.509999999999998 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 61.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 71.430000000000007 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 50.530000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 60.240000000000002 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.477 HD11 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 72.519999999999996 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 23.41 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 70.209999999999994 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 51.100000000000001 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 62.399999999999999 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 52.009999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 65.430000000000007 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 73.530000000000001 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 72.510000000000005 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.340000000000003 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 43.149999999999999 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 62.020000000000003 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.120000000000005 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 61.210000000000001 111.332 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 65.099999999999994 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 63.310000000000002 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 64.430000000000007 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 71.420000000000002 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 72.540000000000006 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 44.240000000000002 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 71.409999999999997 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.501 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo . . . . . 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 64.310000000000002 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 72.010000000000005 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 55.350000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 63.009999999999998 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.3 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 72.200000000000003 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.783 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.230000000000004 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 50.240000000000002 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.685 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 54.32 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 7' ' ' GLN . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 62.119999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 54.509999999999998 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 72.540000000000006 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 61.340000000000003 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 54.240000000000002 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.505 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 64.439999999999998 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 70.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 72.329999999999998 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.0 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.783 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 72.439999999999998 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 54.399999999999999 111.64 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 64.340000000000003 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 62.5 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 54.350000000000001 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 65.209999999999994 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD13 HD11 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.400000000000006 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 71.430000000000007 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 70.340000000000003 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG23 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 61.549999999999997 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.668 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 54.119999999999997 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 64.420000000000002 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 60.020000000000003 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 64.129999999999995 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 64.310000000000002 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 72.349999999999994 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ3' HD13 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 54.210000000000001 110.83 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.685 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo . . . . . 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 t70 . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.329999999999998 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 11' ' ' VAL . 88.4 mm-40 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 51.030000000000001 112.269 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 63.420000000000002 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 64.040000000000006 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 62.520000000000003 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 53.039999999999999 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 73.420000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.120000000000005 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 50.350000000000001 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.557 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 65.5 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 72.409999999999997 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 43.109999999999999 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 55.310000000000002 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 64.519999999999996 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 72.400000000000006 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.229999999999997 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.240000000000002 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 52' ' ' LEU . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 54.109999999999999 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 62.420000000000002 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 35.509999999999998 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 65.049999999999997 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 73.129999999999995 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 54.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 65.209999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.010000000000005 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.340000000000003 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 111.556 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 34.210000000000001 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 64.439999999999998 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 50.049999999999997 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 63.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 54.409999999999997 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 72.400000000000006 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 62.310000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 53.25 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 42.539999999999999 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 52.240000000000002 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 63.119999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.53 HD12 HD13 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 52.420000000000002 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.504 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.099999999999994 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo . . . . . 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 62.219999999999999 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 62.020000000000003 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 61.219999999999999 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 72.409999999999997 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 65.129999999999995 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 81' ' ' GLU . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 61.43 111.493 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 51.509999999999998 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 22' ' ' THR . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 54.439999999999998 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 53.219999999999999 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 73.519999999999996 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 63.310000000000002 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 71.319999999999993 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 64.140000000000001 113.997 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 72.530000000000001 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 60.100000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 64.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.482 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 53.409999999999997 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.010000000000005 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.46 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 63.43 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 32.520000000000003 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 72.099999999999994 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 61.109999999999999 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 70.420000000000002 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 50.210000000000001 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 74.400000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.340000000000003 111.257 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 70.319999999999993 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 64.019999999999996 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 71.239999999999995 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 52.240000000000002 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 70.140000000000001 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 61.210000000000001 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 70.120000000000005 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 71.099999999999994 113.383 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 70.450000000000003 111.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 73.030000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 64.310000000000002 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 54.310000000000002 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG22 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 54.130000000000003 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.813 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 34.119999999999997 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 70.0 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 65.120000000000005 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.434 ' CD1' HG12 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 35.539999999999999 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 70.319999999999993 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 65.099999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 62.399999999999999 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 63.130000000000003 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 71.409999999999997 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 54.340000000000003 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 71.540000000000006 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 52.240000000000002 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 63.409999999999997 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 33.240000000000002 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 62.43 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 55.329999999999998 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 52.5 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 54.420000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 64.219999999999999 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.648 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 44.020000000000003 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 51.119999999999997 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.813 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 62.149999999999999 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.717 HD11 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 72.209999999999994 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 55.240000000000002 111.933 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 64.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 72.510000000000005 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 55.530000000000001 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 72.329999999999998 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 72.040000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 70.340000000000003 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 64.450000000000003 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.648 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 65.430000000000007 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.5 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 64.219999999999999 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 64.349999999999994 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 72.239999999999995 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.6 HD12 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.450000000000003 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 71.230000000000004 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 64.519999999999996 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.129999999999995 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 73.129999999999995 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 55.5 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 74.510000000000005 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 50.119999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 70.530000000000001 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 60.450000000000003 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 52.420000000000002 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 72.329999999999998 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 64.439999999999998 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 55.329999999999998 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 53.030000000000001 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 62.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 44.229999999999997 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 63.329999999999998 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 64.219999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 70.129999999999995 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.150000000000006 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 74.010000000000005 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 65.040000000000006 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.229999999999997 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 64.120000000000005 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.129999999999995 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 61.43 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 62.240000000000002 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 61.009999999999998 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 73.299999999999997 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 64.400000000000006 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 32.109999999999999 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 53.530000000000001 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 72.109999999999999 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 63.310000000000002 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 45.140000000000001 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 62.0 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.603 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 71.340000000000003 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 53.439999999999998 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 62.119999999999997 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 61.219999999999999 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 43.119999999999997 111.9 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 62.109999999999999 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 62.140000000000001 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 63.340000000000003 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 71.530000000000001 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.742 HD11 HD13 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 74.319999999999993 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 64.099999999999994 111.278 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 73.409999999999997 112.697 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 61.32 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.009999999999998 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 63.32 112.993 -178.035 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 72.010000000000005 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 63.009999999999998 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.019999999999996 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 62.119999999999997 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 53.210000000000001 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 41.32 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.545 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 72.549999999999997 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 40.350000000000001 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 25.010000000000002 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.019999999999996 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 43.310000000000002 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 71.25 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 64.230000000000004 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 71.349999999999994 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 72.519999999999996 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.319999999999993 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 72.230000000000004 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.430000000000007 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 53.439999999999998 112.115 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 52.149999999999999 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.578 HG23 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 71.540000000000006 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 73.219999999999999 110.064 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.129999999999995 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 72.319999999999993 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' OE1' HG23 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 53.350000000000001 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 73.109999999999999 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.140000000000001 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 32.5 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 73.510000000000005 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 54.310000000000002 114.612 -172.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 64.329999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 73.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 70.120000000000005 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 64.530000000000001 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 74.019999999999996 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo . . . . . 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 51.140000000000001 112.318 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 6' ' ' VAL . 7.5 m-20 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 72.310000000000002 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 73.129999999999995 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 53.219999999999999 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 64.230000000000004 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 51.350000000000001 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 64.450000000000003 111.409 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 53.420000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 64.230000000000004 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' ILE . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 74.530000000000001 110.592 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 63.450000000000003 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 63.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 54.119999999999997 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 72.219999999999999 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 65.400000000000006 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 71.510000000000005 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 61.439999999999998 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 34.520000000000003 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 74.150000000000006 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.513 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 71.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 73.450000000000003 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 61.310000000000002 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 73.129999999999995 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.453 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 35' ' ' TYR . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 64.239999999999995 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 50.350000000000001 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 63.539999999999999 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 62.439999999999998 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 74.099999999999994 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 63.210000000000001 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.424 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 65.25 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 55.020000000000003 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.531 HH22 ' HA ' ' A' ' 17' ' ' LYS . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 53.539999999999999 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.667 HD11 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 63.210000000000001 111.682 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 74.120000000000005 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 73.519999999999996 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 73.140000000000001 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 54.229999999999997 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 45.030000000000001 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.76 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 62.310000000000002 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 52.210000000000001 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 70.319999999999993 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 45.549999999999997 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 54.25 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 72.519999999999996 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 71.420000000000002 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 53.43 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 61.229999999999997 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 70.209999999999994 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 62.450000000000003 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 72.5 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 55.219999999999999 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 73.019999999999996 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.513 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 16.0 t70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 63.200000000000003 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 74.329999999999998 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 73.310000000000002 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 73.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 54.219999999999999 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 62.039999999999999 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 63.200000000000003 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.200000000000003 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 60.43 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 43.219999999999999 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 41.32 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 73.510000000000005 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 43.009999999999998 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 55.009999999999998 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.329999999999998 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 43.520000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 34.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.129999999999995 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 24.329999999999998 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 70.239999999999995 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 63.049999999999997 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 64.409999999999997 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 61.329999999999998 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 61.25 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.446 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 63.520000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 63.310000000000002 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.57 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.150000000000006 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 62.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 64.430000000000007 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 71.329999999999998 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.150000000000006 111.557 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.512 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 70.120000000000005 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 51.520000000000003 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 74.319999999999993 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.512 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 52.350000000000001 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD13 HD11 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 35.009999999999998 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 64.310000000000002 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 72.019999999999996 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 62.140000000000001 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 54.210000000000001 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 55.0 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 73.099999999999994 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 53.420000000000002 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 70.530000000000001 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 70.109999999999999 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 53.109999999999999 111.289 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 44.329999999999998 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 74.019999999999996 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 54.240000000000002 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 52.130000000000003 111.592 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 65.420000000000002 113.066 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 73.120000000000005 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.901 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 71.140000000000001 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 31.039999999999999 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 71.129999999999995 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 74.200000000000003 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 42.549999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 70.519999999999996 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 61.5 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.533 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 60.420000000000002 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 71.400000000000006 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 70.540000000000006 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 45.0 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 71.209999999999994 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 71.219999999999999 111.376 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 53.340000000000003 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.604 ' HZ3' HD11 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.210000000000001 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 64.230000000000004 113.117 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.901 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 72.140000000000001 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 64.450000000000003 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.571 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.553 HD22 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 53.439999999999998 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.553 ' HB2' HD22 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 65.340000000000003 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 63.439999999999998 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 63.210000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 64.319999999999993 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.109999999999999 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 61.420000000000002 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 52.149999999999999 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 51.039999999999999 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 70.049999999999997 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 87' ' ' GLU . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.658 HD11 HD13 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.109999999999999 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 71.430000000000007 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 73.140000000000001 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.429 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 55.450000000000003 112.74 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 71.239999999999995 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 62.340000000000003 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 63.310000000000002 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 60.32 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.633 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 70.010000000000005 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.573 ' HB ' HD11 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 54.109999999999999 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 71.109999999999999 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 73.400000000000006 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 33.229999999999997 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 71.319999999999993 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 53.5 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 63.32 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 54.530000000000001 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 73.540000000000006 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 72.030000000000001 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 41.530000000000001 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 63.340000000000003 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 73.450000000000003 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 54.439999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 74.230000000000004 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 71.310000000000002 111.437 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 64.230000000000004 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 45.350000000000001 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 45.200000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 61.409999999999997 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 72.319999999999993 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 74.519999999999996 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.209999999999994 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 62.439999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.230000000000004 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.635 HG21 HD12 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 64.430000000000007 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 35.450000000000003 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.542 HG21 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 70.430000000000007 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 63.219999999999999 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 72.409999999999997 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' HG21 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 62.420000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 71.219999999999999 111.744 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 63.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 50.439999999999998 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 64.409999999999997 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.681 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 72.299999999999997 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.635 HD12 HG21 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 72.400000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.420000000000002 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 65.140000000000001 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 65.349999999999994 112.594 178.046 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 44.119999999999997 111.198 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 72.549999999999997 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 52.200000000000003 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 15' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 54.119999999999997 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 72.040000000000006 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 70.549999999999997 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.120000000000005 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 42.350000000000001 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 62.310000000000002 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.219999999999999 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 71.239999999999995 111.435 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.150000000000006 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 53.229999999999997 114.675 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 14.41 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 60.340000000000003 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 61.049999999999997 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.030000000000001 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 32.049999999999997 111.925 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 71.140000000000001 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 55.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 64.510000000000005 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HA ' HE21 ' A' ' 74' ' ' GLN . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 74.430000000000007 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.619 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.420000000000002 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 60.130000000000003 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 72.120000000000005 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 54.409999999999997 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 71.409999999999997 112.443 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 62.420000000000002 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 61.340000000000003 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 64.230000000000004 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 72.099999999999994 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 72.209999999999994 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 73.209999999999994 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 62.25 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.602 HD12 HD13 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 74.120000000000005 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 72.219999999999999 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 63.509999999999998 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 74.150000000000006 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 63.32 111.378 174.351 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 6' ' ' VAL . 17.1 m-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 71.209999999999994 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 42.439999999999998 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' ILE . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG11 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 53.210000000000001 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 62.439999999999998 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 62.329999999999998 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 65.430000000000007 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 64.420000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 71.140000000000001 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HA ' ' HE2' ' A' ' 29' ' ' MET . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 60.509999999999998 110.899 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.696 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 63.32 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.010000000000005 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 63.0 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 62.43 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 45.130000000000003 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 62.210000000000001 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 73.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.451 HD23 HD11 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 63.329999999999998 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.617 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 73.409999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.721 HD22 ' HB3' ' A' ' 63' ' ' LYS . 4.2 p30 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 63.140000000000001 111.865 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' HD22 ' A' ' 59' ' ' ASN . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 61.450000000000003 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.476 ' NZ ' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 63.439999999999998 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 64.420000000000002 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG3' HG21 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 65.010000000000005 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.585 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 63.399999999999999 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 73.349999999999994 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' HA2' ' A' ' 18' ' ' GLY . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 65.030000000000001 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 71.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.010000000000005 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.625 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 71.530000000000001 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 64.25 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 70.349999999999994 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 72.219999999999999 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 51.140000000000001 112.179 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.219999999999999 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.140000000000001 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 71.530000000000001 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.696 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 6' ' ' VAL . 36.7 m-20 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 62.520000000000003 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 61.240000000000002 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ASP . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 71.230000000000004 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 62.530000000000001 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.319999999999993 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ILE . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 55.340000000000003 110.18 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 71.409999999999997 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.409999999999997 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 50.539999999999999 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 55.229999999999997 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.340000000000003 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 64.200000000000003 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 64.439999999999998 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 73.310000000000002 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 54.43 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 73.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.319999999999993 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 62.350000000000001 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 42.100000000000001 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 61.509999999999998 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 73.319999999999993 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.140000000000001 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 53.43 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 63.409999999999997 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 63.109999999999999 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.509 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 72.340000000000003 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.448 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 64.140000000000001 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 61.32 112.591 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 60.219999999999999 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 61.439999999999998 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 64.510000000000005 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.54 HD11 HG11 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 73.129999999999995 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.428 ' OE1' HG23 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.310000000000002 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 52.450000000000003 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 62.32 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 54.43 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 63.43 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 70.409999999999997 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 72.200000000000003 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.844 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 61.32 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 65.230000000000004 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 71.319999999999993 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 74.019999999999996 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 61.229999999999997 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HB ' HH11 ' A' ' 56' ' ' ARG . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 63.539999999999999 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 65.519999999999996 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 72.030000000000001 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 64.239999999999995 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 72.150000000000006 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 62.340000000000003 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 62.149999999999999 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 71.040000000000006 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.239999999999995 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 73.319999999999993 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 71.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.209999999999994 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 62.009999999999998 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 71.340000000000003 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 62.409999999999997 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 73.219999999999999 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 61.100000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 61.149999999999999 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 63.009999999999998 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 73.010000000000005 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.486 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 55.109999999999999 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 63.219999999999999 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 61.310000000000002 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 62.32 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.219999999999999 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 73.209999999999994 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 61.219999999999999 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 71.230000000000004 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 65.430000000000007 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 64.420000000000002 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 64.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 70.510000000000005 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 72.400000000000006 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 72.140000000000001 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 71.120000000000005 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 62.210000000000001 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 72.209999999999994 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 64.430000000000007 111.341 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 74.219999999999999 112.826 177.695 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 63.530000000000001 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 64.420000000000002 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.200000000000003 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 4' ' ' PHE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 71.019999999999996 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 71.239999999999995 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 64.120000000000005 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 62.439999999999998 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 71.439999999999998 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 63.399999999999999 111.269 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 64.310000000000002 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 71.209999999999994 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.4 ' HE3' HG11 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 71.439999999999998 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 61.509999999999998 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' TYR . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 70.150000000000006 112.987 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 37' ' ' ARG . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 54.329999999999998 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 55.310000000000002 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 73.120000000000005 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 53.509999999999998 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 62.5 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 62.329999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.120000000000005 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 73.120000000000005 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 41.149999999999999 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 71.439999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 64.349999999999994 111.856 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 65.549999999999997 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 61.130000000000003 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.71 ' HD2' HD12 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 64.209999999999994 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.71 HD12 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 62.030000000000001 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.435 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 65.340000000000003 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 71.420000000000002 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 64.129999999999995 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 63.43 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 63.450000000000003 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.552 HG23 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 53.229999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 HD13 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 73.439999999999998 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.109999999999999 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 62.25 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.25 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.239999999999995 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 62.340000000000003 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 43.100000000000001 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 62.439999999999998 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 61.109999999999999 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 62.020000000000003 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 73.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 71.299999999999997 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 53.420000000000002 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 71.230000000000004 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 53.219999999999999 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 73.299999999999997 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 73.25 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 71.319999999999993 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 53.210000000000001 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 63.149999999999999 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 54.329999999999998 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 65.040000000000006 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 71.540000000000006 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 44.350000000000001 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 72.230000000000004 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 52.020000000000003 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 73.219999999999999 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 55.140000000000001 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 60.310000000000002 112.952 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 64.040000000000006 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.310000000000002 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 53.340000000000003 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 62.119999999999997 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 63' ' ' LYS . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 54.030000000000001 112.085 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 63.439999999999998 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.209999999999994 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HD21 ' A' ' 59' ' ' ASN . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 64' ' ' ILE . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 63.43 111.401 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 73.340000000000003 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 41.210000000000001 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 43.450000000000003 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.239999999999995 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 73' ' ' ARG . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 64.310000000000002 111.546 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 63.539999999999999 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.712 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 96' ' ' TYR . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 62.329999999999998 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 72.239999999999995 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 54.130000000000003 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 64.329999999999998 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 94' ' ' ARG . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.46 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 44.439999999999998 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 71.430000000000007 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.219999999999999 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 70.530000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 74.310000000000002 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.230000000000004 111.373 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 63.25 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 72.430000000000007 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 94.6 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.611 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 53.420000000000002 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 63.420000000000002 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 42.130000000000003 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 64.400000000000006 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.209999999999994 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 53.340000000000003 111.544 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 53.219999999999999 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 54.200000000000003 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 45.119999999999997 111.805 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 32.140000000000001 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 55.240000000000002 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 64.140000000000001 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 35.43 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 64.230000000000004 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 64.549999999999997 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 71.439999999999998 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 64.120000000000005 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 54.329999999999998 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 63.299999999999997 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.478 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 64.120000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.611 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 52.329999999999998 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD11 HD21 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 54.399999999999999 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 52.329999999999998 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 54.210000000000001 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 61.5 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 64.510000000000005 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 71.209999999999994 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.400000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 44.329999999999998 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 54.020000000000003 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 64.319999999999993 111.44 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.453 HD12 HD22 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 55.109999999999999 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.73 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 61.140000000000001 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 73.230000000000004 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 25.399999999999999 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.663 HD12 HD13 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 71.120000000000005 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.100000000000001 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 71.019999999999996 112.119 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.129999999999995 111.598 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 52.310000000000002 111.031 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.209999999999994 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 65.340000000000003 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 62.140000000000001 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 54.140000000000001 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 34.439999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 63.509999999999998 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' HD13 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 62.5 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.663 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 62.009999999999998 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.010000000000005 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 51.109999999999999 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 70.140000000000001 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 71.010000000000005 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 65.329999999999998 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 72.319999999999993 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 54.310000000000002 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 72.040000000000006 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 61.200000000000003 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 63.399999999999999 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 54.32 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 60.32 111.54 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 71.150000000000006 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 52.219999999999999 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 60.329999999999998 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.663 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 62.310000000000002 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 61.100000000000001 111.956 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.049999999999997 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 74.140000000000001 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 73.420000000000002 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 72.129999999999995 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 51.109999999999999 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 70.439999999999998 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 62.530000000000001 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 44.530000000000001 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 62.210000000000001 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 64.349999999999994 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 71.5 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 53.439999999999998 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 63.130000000000003 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 43.539999999999999 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.694 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 71.430000000000007 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 71.109999999999999 112.198 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo . . . . . 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.87 0.366 . . . . 75.430000000000007 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.59 154.12 36.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 63.409999999999997 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 64.530000000000001 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 61.329999999999998 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 71.310000000000002 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 71.540000000000006 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 72.040000000000006 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HE1' HD12 ' A' ' 43' ' ' LEU . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 61.539999999999999 112.405 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 62.450000000000003 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 63.229999999999997 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 53.43 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 71.239999999999995 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 73.219999999999999 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 61.350000000000001 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD12 ' HE1' ' A' ' 23' ' ' TYR . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.109999999999999 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 72.319999999999993 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.63 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 61.329999999999998 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.46 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.523 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 53.340000000000003 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 72.120000000000005 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 51.219999999999999 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 71.030000000000001 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 65.109999999999999 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 60.439999999999998 111.752 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 42.32 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 70.540000000000006 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 61.329999999999998 109.822 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.63 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.030000000000001 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 70.219999999999999 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 72.400000000000006 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 72.239999999999995 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.576 HG23 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 64.549999999999997 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 73.430000000000007 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 72.409999999999997 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.447 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 74.519999999999996 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo -68.4 -21.02 41.42 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.5 pt? -130.77 108.9 10.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.167 0.508 . . . . 70.329999999999998 111.293 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.529 -0.748 . . . . 72.230000000000004 111.415 178.937 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.86 0.362 . . . . 65.219999999999999 111.681 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 -63.9 156.58 27.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 34.200000000000003 112.516 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 2' ' ' ASP . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 54.340000000000003 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 63.420000000000002 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 71.150000000000006 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 71.519999999999996 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 71.329999999999998 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 54.149999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 26' ' ' ILE . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.340000000000003 111.604 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 24.32 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 65.120000000000005 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 41.310000000000002 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 71.310000000000002 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 15' ' ' ILE . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 65.319999999999993 111.289 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 61.549999999999997 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 53.340000000000003 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 64.230000000000004 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.0 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 74.420000000000002 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 52.509999999999998 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 71.439999999999998 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 62.140000000000001 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 73.409999999999997 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 70.230000000000004 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 74.319999999999993 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 62.119999999999997 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 45.509999999999998 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 61.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 71.430000000000007 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 50.530000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 60.240000000000002 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 HD11 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 72.519999999999996 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 23.41 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 70.209999999999994 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 51.100000000000001 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 62.399999999999999 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 52.009999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 65.430000000000007 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 73.530000000000001 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 72.510000000000005 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.340000000000003 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 43.149999999999999 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 62.020000000000003 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.120000000000005 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 61.210000000000001 111.332 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 65.099999999999994 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 63.310000000000002 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 64.430000000000007 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 71.420000000000002 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 72.540000000000006 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 44.240000000000002 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 71.409999999999997 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.501 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo -73.77 -16.91 23.33 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -134.12 135.09 42.95 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.473 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.35 0 CA-C-O 119.292 -0.385 . . . . 71.019999999999996 112.027 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.535 0.207 . . . . 75.299999999999997 111.188 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.02 143.02 28.0 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 64.310000000000002 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 72.010000000000005 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 55.350000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 63.009999999999998 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.3 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 72.200000000000003 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.783 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.230000000000004 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 50.240000000000002 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.685 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 54.32 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 7' ' ' GLN . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 62.119999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 54.509999999999998 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 72.540000000000006 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 61.340000000000003 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 54.240000000000002 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.505 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 64.439999999999998 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 70.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 72.329999999999998 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.0 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.783 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 72.439999999999998 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 54.399999999999999 111.64 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 64.340000000000003 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 62.5 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 54.350000000000001 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 65.209999999999994 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD13 HD11 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.400000000000006 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 71.430000000000007 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 70.340000000000003 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG23 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 61.549999999999997 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.668 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 54.119999999999997 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 64.420000000000002 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 60.020000000000003 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 64.129999999999995 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 64.310000000000002 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 72.349999999999994 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ3' HD13 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 54.210000000000001 110.83 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.685 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo -72.66 35.21 0.33 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 101' ' ' LEU . 1.9 pt? -144.96 128.21 16.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.324 0.583 . . . . 64.430000000000007 111.695 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.646 -0.692 . . . . 73.120000000000005 111.091 177.788 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 73.239999999999995 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 t70 -66.48 138.96 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.329999999999998 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 11' ' ' VAL . 88.4 mm-40 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 51.030000000000001 112.269 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 63.420000000000002 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 64.040000000000006 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 62.520000000000003 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 53.039999999999999 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 73.420000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.120000000000005 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 50.350000000000001 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 65.5 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 72.409999999999997 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 43.109999999999999 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 55.310000000000002 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 64.519999999999996 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 72.400000000000006 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.229999999999997 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.240000000000002 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 52' ' ' LEU . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 54.109999999999999 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 62.420000000000002 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 35.509999999999998 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 65.049999999999997 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 73.129999999999995 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 54.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 65.209999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.010000000000005 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.340000000000003 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 111.556 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 34.210000000000001 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 64.439999999999998 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 50.049999999999997 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 63.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 54.409999999999997 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 72.400000000000006 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 62.310000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 53.25 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 42.539999999999999 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 52.240000000000002 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 63.119999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.53 HD12 HD13 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 52.420000000000002 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.504 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.099999999999994 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo -81.41 18.37 1.35 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.58 -49.74 6.32 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.342 -0.39 . . . . 74.319999999999993 111.912 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.25 1.105 0 N-CA-C 112.276 0.472 . . . . 74.549999999999997 112.276 -174.28 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 5' ' ' LEU . 24.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.763 0.316 . . . . 64.239999999999995 111.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.7 157.46 24.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 1' ' ' MET . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 62.219999999999999 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 62.020000000000003 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 61.219999999999999 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 72.409999999999997 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 65.129999999999995 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 81' ' ' GLU . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 61.43 111.493 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 51.509999999999998 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 22' ' ' THR . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 54.439999999999998 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 53.219999999999999 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 73.519999999999996 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 63.310000000000002 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 71.319999999999993 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 64.140000000000001 113.997 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 72.530000000000001 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 60.100000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 64.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.482 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 53.409999999999997 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.010000000000005 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.46 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 63.43 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 32.520000000000003 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 72.099999999999994 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 61.109999999999999 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 70.420000000000002 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 50.210000000000001 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 74.400000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.340000000000003 111.257 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 70.319999999999993 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 64.019999999999996 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 71.239999999999995 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 52.240000000000002 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 70.140000000000001 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 61.210000000000001 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 70.120000000000005 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 102' ' ' GLU . 3.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo -82.49 -64.36 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 71.099999999999994 113.383 176.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.3 pt? -81.14 -22.62 38.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.213 0.449 . . . . 71.310000000000002 112.213 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 99' ' ' GLN . 7.4 pt-20 . . . . . 0 C--O 1.254 1.303 0 N-CA-C 111.707 0.262 . . . . 62.210000000000001 111.707 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.5 0.19 . . . . 75.420000000000002 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.35 143.17 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 70.450000000000003 111.64 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 73.030000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 64.310000000000002 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 54.310000000000002 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG22 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 54.130000000000003 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.813 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 34.119999999999997 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 70.0 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 65.120000000000005 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.434 ' CD1' HG12 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 35.539999999999999 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 70.319999999999993 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 65.099999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 62.399999999999999 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 63.130000000000003 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 71.409999999999997 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 54.340000000000003 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 71.540000000000006 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 52.240000000000002 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 63.409999999999997 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 33.240000000000002 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 62.43 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 55.329999999999998 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 52.5 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 54.420000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 64.219999999999999 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.648 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 44.020000000000003 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 51.119999999999997 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.813 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 62.149999999999999 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.717 HD11 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 72.209999999999994 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 55.240000000000002 111.933 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 64.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 72.510000000000005 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 55.530000000000001 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 72.329999999999998 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 72.040000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 70.340000000000003 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 64.450000000000003 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.648 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 65.430000000000007 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.5 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 64.219999999999999 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 64.349999999999994 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 72.239999999999995 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.6 HD12 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.450000000000003 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 71.230000000000004 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 64.519999999999996 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.129999999999995 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 73.129999999999995 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.14 -24.61 79.56 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 101' ' ' LEU . 5.4 mp -88.65 31.26 0.85 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.279 -0.873 . . . . 75.329999999999998 110.594 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 113.181 0.808 . . . . 63.420000000000002 113.181 -176.803 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.629 -0.137 . . . . 52.329999999999998 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -62.9 128.27 35.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 55.5 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 74.510000000000005 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 50.119999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 70.530000000000001 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 60.450000000000003 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 52.420000000000002 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 72.329999999999998 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 64.439999999999998 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 55.329999999999998 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 53.030000000000001 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 62.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 44.229999999999997 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 63.329999999999998 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 64.219999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 70.129999999999995 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.150000000000006 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 74.010000000000005 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 65.040000000000006 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.229999999999997 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 64.120000000000005 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.129999999999995 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 61.43 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 62.240000000000002 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 61.009999999999998 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 73.299999999999997 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 64.400000000000006 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 32.109999999999999 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 53.530000000000001 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 72.109999999999999 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 63.310000000000002 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 45.140000000000001 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 62.0 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.603 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 71.340000000000003 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 53.439999999999998 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 62.119999999999997 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 61.219999999999999 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 43.119999999999997 111.9 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 62.109999999999999 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 62.140000000000001 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 63.340000000000003 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 71.530000000000001 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.742 HD11 HD13 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 74.319999999999993 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 64.099999999999994 111.278 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 73.409999999999997 112.697 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 61.32 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.009999999999998 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.13 -22.96 72.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 63.32 112.993 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.63 -171.57 2.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.546 0.338 . . . . 63.119999999999997 110.721 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.153 0 N-CA-C 112.069 0.396 . . . . 74.209999999999994 112.069 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.81 0.338 . . . . 73.209999999999994 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.05 155.62 40.34 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 72.010000000000005 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 63.009999999999998 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.019999999999996 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 62.119999999999997 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 53.210000000000001 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 41.32 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.545 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 72.549999999999997 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 40.350000000000001 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 25.010000000000002 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.019999999999996 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 43.310000000000002 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 71.25 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 64.230000000000004 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 71.349999999999994 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 72.519999999999996 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.319999999999993 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 72.230000000000004 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.430000000000007 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 53.439999999999998 112.115 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 52.149999999999999 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.578 HG23 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 71.540000000000006 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 73.219999999999999 110.064 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.129999999999995 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 72.319999999999993 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' OE1' HG23 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 53.350000000000001 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 73.109999999999999 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.140000000000001 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 32.5 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 73.510000000000005 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 54.310000000000002 114.612 -172.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 64.329999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 73.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 70.120000000000005 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 64.530000000000001 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 74.019999999999996 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo -62.5 -29.13 78.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 51.140000000000001 112.318 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.73 92.51 8.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.957 -0.565 . . . . 73.040000000000006 110.639 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.812 -0.613 . . . . 72.099999999999994 111.256 178.328 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.769 0.319 . . . . 71.299999999999997 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 6' ' ' VAL . 7.5 m-20 -83.41 173.5 11.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 72.310000000000002 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 73.129999999999995 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 53.219999999999999 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 64.230000000000004 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 51.350000000000001 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 64.450000000000003 111.409 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 53.420000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 64.230000000000004 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' ILE . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 74.530000000000001 110.592 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 63.450000000000003 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 63.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 54.119999999999997 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 72.219999999999999 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 65.400000000000006 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 71.510000000000005 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 61.439999999999998 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 34.520000000000003 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 74.150000000000006 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.513 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 71.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 73.450000000000003 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 61.310000000000002 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 73.129999999999995 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.453 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 35' ' ' TYR . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 64.239999999999995 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 50.350000000000001 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 63.539999999999999 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 62.439999999999998 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 74.099999999999994 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 63.210000000000001 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.424 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 65.25 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 55.020000000000003 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.531 HH22 ' HA ' ' A' ' 17' ' ' LYS . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 53.539999999999999 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.667 HD11 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 63.210000000000001 111.682 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 74.120000000000005 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 73.519999999999996 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 73.140000000000001 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 54.229999999999997 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 45.030000000000001 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.76 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 62.310000000000002 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 52.210000000000001 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 70.319999999999993 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 45.549999999999997 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 54.25 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 72.519999999999996 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 71.420000000000002 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 53.43 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 61.229999999999997 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 70.209999999999994 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 62.450000000000003 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 72.5 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 55.219999999999999 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 73.019999999999996 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.513 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo -57.46 -48.23 18.31 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -113.38 102.0 9.92 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.069 -0.514 . . . . 64.450000000000003 109.837 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 119.061 -0.495 . . . . 73.340000000000003 112.272 -177.192 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 15.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.205 0.446 . . . . 73.049999999999997 112.205 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 16.0 t70 -173.99 128.07 0.38 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 63.200000000000003 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 74.329999999999998 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 73.310000000000002 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 73.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 54.219999999999999 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 62.039999999999999 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 63.200000000000003 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.200000000000003 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 60.43 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 43.219999999999999 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 41.32 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 73.510000000000005 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 43.009999999999998 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 55.009999999999998 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.329999999999998 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 43.520000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 34.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.129999999999995 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 24.329999999999998 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 70.239999999999995 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 63.049999999999997 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 64.409999999999997 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 61.329999999999998 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 61.25 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.446 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 63.520000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 63.310000000000002 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.57 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.150000000000006 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 62.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 64.430000000000007 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 71.329999999999998 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.150000000000006 111.557 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.512 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 70.120000000000005 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 51.520000000000003 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 74.319999999999993 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.512 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 52.350000000000001 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD13 HD11 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 35.009999999999998 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 64.310000000000002 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 72.019999999999996 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 62.140000000000001 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 54.210000000000001 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 55.0 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 73.099999999999994 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 53.420000000000002 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.21 6.12 5.28 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.66 91.9 2.09 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.325 0.583 . . . . 74.120000000000005 111.784 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.363 -0.827 . . . . 64.040000000000006 112.138 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' LEU . 16.8 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.066 -0.346 . . . . 65.549999999999997 110.066 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 54.63 33.25 18.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 166.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 70.530000000000001 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 70.109999999999999 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 53.109999999999999 111.289 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 44.329999999999998 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 74.019999999999996 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 54.240000000000002 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 52.130000000000003 111.592 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 65.420000000000002 113.066 -175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 73.120000000000005 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.901 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 71.140000000000001 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 31.039999999999999 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 71.129999999999995 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 74.200000000000003 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 42.549999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 70.519999999999996 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 61.5 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.533 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 60.420000000000002 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 71.400000000000006 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 70.540000000000006 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 45.0 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 71.209999999999994 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 71.219999999999999 111.376 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 53.340000000000003 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.604 ' HZ3' HD11 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.210000000000001 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 64.230000000000004 113.117 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.901 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 72.140000000000001 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 64.450000000000003 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.571 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.553 HD22 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 53.439999999999998 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.553 ' HB2' HD22 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 65.340000000000003 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 63.439999999999998 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 63.210000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 64.319999999999993 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.109999999999999 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 61.420000000000002 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 52.149999999999999 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 51.039999999999999 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 70.049999999999997 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 87' ' ' GLU . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.658 HD11 HD13 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.109999999999999 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 71.430000000000007 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 73.140000000000001 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.429 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo -61.59 -42.42 33.11 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 55.450000000000003 112.74 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -131.47 -66.55 0.72 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.372 -0.376 . . . . 75.209999999999994 111.089 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.044 -0.503 . . . . 61.219999999999999 111.978 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.774 0.321 . . . . 63.420000000000002 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -65.47 150.74 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 71.239999999999995 112.208 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 62.340000000000003 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 63.310000000000002 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 60.32 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.633 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 70.010000000000005 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.573 ' HB ' HD11 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 54.109999999999999 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 71.109999999999999 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 73.400000000000006 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 33.229999999999997 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 71.319999999999993 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 53.5 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 63.32 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 54.530000000000001 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 73.540000000000006 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 72.030000000000001 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 41.530000000000001 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 63.340000000000003 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 73.450000000000003 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 54.439999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 74.230000000000004 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 71.310000000000002 111.437 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 64.230000000000004 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 45.350000000000001 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 45.200000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 61.409999999999997 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 72.319999999999993 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 74.519999999999996 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.209999999999994 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 62.439999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.230000000000004 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.635 HG21 HD12 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 64.430000000000007 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 35.450000000000003 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.542 HG21 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 70.430000000000007 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 63.219999999999999 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 72.409999999999997 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' HG21 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 62.420000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 71.219999999999999 111.744 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 63.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 50.439999999999998 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 64.409999999999997 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.681 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 72.299999999999997 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.635 HD12 HG21 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 72.400000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.420000000000002 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 65.140000000000001 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -25.22 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 65.349999999999994 112.594 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 pp -163.28 -175.56 4.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.132 -0.485 . . . . 70.209999999999994 110.922 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.306 0 CA-C-O 118.689 -0.672 . . . . 74.430000000000007 111.121 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.71 0.291 . . . . 62.219999999999999 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 109.65 1.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 44.119999999999997 111.198 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 72.549999999999997 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 52.200000000000003 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 15' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 54.119999999999997 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 72.040000000000006 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 70.549999999999997 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.120000000000005 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 42.350000000000001 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 62.310000000000002 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.219999999999999 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 71.239999999999995 111.435 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.150000000000006 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 53.229999999999997 114.675 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 14.41 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 60.340000000000003 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 61.049999999999997 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.030000000000001 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 32.049999999999997 111.925 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 71.140000000000001 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 55.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 64.510000000000005 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HA ' HE21 ' A' ' 74' ' ' GLN . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 74.430000000000007 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.619 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.420000000000002 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 60.130000000000003 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 72.120000000000005 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 54.409999999999997 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 71.409999999999997 112.443 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 62.420000000000002 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 61.340000000000003 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 64.230000000000004 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 72.099999999999994 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 72.209999999999994 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 73.209999999999994 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 62.25 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.602 HD12 HD13 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 74.120000000000005 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 72.219999999999999 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 63.509999999999998 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 74.150000000000006 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.86 -43.15 21.27 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 63.32 111.378 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 101' ' ' LEU . 2.3 pt? -145.05 154.04 42.08 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.549 -0.75 . . . . 72.400000000000006 109.798 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 113.129 0.789 . . . . 71.150000000000006 113.129 -173.009 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.738 0.304 . . . . 72.219999999999999 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 6' ' ' VAL . 17.1 m-20 -69.99 129.55 39.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 -175.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 71.209999999999994 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 42.439999999999998 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' ILE . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG11 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 53.210000000000001 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 62.439999999999998 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 62.329999999999998 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 65.430000000000007 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 64.420000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 71.140000000000001 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HA ' ' HE2' ' A' ' 29' ' ' MET . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 60.509999999999998 110.899 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.696 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 63.32 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.010000000000005 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 63.0 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 62.43 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 45.130000000000003 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 62.210000000000001 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 73.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD23 HD11 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 63.329999999999998 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.617 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 73.409999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.721 HD22 ' HB3' ' A' ' 63' ' ' LYS . 4.2 p30 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 63.140000000000001 111.865 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.721 ' HB3' HD22 ' A' ' 59' ' ' ASN . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 61.450000000000003 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' NZ ' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 63.439999999999998 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 64.420000000000002 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG3' HG21 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 65.010000000000005 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.585 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 63.399999999999999 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 73.349999999999994 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' HA2' ' A' ' 18' ' ' GLY . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 65.030000000000001 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 71.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.010000000000005 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.625 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 71.530000000000001 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 64.25 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 70.349999999999994 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 72.219999999999999 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 51.140000000000001 112.179 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.219999999999999 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.140000000000001 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 71.530000000000001 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.696 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo -66.39 -9.24 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.56 5.2 32.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.925 -0.579 . . . . 70.200000000000003 111.601 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.256 1.426 0 CA-C-O 118.984 -0.531 . . . . 63.399999999999999 111.226 175.129 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.886 0.374 . . . . 73.109999999999999 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 6' ' ' VAL . 36.7 m-20 -68.78 152.34 45.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 62.520000000000003 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 61.240000000000002 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ASP . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 71.230000000000004 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 62.530000000000001 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.319999999999993 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ILE . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 55.340000000000003 110.18 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 71.409999999999997 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.409999999999997 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 50.539999999999999 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 55.229999999999997 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.340000000000003 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 64.200000000000003 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 64.439999999999998 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 73.310000000000002 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 54.43 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 73.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.319999999999993 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 62.350000000000001 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 42.100000000000001 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 61.509999999999998 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 73.319999999999993 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.140000000000001 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 53.43 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 63.409999999999997 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 63.109999999999999 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.509 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 72.340000000000003 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.448 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 64.140000000000001 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 61.32 112.591 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 60.219999999999999 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 61.439999999999998 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 64.510000000000005 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.54 HD11 HG11 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 73.129999999999995 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.428 ' OE1' HG23 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.310000000000002 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 52.450000000000003 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 62.32 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 54.43 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 63.43 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 70.409999999999997 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo -92.94 174.5 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 101' ' ' LEU . 6.1 mp -80.14 79.13 6.74 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.239 0.542 . . . . 71.540000000000006 110.048 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.603 -0.713 . . . . 72.209999999999994 112.257 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.558 0.218 . . . . 72.329999999999998 110.577 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.73 152.49 18.77 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 -175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 72.200000000000003 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.844 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 61.32 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 65.230000000000004 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 71.319999999999993 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 74.019999999999996 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 61.229999999999997 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HB ' HH11 ' A' ' 56' ' ' ARG . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 63.539999999999999 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 65.519999999999996 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 72.030000000000001 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 64.239999999999995 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 72.150000000000006 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 62.340000000000003 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 62.149999999999999 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 71.040000000000006 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.239999999999995 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 73.319999999999993 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 71.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.209999999999994 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 62.009999999999998 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 71.340000000000003 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 62.409999999999997 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 73.219999999999999 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 61.100000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 61.149999999999999 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 63.009999999999998 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 73.010000000000005 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.486 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 55.109999999999999 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 63.219999999999999 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 61.310000000000002 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 62.32 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.219999999999999 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 73.209999999999994 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 61.219999999999999 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 71.230000000000004 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 65.430000000000007 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 64.420000000000002 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 64.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 70.510000000000005 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 72.400000000000006 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 72.140000000000001 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 71.120000000000005 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 62.210000000000001 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 72.209999999999994 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 64.430000000000007 111.341 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.44 -10.94 30.38 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 74.219999999999999 112.826 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.2 mt -97.41 -0.36 46.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 111.903 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 99' ' ' GLN . 7.9 mm-40 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 119.066 -0.492 . . . . 55.43 112.205 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.782 0.325 . . . . 64.310000000000002 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.33 156.16 37.42 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 63.530000000000001 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 64.420000000000002 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.200000000000003 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 4' ' ' PHE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 71.019999999999996 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 71.239999999999995 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 64.120000000000005 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 62.439999999999998 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 71.439999999999998 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 63.399999999999999 111.269 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 64.310000000000002 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 71.209999999999994 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.4 ' HE3' HG11 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 71.439999999999998 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 61.509999999999998 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' TYR . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 70.150000000000006 112.987 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 37' ' ' ARG . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 54.329999999999998 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 55.310000000000002 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 73.120000000000005 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 53.509999999999998 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 62.5 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 62.329999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.120000000000005 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 73.120000000000005 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 41.149999999999999 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 71.439999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 64.349999999999994 111.856 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 65.549999999999997 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 61.130000000000003 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.71 ' HD2' HD12 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 64.209999999999994 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.71 HD12 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 62.030000000000001 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.435 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 65.340000000000003 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 71.420000000000002 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 64.129999999999995 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 63.43 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 63.450000000000003 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.552 HG23 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 53.229999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 HD13 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 73.439999999999998 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.109999999999999 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo -79.57 -7.56 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.04 101.26 0.26 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.465 0.543 . . . . 73.219999999999999 112.465 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.396 -0.335 . . . . 73.140000000000001 111.406 174.792 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.868 0.366 . . . . 71.310000000000002 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.57 148.42 48.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 62.25 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.25 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.239999999999995 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 62.340000000000003 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 43.100000000000001 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 62.439999999999998 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 61.109999999999999 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 62.020000000000003 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 73.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 71.299999999999997 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 53.420000000000002 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 71.230000000000004 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 53.219999999999999 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 73.299999999999997 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 73.25 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 71.319999999999993 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 53.210000000000001 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 63.149999999999999 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 54.329999999999998 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 65.040000000000006 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 71.540000000000006 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 44.350000000000001 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 72.230000000000004 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 52.020000000000003 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 73.219999999999999 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 55.140000000000001 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 60.310000000000002 112.952 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 64.040000000000006 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.310000000000002 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 53.340000000000003 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 62.119999999999997 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 63' ' ' LYS . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 54.030000000000001 112.085 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 63.439999999999998 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.209999999999994 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HD21 ' A' ' 59' ' ' ASN . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 64' ' ' ILE . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 63.43 111.401 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 73.340000000000003 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 41.210000000000001 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 43.450000000000003 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.239999999999995 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 73' ' ' ARG . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 64.310000000000002 111.546 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 63.539999999999999 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.712 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 96' ' ' TYR . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 62.329999999999998 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 72.239999999999995 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 54.130000000000003 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 64.329999999999998 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 94' ' ' ARG . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.46 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 44.439999999999998 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 71.430000000000007 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.219999999999999 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo -73.37 -49.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.21 97.98 5.7 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.847 0.314 . . . . 64.140000000000001 111.847 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 114.282 1.216 . . . . 55.509999999999998 114.282 176.484 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.543 0.211 . . . . 63.200000000000003 111.267 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.2 150.9 16.68 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 70.530000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 74.310000000000002 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.230000000000004 111.373 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 63.25 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 72.430000000000007 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 94.6 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.611 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 53.420000000000002 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 63.420000000000002 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 42.130000000000003 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 64.400000000000006 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.209999999999994 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 53.340000000000003 111.544 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 53.219999999999999 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 54.200000000000003 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 45.119999999999997 111.805 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 32.140000000000001 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 55.240000000000002 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 64.140000000000001 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 35.43 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 64.230000000000004 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 64.549999999999997 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 71.439999999999998 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 64.120000000000005 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 54.329999999999998 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 63.299999999999997 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.478 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 64.120000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.611 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 52.329999999999998 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD11 HD21 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 54.399999999999999 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 52.329999999999998 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 54.210000000000001 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 61.5 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 64.510000000000005 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 71.209999999999994 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.400000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 44.329999999999998 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 54.020000000000003 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 64.319999999999993 111.44 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.453 HD12 HD22 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 55.109999999999999 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.73 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 61.140000000000001 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 73.230000000000004 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 25.399999999999999 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.663 HD12 HD13 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 71.120000000000005 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.100000000000001 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 71.019999999999996 112.119 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.129999999999995 111.598 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 52.310000000000002 111.031 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 11.05 1.04 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.5 mt -94.57 -10.28 32.55 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.349 -0.387 . . . . 74.329999999999998 111.604 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 112.206 0.447 . . . . 72.439999999999998 112.206 -175.788 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.832 0.349 . . . . 45.210000000000001 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.36 153.47 35.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.209999999999994 111.187 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 65.340000000000003 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 62.140000000000001 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 54.140000000000001 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 34.439999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 63.509999999999998 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' HD13 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 62.5 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.663 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 62.009999999999998 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.010000000000005 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 51.109999999999999 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 70.140000000000001 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 71.010000000000005 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 65.329999999999998 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 72.319999999999993 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 54.310000000000002 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 72.040000000000006 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 61.200000000000003 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 63.399999999999999 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 54.32 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 60.32 111.54 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 71.150000000000006 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 52.219999999999999 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 60.329999999999998 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.663 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 62.310000000000002 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 61.100000000000001 111.956 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.049999999999997 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 74.140000000000001 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 73.420000000000002 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 72.129999999999995 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 51.109999999999999 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 70.439999999999998 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 62.530000000000001 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 44.530000000000001 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 62.210000000000001 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 64.349999999999994 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 71.5 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 53.439999999999998 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 63.130000000000003 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 43.539999999999999 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.694 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 71.430000000000007 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 71.109999999999999 112.198 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.88 ' HG3' ' HB2' ' A' ' 102' ' ' GLU . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo -91.5 -16.07 1.34 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp -160.19 23.2 0.16 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.577 0.584 . . . . 74.120000000000005 112.577 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.88 ' HB2' ' HG3' ' A' ' 99' ' ' GLN . 30.2 mm-40 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.942 -0.551 . . . . 73.040000000000006 111.176 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 63.409999999999997 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 64.530000000000001 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 61.329999999999998 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 71.310000000000002 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 71.540000000000006 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 72.040000000000006 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HE1' HD12 ' A' ' 43' ' ' LEU . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 61.539999999999999 112.405 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 62.450000000000003 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 63.229999999999997 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 53.43 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 71.239999999999995 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 73.219999999999999 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 61.350000000000001 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD12 ' HE1' ' A' ' 23' ' ' TYR . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.109999999999999 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 72.319999999999993 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.63 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 61.329999999999998 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.46 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.523 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 53.340000000000003 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 72.120000000000005 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 51.219999999999999 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 71.030000000000001 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 65.109999999999999 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 60.439999999999998 111.752 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 42.32 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 70.540000000000006 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 61.329999999999998 109.822 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.63 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.030000000000001 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 70.219999999999999 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 72.400000000000006 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 72.239999999999995 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.576 HG23 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 64.549999999999997 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 73.430000000000007 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 72.409999999999997 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.447 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 74.519999999999996 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 34.200000000000003 112.516 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 2' ' ' ASP . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 54.340000000000003 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 63.420000000000002 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 71.150000000000006 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 71.519999999999996 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 71.329999999999998 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 54.149999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 26' ' ' ILE . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.340000000000003 111.604 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 24.32 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 65.120000000000005 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 41.310000000000002 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 71.310000000000002 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 15' ' ' ILE . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 65.319999999999993 111.289 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 61.549999999999997 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 53.340000000000003 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 64.230000000000004 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.0 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 74.420000000000002 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 52.509999999999998 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 71.439999999999998 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 62.140000000000001 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 73.409999999999997 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 70.230000000000004 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 74.319999999999993 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 62.119999999999997 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 45.509999999999998 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 61.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 71.430000000000007 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 50.530000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 60.240000000000002 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.477 HD11 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 72.519999999999996 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 23.41 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 70.209999999999994 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 51.100000000000001 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 62.399999999999999 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 52.009999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 65.430000000000007 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 73.530000000000001 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 72.510000000000005 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.340000000000003 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 43.149999999999999 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 62.020000000000003 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.120000000000005 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 61.210000000000001 111.332 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 65.099999999999994 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 63.310000000000002 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 64.430000000000007 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 71.420000000000002 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 72.540000000000006 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 44.240000000000002 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 71.409999999999997 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.501 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo . . . . . 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 64.310000000000002 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 72.010000000000005 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 55.350000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 63.009999999999998 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 24.2 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 72.200000000000003 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.783 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.230000000000004 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 50.240000000000002 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.685 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 54.32 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 7' ' ' GLN . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 62.119999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 54.509999999999998 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 72.540000000000006 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 61.340000000000003 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 54.240000000000002 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.505 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 64.439999999999998 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 70.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 72.329999999999998 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.0 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.783 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 72.439999999999998 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 54.399999999999999 111.64 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 64.340000000000003 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 62.5 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 54.350000000000001 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 65.209999999999994 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.657 HD13 HD11 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.400000000000006 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 71.430000000000007 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 70.340000000000003 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.526 HG23 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 61.549999999999997 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.668 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 54.119999999999997 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 64.420000000000002 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 60.020000000000003 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 64.129999999999995 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 64.310000000000002 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 72.349999999999994 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ3' HD13 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 54.210000000000001 110.83 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.685 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo . . . . . 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 t70 . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.329999999999998 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.6 mm100 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 51.030000000000001 112.269 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 63.420000000000002 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 64.040000000000006 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 62.520000000000003 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 53.039999999999999 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 73.420000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.120000000000005 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 50.350000000000001 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.557 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 65.5 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 72.409999999999997 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 43.109999999999999 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 55.310000000000002 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 64.519999999999996 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 72.400000000000006 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.229999999999997 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.240000000000002 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 52' ' ' LEU . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 54.109999999999999 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 62.420000000000002 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 35.509999999999998 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 65.049999999999997 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 73.129999999999995 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 54.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 65.209999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.010000000000005 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.340000000000003 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 4.8 p-10 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 111.556 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 34.210000000000001 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 64.439999999999998 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 50.049999999999997 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 63.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 54.409999999999997 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 72.400000000000006 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 62.310000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 53.25 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 42.539999999999999 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 52.240000000000002 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 63.119999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.53 HD12 HD13 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 52.420000000000002 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.504 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.099999999999994 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo . . . . . 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 62.219999999999999 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 62.020000000000003 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 61.219999999999999 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 72.409999999999997 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 65.129999999999995 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 81' ' ' GLU . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 61.43 111.493 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 51.509999999999998 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 22' ' ' THR . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 54.439999999999998 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 53.219999999999999 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 73.519999999999996 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 63.310000000000002 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 71.319999999999993 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 64.140000000000001 113.997 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 72.530000000000001 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 60.100000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 64.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.482 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 53.409999999999997 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.010000000000005 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.46 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 63.43 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 32.520000000000003 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 72.099999999999994 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 61.109999999999999 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 70.420000000000002 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 50.210000000000001 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 74.400000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.340000000000003 111.257 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 70.319999999999993 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 64.019999999999996 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 71.239999999999995 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 52.240000000000002 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 70.140000000000001 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 61.210000000000001 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 70.120000000000005 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo . . . . . 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 71.099999999999994 113.383 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 70.450000000000003 111.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 73.030000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 64.310000000000002 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HA ' HE21 ' A' ' 14' ' ' GLN . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 54.310000000000002 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 11' ' ' VAL . 50.8 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG22 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 54.130000000000003 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.813 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 34.119999999999997 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 70.0 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 65.120000000000005 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.434 ' CD1' HG12 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 35.539999999999999 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 70.319999999999993 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 65.099999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 62.399999999999999 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 63.130000000000003 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 71.409999999999997 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 54.340000000000003 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 71.540000000000006 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 52.240000000000002 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 63.409999999999997 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 33.240000000000002 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 62.43 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 55.329999999999998 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 52.5 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 54.420000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 64.219999999999999 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.648 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 44.020000000000003 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 51.119999999999997 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.813 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 62.149999999999999 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.717 HD11 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 72.209999999999994 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 5.8 p-10 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 55.240000000000002 111.933 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 64.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.408 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 72.510000000000005 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 55.530000000000001 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 72.329999999999998 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 72.040000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 70.340000000000003 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 64.450000000000003 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.648 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 65.430000000000007 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 29.0 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 64.219999999999999 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 64.349999999999994 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 72.239999999999995 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.6 HD12 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.450000000000003 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 71.230000000000004 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 64.519999999999996 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.129999999999995 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 73.129999999999995 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 55.5 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 74.510000000000005 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 50.119999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 70.530000000000001 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 60.450000000000003 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 52.420000000000002 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 72.329999999999998 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 64.439999999999998 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 55.329999999999998 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 53.030000000000001 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 62.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 44.229999999999997 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 63.329999999999998 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 64.219999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 70.129999999999995 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.150000000000006 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 74.010000000000005 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 65.040000000000006 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.229999999999997 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 64.120000000000005 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.129999999999995 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 61.43 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 62.240000000000002 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 61.009999999999998 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 73.299999999999997 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 64.400000000000006 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 32.109999999999999 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 53.530000000000001 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 72.109999999999999 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 63.310000000000002 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 45.140000000000001 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 62.0 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.603 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 71.340000000000003 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 53.439999999999998 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 62.119999999999997 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 61.219999999999999 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 43.119999999999997 111.9 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 62.109999999999999 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 62.140000000000001 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 63.340000000000003 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 71.530000000000001 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.742 HD11 HD13 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 74.319999999999993 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 64.099999999999994 111.278 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 73.409999999999997 112.697 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 61.32 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.009999999999998 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 63.32 112.993 -178.035 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 72.010000000000005 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 63.009999999999998 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.019999999999996 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 62.119999999999997 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 53.210000000000001 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 41.32 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.545 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 72.549999999999997 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 40.350000000000001 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 25.010000000000002 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.019999999999996 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 43.310000000000002 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 71.25 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 64.230000000000004 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 71.349999999999994 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 72.519999999999996 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.319999999999993 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 72.230000000000004 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.487 HD22 ' HB2' ' A' ' 61' ' ' GLN . 1.9 p-10 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.430000000000007 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB2' HD22 ' A' ' 59' ' ' ASN . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 53.439999999999998 112.115 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 52.149999999999999 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.578 HG23 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 71.540000000000006 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 73.219999999999999 110.064 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.129999999999995 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 72.319999999999993 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' OE1' HG23 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 53.350000000000001 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 73.109999999999999 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.140000000000001 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 32.5 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 73.510000000000005 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 54.310000000000002 114.612 -172.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 64.329999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 73.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 70.120000000000005 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 64.530000000000001 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 74.019999999999996 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo . . . . . 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 51.140000000000001 112.318 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 6' ' ' VAL . 7.5 m-20 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 72.310000000000002 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 73.129999999999995 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 53.219999999999999 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 64.230000000000004 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 51.350000000000001 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 64.450000000000003 111.409 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 53.420000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 64.230000000000004 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' ILE . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 74.530000000000001 110.592 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 63.450000000000003 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 63.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 54.119999999999997 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 72.219999999999999 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 65.400000000000006 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 71.510000000000005 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 61.439999999999998 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 34.520000000000003 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 74.150000000000006 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.513 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 71.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 73.450000000000003 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 61.310000000000002 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 73.129999999999995 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.453 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 35' ' ' TYR . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 64.239999999999995 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 50.350000000000001 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 63.539999999999999 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 62.439999999999998 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 74.099999999999994 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 63.210000000000001 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.424 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 65.25 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 55.020000000000003 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.531 HH22 ' HA ' ' A' ' 17' ' ' LYS . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 53.539999999999999 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.667 HD11 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 63.210000000000001 111.682 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 74.120000000000005 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 73.519999999999996 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 73.140000000000001 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 54.229999999999997 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 45.030000000000001 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.76 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 62.310000000000002 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 52.210000000000001 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 70.319999999999993 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 45.549999999999997 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 54.25 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 72.519999999999996 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 71.420000000000002 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 53.43 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 61.229999999999997 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 70.209999999999994 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 62.450000000000003 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 72.5 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 55.219999999999999 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 73.019999999999996 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.513 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo . . . . . 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 16.0 t70 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 63.200000000000003 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 74.329999999999998 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 73.310000000000002 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 73.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 54.219999999999999 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 62.039999999999999 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 63.200000000000003 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.200000000000003 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 60.43 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 43.219999999999999 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 41.32 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 73.510000000000005 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 43.009999999999998 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 55.009999999999998 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.329999999999998 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 43.520000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 34.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.129999999999995 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 24.329999999999998 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 70.239999999999995 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 63.049999999999997 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 64.409999999999997 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 61.329999999999998 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 61.25 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.446 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 63.520000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 63.310000000000002 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.57 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.150000000000006 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 62.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 64.430000000000007 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 71.329999999999998 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.150000000000006 111.557 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.512 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 70.120000000000005 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 51.520000000000003 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 74.319999999999993 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.512 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 52.350000000000001 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.452 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD13 HD11 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 35.009999999999998 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 64.310000000000002 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 72.019999999999996 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 62.140000000000001 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 54.210000000000001 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 55.0 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 73.099999999999994 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 53.420000000000002 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo . . . . . 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 70.530000000000001 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 70.109999999999999 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 53.109999999999999 111.289 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 44.329999999999998 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 74.019999999999996 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 54.240000000000002 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' HA ' HE21 ' A' ' 14' ' ' GLN . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 52.130000000000003 111.592 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 11' ' ' VAL . 50.3 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 65.420000000000002 113.066 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 73.120000000000005 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.901 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 71.140000000000001 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 31.039999999999999 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 71.129999999999995 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 74.200000000000003 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 42.549999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 70.519999999999996 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 61.5 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.52 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.533 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 60.420000000000002 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 71.400000000000006 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 70.540000000000006 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 45.0 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 71.209999999999994 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 71.219999999999999 111.376 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 53.340000000000003 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.604 ' HZ3' HD11 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.210000000000001 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 64.230000000000004 113.117 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.901 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 72.140000000000001 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 64.450000000000003 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.571 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.553 HD22 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 53.439999999999998 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.553 ' HB2' HD22 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 65.340000000000003 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 63.439999999999998 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 63.210000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 64.319999999999993 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.109999999999999 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 61.420000000000002 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 52.149999999999999 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 51.039999999999999 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 70.049999999999997 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 87' ' ' GLU . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.658 HD11 HD13 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.109999999999999 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 71.430000000000007 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 73.140000000000001 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.429 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo . . . . . 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 55.450000000000003 112.74 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 71.239999999999995 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 62.340000000000003 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 63.310000000000002 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 60.32 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.633 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 70.010000000000005 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.573 ' HB ' HD11 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 54.109999999999999 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 71.109999999999999 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 73.400000000000006 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 33.229999999999997 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 71.319999999999993 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 53.5 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 63.32 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 54.530000000000001 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 73.540000000000006 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 72.030000000000001 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 41.530000000000001 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 63.340000000000003 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 73.450000000000003 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 54.439999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 74.230000000000004 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 71.310000000000002 111.437 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 64.230000000000004 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 45.350000000000001 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 45.200000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 61.409999999999997 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 72.319999999999993 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 74.519999999999996 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.209999999999994 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 62.439999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.230000000000004 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.635 HG21 HD12 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 64.430000000000007 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 35.450000000000003 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.542 HG21 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 70.430000000000007 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 63.219999999999999 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 72.409999999999997 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' HG21 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 62.420000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 71.219999999999999 111.744 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 63.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 50.439999999999998 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 64.409999999999997 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.681 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 72.299999999999997 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.635 HD12 HG21 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 72.400000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.420000000000002 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 65.140000000000001 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 65.349999999999994 112.594 178.046 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 44.119999999999997 111.198 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 72.549999999999997 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 52.200000000000003 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' HE21 ' A' ' 14' ' ' GLN . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 15' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 11' ' ' VAL . 44.6 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 54.119999999999997 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 72.040000000000006 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 70.549999999999997 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.120000000000005 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 42.350000000000001 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 62.310000000000002 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.219999999999999 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 71.239999999999995 111.435 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.150000000000006 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 53.229999999999997 114.675 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 14.41 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 60.340000000000003 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 61.049999999999997 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.030000000000001 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 32.049999999999997 111.925 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 71.140000000000001 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 55.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 64.510000000000005 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HA ' HE21 ' A' ' 74' ' ' GLN . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 74.430000000000007 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.619 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.420000000000002 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 60.130000000000003 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 72.120000000000005 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.475 HD22 ' HG2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 54.409999999999997 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' HG2' HD22 ' A' ' 59' ' ' ASN . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 71.409999999999997 112.443 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 62.420000000000002 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 61.340000000000003 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 64.230000000000004 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 72.099999999999994 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 72.209999999999994 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 73.209999999999994 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 62.25 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.602 HD12 HD13 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 74.120000000000005 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 72.219999999999999 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 63.509999999999998 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 74.150000000000006 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 63.32 111.378 174.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 6' ' ' VAL . 17.1 m-20 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 71.209999999999994 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 42.439999999999998 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' ILE . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 HG11 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 53.210000000000001 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 62.439999999999998 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 62.329999999999998 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 65.430000000000007 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 64.420000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 71.140000000000001 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HA ' ' HE2' ' A' ' 29' ' ' MET . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 60.509999999999998 110.899 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.696 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 63.32 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.010000000000005 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 63.0 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 62.43 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 45.130000000000003 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 62.210000000000001 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 73.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.451 HD23 HD11 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 63.329999999999998 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.617 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 73.409999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' GLN . 2.8 p-10 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.6 ' HB2' HD21 ' A' ' 59' ' ' ASN . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 63.140000000000001 111.865 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 61.450000000000003 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.476 ' NZ ' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 63.439999999999998 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 64.420000000000002 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG3' HG21 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 65.010000000000005 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.585 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 63.399999999999999 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 73.349999999999994 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' HA2' ' A' ' 18' ' ' GLY . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 65.030000000000001 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 71.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.010000000000005 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.625 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 71.530000000000001 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 64.25 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 70.349999999999994 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 72.219999999999999 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 51.140000000000001 112.179 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.219999999999999 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.140000000000001 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 71.530000000000001 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.696 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo . . . . . 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 6' ' ' VAL . 36.7 m-20 . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 62.520000000000003 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 61.240000000000002 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ASP . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 71.230000000000004 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 62.530000000000001 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' HE21 ' A' ' 14' ' ' GLN . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.319999999999993 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 11' ' ' VAL . 48.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ILE . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 55.340000000000003 110.18 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 71.409999999999997 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.409999999999997 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 50.539999999999999 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 55.229999999999997 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.340000000000003 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 64.200000000000003 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 64.439999999999998 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 73.310000000000002 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 54.43 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 73.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.319999999999993 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 62.350000000000001 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 42.100000000000001 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 61.509999999999998 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 73.319999999999993 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.140000000000001 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 53.43 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 63.409999999999997 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 63.109999999999999 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.509 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 72.340000000000003 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.448 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 64.140000000000001 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 61.32 112.591 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 60.219999999999999 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 61.439999999999998 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 64.510000000000005 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.54 HD11 HG11 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 73.129999999999995 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.428 ' OE1' HG23 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.310000000000002 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 52.450000000000003 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 62.32 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 54.43 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 63.43 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 70.409999999999997 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 72.200000000000003 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.844 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 61.32 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 65.230000000000004 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 71.319999999999993 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 74.019999999999996 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 61.229999999999997 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HB ' HH11 ' A' ' 56' ' ' ARG . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 63.539999999999999 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 65.519999999999996 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 72.030000000000001 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 64.239999999999995 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 72.150000000000006 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 62.340000000000003 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 62.149999999999999 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 71.040000000000006 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.239999999999995 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 73.319999999999993 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 71.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.209999999999994 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 62.009999999999998 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 71.340000000000003 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 62.409999999999997 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 73.219999999999999 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 61.100000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 61.149999999999999 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 63.009999999999998 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 73.010000000000005 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.486 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 55.109999999999999 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 63.219999999999999 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 61.310000000000002 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 62.32 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.219999999999999 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 73.209999999999994 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 61.219999999999999 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 71.230000000000004 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 65.430000000000007 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 64.420000000000002 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 64.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 70.510000000000005 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 72.400000000000006 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 72.140000000000001 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 71.120000000000005 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 62.210000000000001 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 72.209999999999994 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 64.430000000000007 111.341 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 74.219999999999999 112.826 177.695 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 63.530000000000001 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 64.420000000000002 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.200000000000003 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 4' ' ' PHE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 71.019999999999996 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 71.239999999999995 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 64.120000000000005 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 62.439999999999998 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 71.439999999999998 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 63.399999999999999 111.269 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 64.310000000000002 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 71.209999999999994 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.4 ' HE3' HG11 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 71.439999999999998 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 61.509999999999998 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' TYR . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 70.150000000000006 112.987 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 37' ' ' ARG . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 54.329999999999998 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 55.310000000000002 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 73.120000000000005 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 53.509999999999998 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 62.5 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 62.329999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.120000000000005 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 73.120000000000005 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 41.149999999999999 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 71.439999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 64.349999999999994 111.856 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 65.549999999999997 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 61.130000000000003 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.71 ' HD2' HD12 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 64.209999999999994 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.71 HD12 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 62.030000000000001 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.435 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 65.340000000000003 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 71.420000000000002 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 64.129999999999995 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 63.43 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 63.450000000000003 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.552 HG23 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 53.229999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 HD13 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 73.439999999999998 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.109999999999999 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo . . . . . 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 62.25 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.25 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.239999999999995 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 62.340000000000003 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 43.100000000000001 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 62.439999999999998 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 61.109999999999999 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 62.020000000000003 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 73.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 71.299999999999997 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 53.420000000000002 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 71.230000000000004 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 53.219999999999999 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 73.299999999999997 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 73.25 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 71.319999999999993 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 53.210000000000001 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 63.149999999999999 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 54.329999999999998 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 65.040000000000006 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 71.540000000000006 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 44.350000000000001 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 72.230000000000004 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 52.020000000000003 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 73.219999999999999 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 55.140000000000001 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 60.310000000000002 112.952 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 64.040000000000006 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.310000000000002 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 53.340000000000003 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 62.119999999999997 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 63' ' ' LYS . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 54.030000000000001 112.085 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 63.439999999999998 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.209999999999994 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HD21 ' A' ' 59' ' ' ASN . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 64' ' ' ILE . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 63.43 111.401 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 73.340000000000003 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 41.210000000000001 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 43.450000000000003 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.239999999999995 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 73' ' ' ARG . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 64.310000000000002 111.546 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 63.539999999999999 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.712 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 96' ' ' TYR . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 62.329999999999998 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 72.239999999999995 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 54.130000000000003 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 64.329999999999998 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 94' ' ' ARG . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.46 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 44.439999999999998 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 71.430000000000007 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.219999999999999 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 70.530000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 74.310000000000002 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.230000000000004 111.373 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 63.25 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 72.430000000000007 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 25.3 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.611 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 53.420000000000002 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 63.420000000000002 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 42.130000000000003 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 64.400000000000006 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.209999999999994 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 53.340000000000003 111.544 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 53.219999999999999 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 54.200000000000003 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 45.119999999999997 111.805 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 32.140000000000001 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 55.240000000000002 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 64.140000000000001 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 35.43 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 64.230000000000004 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 64.549999999999997 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 71.439999999999998 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 64.120000000000005 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 54.329999999999998 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 63.299999999999997 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.478 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 64.120000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.611 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 52.329999999999998 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD11 HD21 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 54.399999999999999 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 52.329999999999998 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 54.210000000000001 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 61.5 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 64.510000000000005 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 71.209999999999994 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.400000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 44.329999999999998 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 54.020000000000003 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 64.319999999999993 111.44 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.453 HD12 HD22 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 55.109999999999999 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.73 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 61.140000000000001 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 73.230000000000004 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 25.399999999999999 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.663 HD12 HD13 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 71.120000000000005 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.100000000000001 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 71.019999999999996 112.119 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.647 ' HD3' HE21 ' A' ' 99' ' ' GLN . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.129999999999995 111.598 175.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.647 HE21 ' HD3' ' A' ' 97' ' ' LYS . 85.9 mm-40 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 52.310000000000002 111.031 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.209999999999994 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 65.340000000000003 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 62.140000000000001 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 54.140000000000001 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 34.439999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 63.509999999999998 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' HD13 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 62.5 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.663 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 62.009999999999998 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.010000000000005 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 51.109999999999999 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 70.140000000000001 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 71.010000000000005 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 65.329999999999998 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 72.319999999999993 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 54.310000000000002 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 72.040000000000006 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 61.200000000000003 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 63.399999999999999 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 54.32 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 60.32 111.54 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 71.150000000000006 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 52.219999999999999 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 60.329999999999998 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.663 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 62.310000000000002 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.477 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 61.100000000000001 111.956 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' HD21 ' A' ' 59' ' ' ASN . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.049999999999997 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 74.140000000000001 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 73.420000000000002 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 72.129999999999995 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 51.109999999999999 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 70.439999999999998 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 62.530000000000001 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 44.530000000000001 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 62.210000000000001 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 64.349999999999994 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 71.5 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 53.439999999999998 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 63.130000000000003 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 43.539999999999999 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.694 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 71.430000000000007 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 71.109999999999999 112.198 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo . . . . . 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.87 0.366 . . . . 75.430000000000007 111.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.59 154.12 36.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.81 0.338 . . . . 71.019999999999996 111.651 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -58.09 -30.15 66.03 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.041 0.448 . . . . 72.120000000000005 110.264 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -50.76 -51.58 48.88 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.983 -0.553 . . . . 63.409999999999997 110.844 171.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.98 -48.26 81.13 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.93 -0.577 . . . . 71.120000000000005 111.037 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.0 t -54.1 -46.48 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 64.530000000000001 111.658 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -66.08 -58.12 6.18 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.186 0.439 . . . . 75.530000000000001 112.186 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.5 pt -57.29 -40.49 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.692 0.256 . . . . 74.310000000000002 111.692 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -64.37 -41.29 96.79 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.764 0.316 . . . . 74.049999999999997 111.25 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.76 73.07 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.123 0.487 . . . . 74.439999999999998 111.14 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -68.56 -42.48 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.245 -0.434 . . . . 63.509999999999998 110.931 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 8' ' ' ILE . 71.9 mt -60.32 -39.2 80.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.418 -0.356 . . . . 61.329999999999998 111.925 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -61.28 -16.21 43.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 111.979 0.363 . . . . 74.109999999999999 111.979 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -95.64 0.37 52.67 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.545 0.572 . . . . 71.310000000000002 112.545 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 56' ' ' ARG . 44.0 mm -73.46 119.48 76.09 Favored Pre-proline 0 CA--C 1.545 0.778 0 O-C-N 122.341 -0.224 . . . . 71.540000000000006 111.302 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.2 Cg_endo -82.33 -179.7 4.85 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.983 2.455 . . . . 73.030000000000001 114.473 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HA ' HH22 ' A' ' 56' ' ' ARG . 1.1 tmtp? -74.89 129.85 38.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.783 -0.644 . . . . 71.019999999999996 111.708 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.96 4.57 86.03 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.162 -0.542 . . . . 52.32 113.81 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 74.7 mmtt -120.12 144.72 47.48 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 110.866 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.1 m -125.69 168.09 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.028 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -140.79 167.69 21.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.027 0.442 . . . . 63.420000000000002 111.067 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -110.18 150.68 28.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.328 -0.396 . . . . 72.040000000000006 111.596 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' HE1' HD12 ' A' ' 43' ' ' LEU . 42.7 m-85 -50.25 -39.57 45.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.405 0.52 . . . . 61.539999999999999 112.405 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -56.53 -43.06 90.8 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.986 -0.626 . . . . 75.040000000000006 112.918 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.34 -51.43 44.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.835 0.35 . . . . 72.120000000000005 111.023 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -53.57 -48.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.077 -0.511 . . . . 74.329999999999998 111.397 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.34 -51.13 70.62 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 111.789 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 62.2 mttp -61.55 -45.86 92.39 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.853 0.359 . . . . 72.230000000000004 111.833 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -68.0 -25.85 65.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.893 0.331 . . . . 62.450000000000003 111.893 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 -10.1 58.91 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.956 0.354 . . . . 63.229999999999997 111.956 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 25.04 29.0 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.319 -0.467 . . . . 53.43 113.454 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -133.35 72.34 75.27 Favored Pre-proline 0 CA--C 1.541 0.634 0 O-C-N 122.414 -0.463 . . . . 71.239999999999995 111.251 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.82 121.08 8.23 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.218 1.945 . . . . 71.510000000000005 112.56 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.46 6.21 53.32 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.065 -0.588 . . . . 73.219999999999999 113.332 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -112.05 18.85 18.38 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.479 -0.424 . . . . 61.350000000000001 111.815 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -45.67 77.4 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.24 0.543 . . . . 64.239999999999995 111.916 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -60.28 -32.39 71.15 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.977 -0.556 . . . . 72.239999999999995 111.401 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -73.38 -34.69 65.68 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.381 -0.372 . . . . 71.420000000000002 111.412 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 8' ' ' ILE . 48.4 t -57.43 -49.7 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.078 0.466 . . . . 72.430000000000007 110.499 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.24 95.35 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.174 -0.536 . . . . 74.219999999999999 112.816 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -62.84 -22.03 66.37 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.975 0.417 . . . . 75.450000000000003 111.253 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.22 -46.34 9.33 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 65.129999999999995 111.823 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD12 ' HE1' ' A' ' 23' ' ' TYR . 27.3 mt -61.01 -35.81 77.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.936 0.347 . . . . 72.349999999999994 111.936 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.09 -13.57 42.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 121.191 -0.528 . . . . 72.420000000000002 113.327 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -96.56 -1.96 45.97 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.431 -0.452 . . . . 72.109999999999999 111.607 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 94.6 mt -80.63 143.75 55.3 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 112.178 0.436 . . . . 74.400000000000006 112.178 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.06 128.3 9.02 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.493 2.129 . . . . 72.319999999999993 112.005 173.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.63 ' HG3' ' HD2' ' A' ' 73' ' ' ARG . 0.5 OUTLIER -59.44 124.24 19.4 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.934 0.397 . . . . 72.25 110.772 -177.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 102.2 3.83 50.87 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.266 -0.492 . . . . 74.109999999999999 112.787 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.3 p -61.79 153.43 28.65 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.691 0.282 . . . . 75.5 111.53 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -54.49 -33.51 59.95 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.114 0.483 . . . . 74.519999999999996 111.196 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD12 ' HD2' ' A' ' 53' ' ' PRO . 51.2 tp -80.36 120.81 80.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.051 -0.522 . . . . 75.030000000000001 110.701 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.3 Cg_endo -76.69 96.56 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 121.942 1.762 . . . . 61.329999999999998 113.022 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.46 ' CZ2' ' HG2' ' A' ' 48' ' ' GLU . 42.8 p-90 -71.78 -39.86 69.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 112.236 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -61.91 -14.97 39.36 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.991 1.108 . . . . 74.120000000000005 113.991 -171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.523 HH22 ' HA ' ' A' ' 17' ' ' LYS . 29.4 mtp85 -83.28 -8.29 59.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.355 0.502 . . . . 53.340000000000003 112.355 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG21 HG12 ' A' ' 12' ' ' ILE . 60.2 t -117.16 113.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.941 0.401 . . . . 62.539999999999999 111.706 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -107.48 -170.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.128 0.489 . . . . 73.299999999999997 111.539 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -87.25 161.41 18.02 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.968 0.413 . . . . 72.120000000000005 111.58 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -69.91 0.5 5.74 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 111.987 0.366 . . . . 75.319999999999993 111.987 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.26 -3.59 58.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.763 0.316 . . . . 73.239999999999995 111.118 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 28.81 58.44 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.363 -0.446 . . . . 51.219999999999999 113.069 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 49.5 mttp -135.0 166.51 22.86 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.999 0.428 . . . . 71.030000000000001 111.077 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mt -63.12 139.12 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.186 0.517 . . . . 65.109999999999999 111.454 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -73.36 -40.38 64.44 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 112.23 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.9 mt -95.91 160.01 14.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.022 0.439 . . . . 70.430000000000007 111.447 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 59.4 pttt -122.61 178.4 5.02 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.942 0.401 . . . . 60.439999999999998 111.752 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.61 -124.86 25.08 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.33 -0.462 . . . . 42.32 113.21 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -74.69 -42.14 58.96 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.539 -0.389 . . . . 70.540000000000006 111.349 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 73' ' ' ARG . 6.8 m-20 -63.3 -20.91 65.9 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.037 0.384 . . . . 73.349999999999994 112.037 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.0 tt -61.5 -53.85 50.98 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.822 -0.436 . . . . 61.329999999999998 109.822 173.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 32.1 t70 -69.94 -33.21 71.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.36 -0.382 . . . . 72.010000000000005 111.287 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.63 ' HD2' ' HG3' ' A' ' 48' ' ' GLU . 25.1 ttp180 -62.52 -47.36 84.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.656 0.265 . . . . 75.420000000000002 111.365 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -63.14 -46.28 87.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.276 0.56 . . . . 74.230000000000004 109.838 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 30.9 tttm -48.42 -49.53 34.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.334 -0.848 . . . . 75.299999999999997 112.212 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -61.31 -43.89 98.13 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.827 0.306 . . . . 74.230000000000004 111.827 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -63.34 -28.83 70.27 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 75.030000000000001 111.278 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.72 -43.94 52.48 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.364 -0.38 . . . . 70.219999999999999 110.884 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.1 mt-10 -56.9 -38.24 72.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.811 0.339 . . . . 71.400000000000006 110.807 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.82 -27.3 66.5 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.176 -0.465 . . . . 62.5 112.139 176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -89.71 -4.07 57.9 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.348 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.84 43.33 7.27 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.429 -0.415 . . . . 62.240000000000002 112.722 -176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 96' ' ' TYR . 66.2 mt -115.57 131.4 68.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.194 0.521 . . . . 72.400000000000006 112.333 -176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.32 127.08 31.4 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.819 -0.628 . . . . 62.130000000000003 112.151 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.71 103.12 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.339 -0.392 . . . . 64.099999999999994 110.535 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.835 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 67.9 m -80.96 178.88 8.14 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.235 0.457 . . . . 72.530000000000001 112.235 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -41.74 -53.31 3.69 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.827 1.417 . . . . 72.239999999999995 114.827 -167.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.576 HG23 ' HG2' ' A' ' 87' ' ' GLU . 42.1 pt -86.41 20.92 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.776 -0.578 . . . . 64.549999999999997 112.178 -176.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.85 41.92 47.54 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.739 -0.743 . . . . 75.25 111.39 -172.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 38.6 ttmt -89.6 118.15 29.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.633 0.373 . . . . 75.310000000000002 111.932 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 62.2 mt -114.27 129.25 70.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 110.9 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.74 92.7 5.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.126 0.489 . . . . 61.32 111.58 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.783 HD21 HD11 ' A' ' 58' ' ' ILE . 91.2 mt -60.13 -31.81 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.32 -0.4 . . . . 72.209999999999994 111.46 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -48.86 -32.52 8.97 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 112.568 0.581 . . . . 73.430000000000007 112.568 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -114.28 -13.63 12.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.69 0.626 . . . . 75.310000000000002 112.69 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 83' ' ' ILE . 83.5 m-85 -108.45 7.19 26.84 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.978 -0.451 . . . . 75.230000000000004 112.025 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -60.46 130.31 45.97 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.327 -0.397 . . . . 72.409999999999997 111.957 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.447 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.9 t90 -75.48 120.8 21.41 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.904 0.383 . . . . 74.519999999999996 110.575 173.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -105.62 97.34 14.27 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.831 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 17.3 Cg_exo -68.4 -21.02 41.42 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.79 2.327 . . . . 74.430000000000007 113.108 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.5 pt? -130.77 108.9 10.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.167 0.508 . . . . 70.329999999999998 111.293 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.529 -0.748 . . . . 72.230000000000004 111.415 178.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.86 0.362 . . . . 65.219999999999999 111.681 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 6' ' ' VAL . 4.9 m-20 -63.9 156.58 27.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.516 0.561 . . . . 34.200000000000003 112.516 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 31.4 mm-40 -55.59 -44.18 76.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.234 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -51.98 -48.34 64.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.085 -0.507 . . . . 74.140000000000001 110.964 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.83 -45.75 92.47 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.078 -0.51 . . . . 72.340000000000003 110.954 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 2' ' ' ASP . 57.8 t -58.09 -41.97 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.946 0.403 . . . . 54.340000000000003 111.21 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 30.5 mm-40 -67.44 -53.05 32.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 112.045 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.6 pt -61.92 -43.03 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.713 0.292 . . . . 65.409999999999997 111.492 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -62.52 -41.4 98.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.652 0.263 . . . . 63.420000000000002 111.234 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 -36.59 70.77 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.972 0.415 . . . . 60.210000000000001 111.471 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.52 -43.62 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 120.808 0.337 . . . . 71.150000000000006 111.316 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HD2' ' A' ' 53' ' ' PRO . 64.3 mt -61.89 -40.4 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 111.953 0.353 . . . . 71.519999999999996 111.953 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -63.18 -13.13 33.68 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.264 0.468 . . . . 71.329999999999998 112.264 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -98.51 -2.57 38.51 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.747 0.647 . . . . 54.149999999999999 112.747 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 26' ' ' ILE . 48.6 mt -77.97 115.25 48.91 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 120.758 0.314 . . . . 73.439999999999998 111.55 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 98' ' ' TRP . 75.5 Cg_exo -51.47 148.15 20.8 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.86 3.04 . . . . 74.140000000000001 114.416 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -55.91 123.57 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.477 -0.783 . . . . 63.340000000000003 111.604 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.66 -10.73 60.98 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 114.402 0.521 . . . . 24.32 114.402 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -103.6 162.95 12.63 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.691 0.746 . . . . 74.109999999999999 112.499 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.05 170.73 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.504 -0.771 . . . . 65.120000000000005 111.257 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -147.44 172.19 14.33 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.468 -0.333 . . . . 41.310000000000002 110.665 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 30.8 p -106.52 157.9 17.32 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.753 0.279 . . . . 72.430000000000007 111.753 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -54.12 -41.01 67.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.974 0.416 . . . . 71.310000000000002 111.345 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.527 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.54 -54.32 38.08 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.969 -0.559 . . . . 75.329999999999998 112.855 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 23.3 mm-40 -59.05 -50.93 72.19 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 122.695 -0.297 . . . . 74.5 111.709 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 15' ' ' ILE . 46.2 mm -53.09 -46.47 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.085 0.469 . . . . 65.319999999999993 111.289 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.76 -34.44 77.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 112.021 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.8 mttt -61.31 -56.81 16.22 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.881 0.326 . . . . 61.549999999999997 111.881 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -65.5 -24.11 67.06 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.999 0.428 . . . . 53.340000000000003 111.457 177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.87 -30.53 66.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.992 0.425 . . . . 64.230000000000004 111.413 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.66 12.01 39.16 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.436 -0.411 . . . . 52.43 113.231 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -138.99 62.79 28.11 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 122.501 -0.411 . . . . 74.019999999999996 110.925 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.87 -27.17 74.76 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.838 2.359 . . . . 75.239999999999995 113.743 -173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -20.31 76.91 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.021 -0.609 . . . . 41.0 113.327 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -91.85 30.13 1.44 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.173 0.434 . . . . 74.420000000000002 112.173 -176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.37 -39.86 57.99 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.597 0.591 . . . . 52.509999999999998 112.597 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 37' ' ' ARG . 8.8 tpt180 -67.77 -36.34 80.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.001 0.429 . . . . 71.439999999999998 111.261 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -70.05 -28.68 65.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.246 -0.434 . . . . 65.25 111.424 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.64 -47.9 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.105 0.479 . . . . 62.140000000000001 110.163 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.09 -37.85 94.64 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.819 -0.628 . . . . 73.340000000000003 112.522 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -57.35 -35.48 69.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.097 0.475 . . . . 71.099999999999994 111.076 176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.95 -50.96 24.53 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.647 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.27 -35.62 75.95 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.333 -0.394 . . . . 73.409999999999997 111.945 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.84 -14.54 45.08 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.104 -0.569 . . . . 62.439999999999998 113.574 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -94.72 -14.72 24.51 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.482 -0.422 . . . . 70.230000000000004 111.491 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 52' ' ' LEU . 87.2 mt -82.77 138.68 43.54 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.563 0.579 . . . . 74.319999999999993 112.563 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.42 168.37 11.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.83 2.353 . . . . 62.119999999999997 112.627 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -80.21 -13.17 59.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.874 0.369 . . . . 75.140000000000001 111.521 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.3 70.43 1.47 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.195 -0.526 . . . . 45.509999999999998 112.29 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.3 p -152.19 156.88 40.63 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.664 -0.316 . . . . 70.540000000000006 111.28 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 50.2 mtpt -65.51 -46.36 79.97 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.0 176.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 46' ' ' LEU . 10.2 tt -65.19 122.28 79.0 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.796 -0.638 . . . . 65.319999999999993 111.278 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 58.8 Cg_endo -87.22 95.3 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.966 1.777 . . . . 61.219999999999999 112.235 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -70.94 -29.01 64.92 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.892 -0.594 . . . . 71.430000000000007 111.596 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -62.31 -10.98 12.73 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.992 0.738 . . . . 50.530000000000001 112.992 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 68.6 mtt-85 -79.52 -30.88 42.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.05 0.389 . . . . 60.240000000000002 112.05 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.9 t -92.61 103.88 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.355 0.597 . . . . 62.409999999999997 111.797 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 HD11 HD21 ' A' ' 93' ' ' LEU . 25.3 pt -121.17 -174.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.877 -0.601 . . . . 72.519999999999996 112.143 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 3.1 p-10 -76.88 158.17 30.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.933 0.397 . . . . 74.409999999999997 111.87 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.0 m -57.02 -32.46 66.17 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.717 0.636 . . . . 23.41 112.717 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.478 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 78.9 mt-30 -68.03 -9.77 48.4 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.933 0.397 . . . . 70.209999999999994 111.96 176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.15 74.81 0.73 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.271 -0.49 . . . . 51.100000000000001 113.125 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -151.3 156.66 41.26 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.857 0.36 . . . . 75.540000000000006 111.492 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.53 130.16 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.023 0.439 . . . . 62.399999999999999 111.232 176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -71.63 -43.83 65.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.142 0.496 . . . . 52.009999999999998 111.266 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 70' ' ' ASP . 90.4 mt -76.4 166.91 22.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.083 -0.508 . . . . 73.430000000000007 111.417 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 3.4 ptpp? -151.87 177.19 10.68 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.818 0.342 . . . . 65.430000000000007 111.633 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.51 -125.32 10.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.938 -0.649 . . . . 73.530000000000001 111.914 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? -73.45 -38.71 65.38 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.2 0.524 . . . . 72.510000000000005 110.636 174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 66' ' ' LEU . 2.7 m-20 -65.44 -16.01 63.2 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 112.645 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.6 tt -61.66 -54.85 37.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.115 0.483 . . . . 72.340000000000003 110.062 174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 7.3 m-20 -64.54 -34.74 78.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.071 -0.513 . . . . 43.149999999999999 110.665 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.3 ttt180 -51.82 -60.0 3.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.311 -0.404 . . . . 75.439999999999998 111.428 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -62.02 -40.59 96.19 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.897 0.379 . . . . 62.020000000000003 110.661 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 62.4 tttm -57.5 -45.78 84.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 111.635 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 79.2 mt-30 -61.05 -38.03 84.74 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 111.324 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.718 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.9 mmpt? -64.15 -42.75 96.63 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.231 0.539 . . . . 64.120000000000005 110.818 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.3 -39.74 92.89 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.17 0.509 . . . . 73.120000000000005 111.318 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 71.5 mm-40 -60.16 -35.44 75.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.301 -0.409 . . . . 71.010000000000005 110.791 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.52 76.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.199 0.523 . . . . 73.349999999999994 111.035 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -72.67 -7.93 52.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.038 -0.528 . . . . 61.210000000000001 111.332 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.69 25.14 61.1 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.206 -0.521 . . . . 65.099999999999994 112.403 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 96' ' ' TYR . 74.2 mt -88.86 127.39 41.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.181 0.515 . . . . 63.310000000000002 112.041 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.92 92.52 0.51 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.186 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 t -98.82 114.98 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 122.258 -0.276 . . . . 73.120000000000005 111.239 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.0 t -65.56 148.62 51.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.734 -0.212 . . . . 74.310000000000002 111.002 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -49.58 -40.45 38.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.721 1.008 . . . . 72.129999999999995 113.721 -170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.2 pt -73.1 8.79 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.017 0.377 . . . . 65.109999999999999 112.017 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.76 24.69 52.46 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.542 -0.361 . . . . 64.430000000000007 112.704 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 26.7 tptp -92.74 127.73 38.34 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.298 -0.53 . . . . 71.420000000000002 111.69 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 58' ' ' ILE . 55.6 mt -115.43 140.2 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.054 -0.521 . . . . 72.540000000000006 110.79 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.18 95.9 9.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.094 0.473 . . . . 44.240000000000002 111.58 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.477 HD21 HD11 ' A' ' 58' ' ' ILE . 93.6 mt -56.67 -34.29 67.22 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 111.33 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -50.53 -23.31 2.41 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.913 0.708 . . . . 75.420000000000002 112.913 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -112.83 -39.62 4.22 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.151 0.426 . . . . 71.019999999999996 112.151 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CZ ' ' HA ' ' A' ' 83' ' ' ILE . 60.5 m-85 -97.47 9.39 42.53 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.824 1.046 . . . . 71.409999999999997 113.824 -174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.54 139.39 57.92 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.41 0.624 . . . . 73.140000000000001 111.603 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.501 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 17.9 t90 -72.44 139.58 47.82 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.583 . . . . 73.530000000000001 111.905 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -98.96 99.17 7.37 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 110.968 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 8.8 Cg_exo -73.77 -16.91 23.33 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.969 2.446 . . . . 75.010000000000005 113.738 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.2 pt? -134.12 135.09 42.95 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.473 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.255 1.35 0 CA-C-O 119.292 -0.385 . . . . 71.019999999999996 112.027 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.535 0.207 . . . . 75.299999999999997 111.188 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.02 143.02 28.0 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.93 0.715 . . . . 70.510000000000005 112.93 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.1 mm-40 -51.14 -42.87 61.03 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.396 -0.82 . . . . 74.319999999999993 112.176 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -48.2 -52.65 19.97 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.905 0.383 . . . . 73.409999999999997 111.504 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -61.68 -45.32 94.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.091 -0.504 . . . . 75.5 111.068 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.92 -41.73 80.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.506 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 31.9 mm-40 -68.27 -58.92 3.66 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.417 -0.356 . . . . 73.340000000000003 111.834 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 ' O ' HG13 ' A' ' 12' ' ' ILE . 33.5 pt -57.26 -41.13 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.589 0.233 . . . . 64.310000000000002 111.612 -177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -62.59 -45.68 91.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.782 0.325 . . . . 72.010000000000005 111.191 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -57.77 -40.04 78.85 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.893 0.378 . . . . 51.509999999999998 111.51 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.47 -43.56 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 111.307 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.575 ' HB ' HD11 ' A' ' 52' ' ' LEU . 72.5 mt -64.73 -33.57 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 111.93 0.344 . . . . 55.350000000000001 111.93 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -64.61 -21.06 66.61 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.851 -0.531 . . . . 63.009999999999998 111.664 174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 24.2 mt-30 -85.88 -6.17 59.12 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.548 0.573 . . . . 72.200000000000003 112.548 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.783 ' HB ' HH11 ' A' ' 56' ' ' ARG . 21.3 mm -60.88 127.47 87.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 CA-C-O 120.297 0.094 . . . . 74.150000000000006 110.938 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.601 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 39.6 Cg_endo -66.49 150.97 83.98 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.37 2.046 . . . . 71.519999999999996 112.935 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.44 89.61 0.51 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.266 -0.425 . . . . 65.239999999999995 111.193 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.17 -1.74 3.81 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.884 -0.674 . . . . 74.430000000000007 114.218 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.601 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 31.4 mmtp -120.46 164.18 16.79 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.463 0.632 . . . . 71.230000000000004 111.615 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.23 176.02 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.728 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 t -152.51 -179.88 7.98 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 111.314 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 71.4 p -112.61 153.48 27.52 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.159 0.429 . . . . 73.409999999999997 112.159 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -51.87 -40.27 60.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.235 -0.439 . . . . 74.400000000000006 111.476 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.49 -47.63 89.55 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.969 -0.56 . . . . 75.150000000000006 113.181 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.2 -45.87 86.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.753 0.277 . . . . 74.430000000000007 111.365 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.5 mm -54.39 -47.75 69.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 120.862 0.363 . . . . 72.519999999999996 111.219 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.63 -50.8 72.07 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.278 -0.419 . . . . 50.240000000000002 111.805 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -63.67 -48.24 78.0 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 111.91 0.337 . . . . 75.519999999999996 111.91 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.685 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 72.3 mtm -61.44 -28.11 69.04 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 111.607 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.32 -15.72 59.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.349 -0.387 . . . . 54.32 111.491 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.72 14.32 29.86 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.341 -0.39 . . . . 64.120000000000005 113.211 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HE1' ' HG3' ' A' ' 7' ' ' GLN . 66.4 m-85 -133.98 70.36 74.53 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.699 -0.295 . . . . 73.129999999999995 111.628 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.52 138.1 53.26 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.281 1.988 . . . . 62.119999999999997 112.709 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.12 -23.97 34.17 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.358 -0.449 . . . . 54.509999999999998 113.252 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.27 23.53 0.73 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.316 -0.52 . . . . 73.450000000000003 112.155 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -38.12 64.66 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.301 0.482 . . . . 72.540000000000006 112.301 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -67.74 -37.05 81.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.767 0.318 . . . . 61.340000000000003 111.279 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -64.35 -42.01 96.45 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.374 -0.375 . . . . 70.120000000000005 110.783 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.22 -41.17 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.168 -0.469 . . . . 65.040000000000006 110.462 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -54.02 -45.81 71.04 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 116.087 -0.506 . . . . 65.129999999999995 112.94 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -63.42 -47.89 80.07 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.556 -0.379 . . . . 75.230000000000004 111.483 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.15 -34.39 60.27 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.928 0.394 . . . . 73.5 111.633 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.4 mt -85.07 -38.27 19.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.321 -0.399 . . . . 64.120000000000005 111.679 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.09 -20.68 62.95 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.216 -0.516 . . . . 74.209999999999994 113.207 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.06 1.88 37.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.163 0.431 . . . . 54.240000000000002 112.163 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 HD23 ' A' ' 52' ' ' LEU . 85.5 mt -97.47 139.05 21.18 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.885 0.374 . . . . 62.219999999999999 111.909 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 50' ' ' SER . 80.0 Cg_endo -83.34 179.49 5.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.766 2.311 . . . . 75.239999999999995 113.493 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.505 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 43.9 mt-10 -66.55 -17.14 64.65 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.545 0.572 . . . . 64.439999999999998 112.545 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.85 40.95 2.26 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.136 -0.554 . . . . 65.409999999999997 113.321 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 47' ' ' PRO . 41.6 t -84.13 149.09 26.42 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.39 -0.476 . . . . 72.150000000000006 111.1 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -77.2 -24.01 51.38 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.145 0.498 . . . . 70.409999999999997 110.55 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' HB ' ' A' ' 12' ' ' ILE . 56.1 tp -86.4 114.5 57.95 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 115.833 -0.621 . . . . 72.329999999999998 110.363 176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HD2' HD12 ' A' ' 52' ' ' LEU . 59.5 Cg_endo -72.14 94.04 0.73 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.317 1.345 . . . . 74.510000000000005 112.581 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -78.76 -30.19 45.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.846 -0.616 . . . . 75.0 110.985 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 18.5 p90 -59.61 -17.31 32.25 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.041 0.756 . . . . 73.439999999999998 113.041 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.783 HH11 ' HB ' ' A' ' 15' ' ' ILE . 98.9 mtt180 -78.33 -7.04 56.81 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.431 0.53 . . . . 72.219999999999999 112.431 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -109.98 117.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.076 0.465 . . . . 74.140000000000001 112.086 -175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 93' ' ' LEU . 31.8 pt -122.68 -179.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 116.244 -0.434 . . . . 72.439999999999998 111.268 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.64 159.53 20.57 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.013 -0.43 . . . . 54.399999999999999 111.64 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 81.6 p -57.69 -18.55 21.4 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.647 0.61 . . . . 64.340000000000003 112.647 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -71.33 -8.49 54.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.06 0.393 . . . . 62.5 112.06 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.49 41.89 15.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.415 -0.421 . . . . 63.020000000000003 113.665 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -151.58 154.35 36.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.143 0.496 . . . . 74.200000000000003 112.092 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 66' ' ' LEU . 71.1 mt -69.17 128.04 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 116.015 -0.539 . . . . 75.219999999999999 110.68 174.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.4 t -90.17 10.72 23.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.724 0.639 . . . . 74.340000000000003 112.724 -173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.559 ' H ' HG22 ' A' ' 64' ' ' ILE . 93.5 mt -97.11 161.58 13.75 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.012 0.434 . . . . 70.109999999999999 111.845 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -74.06 155.69 38.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.34 -0.391 . . . . 75.049999999999997 111.204 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -32.87 -56.09 0.5 Allowed Glycine 0 CA--C 1.536 1.359 0 N-CA-C 115.735 1.054 . . . . 54.119999999999997 115.735 -171.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -57.72 -55.02 40.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.358 0.599 . . . . 75.400000000000006 111.718 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 73' ' ' ARG . 1.1 m-20 -69.44 -21.52 63.73 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.01 -0.541 . . . . 73.400000000000006 111.156 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' A' ' 89' ' ' GLY . 8.4 tt -71.42 -50.22 34.04 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.99 -0.55 . . . . 70.239999999999995 109.968 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 62.5 m-20 -61.48 -31.35 71.32 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.71 0.291 . . . . 54.350000000000001 110.962 175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 38.3 ttm180 -56.19 -56.61 18.82 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.148 0.499 . . . . 72.340000000000003 110.993 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 51.7 tt0 -62.39 -38.91 91.43 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.669 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 39.3 ttmt -54.71 -57.52 11.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.473 -0.785 . . . . 65.209999999999994 111.671 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 97.0 mt-30 -55.01 -43.66 73.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.764 0.316 . . . . 72.299999999999997 111.671 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 75.0 mmtt -57.8 -49.08 77.84 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.015 0.436 . . . . 74.120000000000005 111.237 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.657 HD13 HD11 ' A' ' 91' ' ' ILE . 88.7 mt -62.07 -40.27 95.23 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 75.400000000000006 111.654 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 48.2 mt-10 -58.02 -39.59 78.72 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.006 0.431 . . . . 71.430000000000007 110.824 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.71 -29.62 70.61 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 111.287 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 11.0 mm-40 -74.23 -11.28 60.24 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.245 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.35 22.12 25.4 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.395 -0.366 . . . . 62.520000000000003 112.588 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.3 mt -100.99 133.1 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.222 0.534 . . . . 74.329999999999998 111.935 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.24 105.19 14.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.065 -0.516 . . . . 70.340000000000003 110.957 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.59 118.3 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.045 0.45 . . . . 71.439999999999998 111.216 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 19.0 t -63.38 151.71 40.15 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.535 -0.302 . . . . 54.140000000000001 110.547 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.085 1.143 . . . . 60.520000000000003 114.085 -168.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.526 HG23 ' HG2' ' A' ' 87' ' ' GLU . 34.4 pt -78.08 16.22 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 112.889 0.7 . . . . 61.549999999999997 112.889 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' A' ' 71' ' ' LEU . . . 77.49 38.19 29.18 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.226 -0.512 . . . . 74.439999999999998 112.58 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.668 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.4 ttpp -103.11 135.03 45.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.943 0.401 . . . . 54.119999999999997 111.837 -177.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 78' ' ' LEU . 61.3 mt -123.79 118.08 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.93 0.395 . . . . 64.420000000000002 111.105 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.51 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.03 0.443 . . . . 60.020000000000003 111.655 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 58' ' ' ILE . 98.0 mt -55.83 -33.16 64.23 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.266 -0.425 . . . . 64.129999999999995 111.988 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -52.6 -25.61 11.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.296 0.48 . . . . 74.299999999999997 112.296 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -112.79 -38.68 4.49 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.973 -0.455 . . . . 64.310000000000002 111.902 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -86.84 14.21 7.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.63 0.604 . . . . 72.349999999999994 112.63 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -63.05 134.01 55.43 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.269 0.47 . . . . 73.219999999999999 112.269 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.467 ' CZ3' HD13 ' A' ' 15' ' ' ILE . 28.3 t90 -113.55 131.72 55.98 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.855 0.36 . . . . 72.019999999999996 110.705 166.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 33.5 mm-40 -125.29 118.48 25.08 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.136 -0.484 . . . . 54.210000000000001 110.83 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.685 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 11.3 Cg_exo -72.66 35.21 0.33 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.286 2.658 . . . . 75.209999999999994 114.271 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 101' ' ' LEU . 1.9 pt? -144.96 128.21 16.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.324 0.583 . . . . 64.430000000000007 111.695 177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.646 -0.692 . . . . 73.120000000000005 111.091 177.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 73.239999999999995 111.002 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 6' ' ' VAL . 15.3 t70 -66.48 138.96 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.025 0.38 . . . . 75.239999999999995 112.025 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.87 -28.8 66.46 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.864 0.69 . . . . 72.019999999999996 112.864 -176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -58.84 -48.81 80.02 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.116 0.484 . . . . 72.310000000000002 110.142 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.15 -40.79 82.31 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.748 -0.66 . . . . 74.329999999999998 110.998 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 2' ' ' ASP . 84.9 t -54.68 -53.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 111.638 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' O ' HG23 ' A' ' 11' ' ' VAL . 16.6 mm100 -62.96 -55.05 29.24 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.269 0.47 . . . . 51.030000000000001 112.269 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.3 pt -61.26 -44.51 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.018 0.377 . . . . 63.420000000000002 112.018 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CD1' HG13 ' A' ' 8' ' ' ILE . 11.6 m-30 -64.41 -38.24 90.33 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.097 -0.377 . . . . 73.200000000000003 111.182 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.15 -40.72 74.29 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.901 0.382 . . . . 71.129999999999995 111.406 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 26' ' ' ILE . 39.1 t -67.92 -39.61 82.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 120.953 0.406 . . . . 70.340000000000003 111.305 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 15' ' ' ILE . 61.7 mt -68.33 -30.73 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 120.792 0.329 . . . . 64.040000000000006 111.685 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 66.8 m-70 -64.67 -10.23 25.42 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.919 -0.488 . . . . 63.43 111.573 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -92.39 -5.14 52.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.379 0.511 . . . . 73.209999999999994 112.379 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.3 mm -67.46 128.09 93.55 Favored Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 122.225 -0.297 . . . . 75.230000000000004 111.182 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.45 158.01 25.6 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.538 2.159 . . . . 72.040000000000006 113.256 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -67.3 99.27 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.947 -0.569 . . . . 65.230000000000004 111.568 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.8 -5.17 7.0 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 120.832 -0.699 . . . . 75.129999999999995 114.297 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -124.63 157.23 36.02 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.747 0.774 . . . . 73.349999999999994 111.735 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 m -116.96 175.44 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.012 0.434 . . . . 62.520000000000003 111.661 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.6 p -145.08 175.33 10.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 53.039999999999999 111.263 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.4 p -114.61 152.93 31.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.471 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -56.02 -42.16 76.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.952 0.405 . . . . 75.120000000000005 111.483 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -41.36 98.57 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.144 -0.48 . . . . 53.140000000000001 113.111 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -59.34 -51.84 68.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.246 0.546 . . . . 74.530000000000001 111.028 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG23 ' HB ' ' A' ' 11' ' ' VAL . 50.5 mm -60.03 -53.7 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.692 -0.685 . . . . 73.420000000000002 111.384 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.59 -43.22 84.49 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.9 -0.591 . . . . 65.120000000000005 112.061 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -53.97 -57.74 9.89 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 111.633 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.8 mtm -70.54 -17.14 62.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.994 0.368 . . . . 50.350000000000001 111.994 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.22 -17.5 56.65 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.012 0.434 . . . . 71.400000000000006 111.574 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.01 0.9 41.86 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.447 -0.406 . . . . 62.539999999999999 113.447 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 27.9 m-85 -122.25 71.16 34.12 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 122.511 -0.405 . . . . 75.150000000000006 111.102 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.85 -47.76 21.77 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.947 2.432 . . . . 65.5 114.056 -170.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.96 11.35 72.35 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.047 -0.597 . . . . 72.409999999999997 114.388 -176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -102.61 17.62 23.28 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 117.245 0.523 . . . . 72.409999999999997 111.945 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.75 -31.87 50.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.961 0.41 . . . . 43.109999999999999 111.919 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -59.82 -39.77 86.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.16 0.505 . . . . 74.030000000000001 111.334 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -73.98 -34.9 64.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.123 -0.489 . . . . 75.129999999999995 110.939 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG21 ' HB2' ' A' ' 27' ' ' ALA . 57.8 t -57.8 -43.05 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.008 0.432 . . . . 73.310000000000002 110.589 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.65 -44.04 97.21 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.025 -0.607 . . . . 55.310000000000002 112.549 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -62.1 -35.76 79.66 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.873 0.368 . . . . 64.519999999999996 111.499 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.58 -50.64 68.64 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.998 0.427 . . . . 72.400000000000006 111.364 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.22 -28.89 69.69 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.268 -0.424 . . . . 62.229999999999997 111.411 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.65 -19.08 66.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.038 -0.601 . . . . 60.240000000000002 113.027 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -82.54 -21.46 35.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.97 0.414 . . . . 62.100000000000001 111.259 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 52' ' ' LEU . 89.0 mt -72.78 139.69 80.59 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-O 120.934 0.397 . . . . 73.040000000000006 112.001 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.46 164.36 16.65 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.597 2.198 . . . . 54.109999999999999 112.701 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -68.87 -32.33 71.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.947 0.404 . . . . 62.420000000000002 111.119 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -91.25 61.3 2.92 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.296 -0.478 . . . . 35.509999999999998 112.556 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.3 p -119.72 -171.88 2.22 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.549 -0.383 . . . . 65.049999999999997 111.59 -177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.54 -36.85 8.64 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.906 0.336 . . . . 73.129999999999995 111.906 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.532 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.0 tp -84.35 122.05 75.31 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.487 -0.324 . . . . 54.340000000000003 111.388 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.0 Cg_endo -70.73 95.64 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 121.751 1.634 . . . . 65.439999999999998 112.706 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -73.55 -27.61 61.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.898 -0.592 . . . . 65.209999999999994 111.632 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.458 ' CB ' ' HG3' ' A' ' 74' ' ' GLN . 16.0 p90 -67.27 -10.18 48.16 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.51 0.929 . . . . 74.120000000000005 113.51 -176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -91.22 -6.44 53.36 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.859 0.689 . . . . 75.010000000000005 112.859 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -110.01 111.59 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.26 0.553 . . . . 74.209999999999994 111.949 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 91' ' ' ILE . 36.8 pt -120.19 -176.29 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.119 -0.492 . . . . 75.340000000000003 111.613 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 4.8 p-10 -87.45 154.82 20.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.032 0.444 . . . . 62.140000000000001 111.556 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.0 p -58.0 -16.06 11.23 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.669 0.989 . . . . 34.210000000000001 113.669 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.4 mt-30 -78.84 -6.06 55.09 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 71.140000000000001 111.725 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.8 53.77 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.36 -0.382 . . . . 73.540000000000006 113.976 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 87.7 tttt -150.54 156.83 42.16 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.481 -0.423 . . . . 74.349999999999994 111.416 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.21 130.17 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 116.381 -0.372 . . . . 73.239999999999995 111.176 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 95.9 p -79.42 -32.56 42.87 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.685 0.278 . . . . 62.240000000000002 111.529 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.8 mt -63.08 156.45 24.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.425 -0.352 . . . . 62.450000000000003 111.327 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.2 141.98 48.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.437 0.532 . . . . 64.439999999999998 112.437 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 -134.98 19.18 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.947 -0.57 . . . . 50.049999999999997 113.732 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -55.02 -36.33 65.37 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.617 0.367 . . . . 72.530000000000001 111.634 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.34 -39.9 85.83 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.302 -0.408 . . . . 74.530000000000001 111.407 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.46 -54.17 48.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.087 0.47 . . . . 63.299999999999997 110.648 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.52 -32.65 74.37 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 64.129999999999995 110.953 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 41.0 ttm180 -58.67 -48.91 79.45 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 110.716 174.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -58.3 -46.77 85.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.834 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -57.86 -45.68 85.96 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 111.588 177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -60.01 -35.87 75.98 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.938 0.347 . . . . 73.099999999999994 111.938 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 11.3 mmpt? -68.39 -44.91 74.08 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.953 0.406 . . . . 54.409999999999997 110.912 176.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 91.2 mt -65.3 -50.36 65.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.004 -0.543 . . . . 72.400000000000006 111.877 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.68 -39.59 62.05 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.901 0.381 . . . . 71.310000000000002 111.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.41 70.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.268 -0.423 . . . . 70.040000000000006 111.65 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.19 -14.3 47.31 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.888 0.375 . . . . 62.310000000000002 111.186 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.81 17.54 18.55 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.322 -0.399 . . . . 71.400000000000006 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 66.4 mt -92.63 115.79 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.094 0.474 . . . . 53.25 111.822 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.74 105.58 1.97 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.809 -0.632 . . . . 42.539999999999999 112.478 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.28 131.16 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.42 -0.355 . . . . 71.439999999999998 110.879 173.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.702 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 55.7 m -73.74 146.8 44.09 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.35 -0.219 . . . . 75.230000000000004 110.448 174.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.3 pt-20 -38.72 -45.48 1.13 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.89 1.07 . . . . 52.240000000000002 113.89 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 87' ' ' GLU . 34.4 pt -81.46 21.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 112.408 0.521 . . . . 74.319999999999993 112.408 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.51 30.04 67.19 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.091 -0.576 . . . . 54.299999999999997 112.564 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 60.0 tttp -102.24 115.24 30.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.75 0.31 . . . . 63.119999999999997 111.542 -176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.53 HD12 HD13 ' A' ' 58' ' ' ILE . 71.0 mt -102.58 131.24 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 120.843 0.354 . . . . 72.310000000000002 111.383 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.27 94.96 4.89 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.138 0.494 . . . . 52.420000000000002 111.679 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 58' ' ' ILE . 93.9 mt -58.51 -31.3 67.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.59 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -54.64 -31.28 57.16 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.261 0.467 . . . . 73.439999999999998 112.261 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 21.6 ptmt -113.79 -6.55 13.27 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.524 0.565 . . . . 75.420000000000002 112.524 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.495 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 73.7 m-85 -126.53 13.99 7.59 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.89 1.07 . . . . 73.510000000000005 113.89 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -67.95 126.75 30.44 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.912 -0.493 . . . . 75.329999999999998 111.172 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.504 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 22.1 t90 -57.98 123.29 15.34 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.199 0.523 . . . . 73.239999999999995 111.529 177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -107.4 91.37 6.88 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.89 -0.595 . . . . 73.099999999999994 110.482 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 2.5 Cg_endo -81.41 18.37 1.35 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.17 2.58 . . . . 73.420000000000002 113.058 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.58 -49.74 6.32 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.342 -0.39 . . . . 74.319999999999993 111.912 -175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 C--O 1.25 1.105 0 N-CA-C 112.276 0.472 . . . . 74.549999999999997 112.276 -174.28 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' HD12 ' A' ' 5' ' ' LEU . 24.4 ptt? . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.763 0.316 . . . . 64.239999999999995 111.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.7 157.46 24.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.078 0.466 . . . . 74.140000000000001 111.884 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -49.05 -38.75 24.94 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.886 -0.597 . . . . 70.019999999999996 112.338 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -53.62 -54.12 42.18 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.93 0.395 . . . . 74.200000000000003 111.365 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 1' ' ' MET . 93.7 mt -63.29 -40.76 98.26 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 111.219 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.8 t -55.98 -48.85 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.044 0.45 . . . . 74.329999999999998 111.775 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.425 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.1 mm-40 -69.92 -52.53 23.78 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.463 0.542 . . . . 74.099999999999994 112.463 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 38.4 pt -59.91 -40.73 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 111.937 0.347 . . . . 62.219999999999999 111.937 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -63.31 -40.67 97.99 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.67 0.272 . . . . 75.420000000000002 111.237 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -43.91 92.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.135 0.493 . . . . 71.310000000000002 111.253 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 61.0 t -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.097 -0.501 . . . . 62.020000000000003 111.484 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' HD11 ' A' ' 52' ' ' LEU . 76.4 mt -67.26 -33.61 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.165 0.432 . . . . 61.219999999999999 112.165 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -63.57 -21.38 66.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.726 -0.609 . . . . 63.149999999999999 111.74 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -87.01 -3.93 59.13 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.927 0.714 . . . . 72.409999999999997 112.927 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 12' ' ' ILE . 38.1 mm -57.42 115.89 12.14 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 120.694 0.283 . . . . 72.109999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 72.3 Cg_endo -73.17 154.86 52.16 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.689 2.259 . . . . 65.129999999999995 113.726 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HE2' ' HG3' ' A' ' 81' ' ' GLU . 23.3 tptm -62.54 95.69 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.507 -0.77 . . . . 61.43 111.493 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.89 -17.22 5.74 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 120.884 -0.674 . . . . 63.229999999999997 114.278 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 29.8 mmtp -112.23 166.49 11.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 117.681 0.74 . . . . 72.430000000000007 112.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.64 177.57 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.05 -0.523 . . . . 70.140000000000001 111.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.2 t -151.48 -175.87 5.36 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.338 -0.392 . . . . 74.409999999999997 110.998 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 17.2 p -125.93 157.55 37.45 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.784 0.326 . . . . 64.510000000000005 111.339 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -52.49 -37.91 58.31 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.168 0.508 . . . . 74.219999999999999 111.261 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.57 -46.05 64.12 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.776 -0.647 . . . . 51.509999999999998 113.043 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 20.3 mm-40 -62.23 -43.27 99.22 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.729 0.3 . . . . 72.400000000000006 111.168 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 22' ' ' THR . 47.3 mm -55.99 -56.25 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 116.474 -0.33 . . . . 74.109999999999999 111.452 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.27 82.18 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.099 0.476 . . . . 63.219999999999999 111.618 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -56.31 -43.63 79.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.929 -0.578 . . . . 72.140000000000001 111.862 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.6 mtm -79.37 -26.92 41.95 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.97 0.359 . . . . 74.049999999999997 111.97 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.17 -16.61 62.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.059 0.457 . . . . 74.409999999999997 111.483 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.06 18.46 15.09 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.288 -0.482 . . . . 65.349999999999994 113.166 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.88 79.88 66.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.504 0.322 . . . . 73.219999999999999 111.023 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.19 142.62 56.23 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.44 2.094 . . . . 74.540000000000006 112.573 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.53 -22.7 19.23 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.084 -0.579 . . . . 54.439999999999998 113.693 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -74.91 27.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.271 0.841 . . . . 75.099999999999994 113.271 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.39 -43.33 92.95 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.184 0.438 . . . . 53.219999999999999 112.184 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -63.38 -41.89 98.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 75.430000000000007 110.976 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -61.71 -43.91 97.94 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.866 -0.607 . . . . 63.32 111.918 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.28 -47.85 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.951 0.405 . . . . 72.200000000000003 111.106 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.35 -38.15 92.97 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.991 -0.623 . . . . 54.439999999999998 112.872 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -59.46 -47.99 83.35 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.974 0.416 . . . . 73.519999999999996 111.136 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -50.42 67.17 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.956 0.408 . . . . 71.230000000000004 111.803 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.2 -31.21 72.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.992 0.367 . . . . 73.129999999999995 111.992 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.14 -18.06 47.3 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.381 -0.438 . . . . 44.32 113.61 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -80.65 -33.75 35.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.873 0.368 . . . . 63.310000000000002 111.601 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 54' ' ' TRP . 82.8 mt -59.39 137.13 88.98 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.445 0.535 . . . . 71.319999999999993 112.445 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' LEU . 34.2 Cg_endo -92.83 -161.95 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.405 2.736 . . . . 64.140000000000001 113.997 -175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 73' ' ' ARG . 39.7 mt-10 -84.64 129.35 34.85 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.963 -0.562 . . . . 72.530000000000001 111.357 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.82 51.08 26.26 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.293 -0.48 . . . . 73.120000000000005 113.552 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.7 p -96.58 166.13 11.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.817 0.341 . . . . 60.100000000000001 111.605 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -61.34 -59.54 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.948 0.404 . . . . 74.400000000000006 111.138 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.579 HD11 ' HB ' ' A' ' 12' ' ' ILE . 26.2 tp -71.55 117.5 57.85 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.217 -0.447 . . . . 72.299999999999997 110.907 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.4 95.76 1.08 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 121.899 1.733 . . . . 64.030000000000001 112.96 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.544 ' HB3' HD12 ' A' ' 46' ' ' LEU . 57.2 p-90 -80.82 -26.86 36.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.13 -0.486 . . . . 74.040000000000006 111.665 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 42.3 p90 -63.07 -8.64 8.0 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.045 0.758 . . . . 74.319999999999993 113.045 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.482 HH22 ' CD ' ' A' ' 81' ' ' GLU . 89.5 mtt-85 -101.59 9.79 40.84 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.064 -0.397 . . . . 73.349999999999994 111.621 178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -122.43 110.79 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.185 0.517 . . . . 53.409999999999997 111.481 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 HD21 ' A' ' 93' ' ' LEU . 31.6 pt -112.18 -170.21 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.428 -0.351 . . . . 73.219999999999999 111.574 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 2.3 p-10 -93.84 153.56 18.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.812 -0.555 . . . . 72.510000000000005 111.334 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HA ' HG21 ' A' ' 22' ' ' THR . 48.0 m -54.51 -25.6 26.59 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.536 0.939 . . . . 71.010000000000005 113.536 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.46 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 28.3 mm-40 -55.96 -19.12 11.07 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.245 0.461 . . . . 63.43 112.245 176.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.31 32.78 8.52 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.425 -0.417 . . . . 32.520000000000003 112.565 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 39.9 ttmt -143.76 156.02 44.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.906 0.384 . . . . 72.099999999999994 111.475 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 67.0 mt -71.36 126.82 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.245 -0.434 . . . . 61.109999999999999 110.517 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.8 p -66.5 -28.73 68.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.934 0.397 . . . . 63.219999999999999 111.752 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.46 156.12 20.95 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.532 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -130.16 173.9 10.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.993 0.425 . . . . 75.129999999999995 111.665 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.89 -153.84 47.57 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.267 -0.492 . . . . 60.43 112.734 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 ttp180 -62.15 -20.13 63.78 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.395 -0.474 . . . . 70.420000000000002 111.227 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.57 -37.69 88.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.97 0.414 . . . . 60.530000000000001 110.616 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 tt -67.21 -50.62 60.18 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.118 -0.492 . . . . 50.210000000000001 110.016 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.47 -34.0 72.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.315 -0.402 . . . . 71.099999999999994 111.356 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' HD3' ' HG2' ' A' ' 48' ' ' GLU . 42.3 ttm180 -58.02 -59.4 5.32 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.994 0.426 . . . . 74.400000000000006 110.963 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -61.81 -41.62 97.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.078 -0.51 . . . . 71.340000000000003 111.257 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 48.4 tttm -54.29 -52.65 60.79 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.912 -0.586 . . . . 70.319999999999993 111.81 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.51 -38.8 88.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.898 0.38 . . . . 73.319999999999993 111.756 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.782 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.7 mmpt? -59.72 -29.8 68.37 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.701 0.286 . . . . 75.239999999999995 111.496 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.45 -34.1 21.73 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.239 0.542 . . . . 64.019999999999996 110.957 175.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 43.1 mt-10 -63.54 -11.88 27.97 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.375 -0.375 . . . . 73.120000000000005 111.443 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.03 49.08 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.309 0.485 . . . . 71.239999999999995 112.309 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.482 ' CD ' HH22 ' A' ' 56' ' ' ARG . 8.6 mp0 -95.63 0.06 52.35 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.877 0.37 . . . . 72.099999999999994 111.486 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.57 19.61 59.8 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.385 -0.436 . . . . 71.310000000000002 112.983 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.28 129.44 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.396 . . . . 64.519999999999996 111.822 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -68.72 109.65 3.93 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.422 0.629 . . . . 52.240000000000002 111.522 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.51 107.04 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.545 -0.752 . . . . 70.140000000000001 109.763 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.9 t -56.81 145.48 29.31 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.705 -0.225 . . . . 74.25 111.231 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -49.22 -28.32 4.47 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.956 0.725 . . . . 73.310000000000002 112.956 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -82.21 15.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 72.519999999999996 111.865 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.97 30.62 65.37 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 116.242 -0.436 . . . . 61.409999999999997 113.203 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -112.06 125.45 54.1 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.053 0.454 . . . . 74.319999999999993 111.885 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 59.4 mt -110.34 147.54 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.049 -0.523 . . . . 61.210000000000001 111.428 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.96 93.16 6.28 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.212 0.53 . . . . 65.349999999999994 111.017 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.724 HD21 HD11 ' A' ' 58' ' ' ILE . 84.6 mt -66.97 -29.32 69.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.223 0.453 . . . . 64.329999999999998 112.223 -176.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -55.27 -31.44 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.719 0.295 . . . . 75.109999999999999 111.746 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -107.95 -33.47 7.2 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 111.842 0.312 . . . . 73.329999999999998 111.842 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -88.64 8.81 26.66 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.673 0.62 . . . . 73.310000000000002 112.673 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -62.63 145.94 53.28 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.259 0.552 . . . . 70.120000000000005 111.992 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 22.7 t90 -94.32 144.05 25.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 110.91 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.61 ' HB2' ' HG3' ' A' ' 102' ' ' GLU . 3.9 pt20 -124.4 87.0 54.48 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 121.148 0.499 . . . . 70.200000000000003 112.28 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 74.5 Cg_endo -82.49 -64.36 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.361 2.04 . . . . 71.099999999999994 113.383 176.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 101' ' ' LEU . 2.3 pt? -81.14 -22.62 38.91 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.213 0.449 . . . . 71.310000000000002 112.213 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 99' ' ' GLN . 7.4 pt-20 . . . . . 0 C--O 1.254 1.303 0 N-CA-C 111.707 0.262 . . . . 62.210000000000001 111.707 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.5 0.19 . . . . 75.420000000000002 110.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -64.35 143.17 58.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.867 0.365 . . . . 70.450000000000003 111.64 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 85.6 mm-40 -61.36 -26.12 67.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.396 0.517 . . . . 74.049999999999997 112.396 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -54.44 -53.48 53.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.009 0.433 . . . . 75.140000000000001 110.795 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.95 -42.82 97.2 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.059 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.4 t -56.4 -45.43 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.973 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.6 mm-40 -72.87 -51.02 20.36 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.311 0.485 . . . . 75.409999999999997 112.311 -177.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 12' ' ' ILE . 35.1 pt -60.32 -43.3 93.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 122.126 -0.359 . . . . 73.030000000000001 111.83 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -64.94 -38.61 91.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.685 0.279 . . . . 64.310000000000002 111.176 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -34.61 69.07 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.976 0.417 . . . . 71.120000000000005 111.301 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HA ' HE21 ' A' ' 14' ' ' GLN . 48.3 t -73.72 -40.97 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.943 0.401 . . . . 71.409999999999997 111.168 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 8' ' ' ILE . 77.1 mt -59.79 -42.64 89.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 112.228 0.455 . . . . 54.310000000000002 112.228 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -61.25 -16.78 48.91 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.004 0.372 . . . . 75.329999999999998 112.004 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.428 HE21 ' HA ' ' A' ' 11' ' ' VAL . 50.8 mt-30 -92.49 -5.35 52.02 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.658 0.614 . . . . 65.540000000000006 112.658 -178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG22 ' NH1' ' A' ' 56' ' ' ARG . 20.4 mm -71.24 112.73 14.65 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 122.086 -0.384 . . . . 72.400000000000006 110.957 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.14 147.16 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.967 2.445 . . . . 54.130000000000003 113.448 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.813 ' HA ' HH22 ' A' ' 56' ' ' ARG . 11.8 tptp -60.91 95.39 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.915 0.388 . . . . 74.409999999999997 111.711 -175.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 132.81 -32.35 2.79 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.093 -0.575 . . . . 34.119999999999997 113.363 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -83.64 153.6 24.17 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.301 -0.529 . . . . 75.329999999999998 112.095 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.8 m -110.34 176.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.08 0.467 . . . . 70.0 111.561 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.4 p -154.26 164.04 39.2 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.269 -0.423 . . . . 62.450000000000003 110.936 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.478 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 67.2 p -118.53 156.02 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.042 0.449 . . . . 65.120000000000005 111.772 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.434 ' CD1' HG12 ' A' ' 57' ' ' VAL . 46.0 m-85 -52.7 -47.73 67.07 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.859 -0.609 . . . . 71.519999999999996 112.609 -177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.76 -38.41 96.44 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.275 -0.488 . . . . 35.539999999999999 113.764 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 9.3 mm-40 -72.39 -43.82 63.41 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.48 -0.423 . . . . 70.319999999999993 111.319 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.8 mm -58.49 -44.06 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.088 0.471 . . . . 71.420000000000002 110.374 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -54.99 -42.9 73.04 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.841 -0.618 . . . . 65.099999999999994 111.975 177.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 64.4 mttp -58.24 -53.9 53.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.013 0.435 . . . . 74.310000000000002 111.663 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 61.7 mtm -70.55 -16.29 62.86 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.207 0.447 . . . . 62.399999999999999 112.207 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.59 -23.74 24.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.974 0.361 . . . . 64.129999999999995 111.974 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.61 23.56 28.21 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.135 -0.555 . . . . 63.130000000000003 112.88 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 88.4 m-85 -138.08 63.09 35.69 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.718 0.407 . . . . 71.409999999999997 111.03 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.27 -41.13 79.69 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.869 2.379 . . . . 54.340000000000003 113.8 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.78 -9.88 86.26 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.012 -0.613 . . . . 75.129999999999995 113.785 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' CD1' ' HB3' ' A' ' 32' ' ' TYR . 28.7 m-85 -93.84 14.19 20.19 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.455 -0.438 . . . . 71.540000000000006 111.848 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.69 -51.95 25.95 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.409 0.522 . . . . 63.109999999999999 112.409 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -61.15 -29.76 69.98 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.021 0.439 . . . . 74.340000000000003 111.657 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' NZ ' ' A' ' 41' ' ' LYS . 67.4 m-70 -76.74 -27.4 55.38 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.476 -0.329 . . . . 74.140000000000001 111.751 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 59.2 t -57.5 -45.68 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.327 0.584 . . . . 52.240000000000002 109.868 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.69 -41.79 95.69 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.751 -0.658 . . . . 64.340000000000003 112.91 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.3 ttpm? -59.25 -36.01 74.71 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.506 -0.408 . . . . 63.409999999999997 110.795 177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.48 -44.32 78.83 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.041 0.448 . . . . 33.240000000000002 111.266 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.2 mt -64.42 -30.42 71.46 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.921 0.391 . . . . 62.43 111.484 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.72 -10.7 58.81 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.364 -0.446 . . . . 55.329999999999998 113.17 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -87.69 -14.26 40.34 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.084 0.469 . . . . 52.5 110.721 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.71 152.51 51.68 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 54.420000000000002 111.929 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.73 -170.17 0.88 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.921 2.414 . . . . 64.219999999999999 112.595 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.648 ' HB2' ' HD2' ' A' ' 73' ' ' ARG . 39.5 tt0 -79.61 -63.17 1.47 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.177 -0.327 . . . . 70.120000000000005 111.416 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.37 72.9 0.76 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.382 -0.372 . . . . 63.039999999999999 113.092 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.3 t -115.45 143.41 45.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.715 0.406 . . . . 44.020000000000003 111.424 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.37 -23.24 61.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.274 0.559 . . . . 72.019999999999996 110.274 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.1 tp -91.2 110.34 41.84 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.528 -0.76 . . . . 51.119999999999997 110.036 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.89 94.49 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.015 1.81 . . . . 71.030000000000001 112.98 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -72.86 -34.92 67.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 111.448 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -67.32 1.0 2.42 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.567 0.951 . . . . 73.120000000000005 113.567 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.813 HH22 ' HA ' ' A' ' 17' ' ' LYS . 16.7 mmt85 -85.12 -20.96 29.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.609 0.596 . . . . 62.149999999999999 112.609 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 23' ' ' TYR . 16.1 t -108.43 102.21 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.139 0.495 . . . . 75.150000000000006 111.663 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.717 HD11 HD21 ' A' ' 93' ' ' LEU . 37.9 pt -109.15 -172.08 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.127 0.489 . . . . 72.209999999999994 111.891 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 5.8 p-10 -90.79 153.3 20.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.152 0.501 . . . . 55.240000000000002 111.933 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.7 m -65.21 -0.21 1.64 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.153 1.168 . . . . 64.420000000000002 114.153 -169.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.408 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 77.7 mt-30 -78.56 -20.37 50.73 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.74 -0.6 . . . . 74.420000000000002 111.673 175.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.48 44.73 6.4 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.915 -0.874 . . . . 72.510000000000005 110.915 -168.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -140.0 173.49 11.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.193 0.521 . . . . 74.540000000000006 111.169 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.88 131.81 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.767 -0.651 . . . . 74.329999999999998 109.948 173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 p -65.44 -50.1 66.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.971 0.415 . . . . 55.530000000000001 111.829 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.41 163.35 25.71 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.317 -0.402 . . . . 72.329999999999998 111.711 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 65.6 mttm -130.59 166.99 19.45 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.888 0.375 . . . . 72.040000000000006 111.902 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.23 -137.17 35.27 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.409 -0.424 . . . . 70.340000000000003 113.503 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -49.45 -42.8 43.99 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.307 0.484 . . . . 74.540000000000006 112.307 178.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.88 -29.0 67.2 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.721 0.296 . . . . 75.540000000000006 111.694 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 9.1 tt -65.97 -51.73 55.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.16 -0.311 . . . . 64.450000000000003 110.16 175.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 76' ' ' GLN . 55.3 m-20 -64.11 -36.89 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.724 0.297 . . . . 65.319999999999993 111.559 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.648 ' HD2' ' HB2' ' A' ' 48' ' ' GLU . 53.5 ttp85 -60.47 -53.13 61.26 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.093 0.473 . . . . 54.229999999999997 111.175 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? -59.63 -42.78 93.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.28 0.562 . . . . 74.549999999999997 110.108 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -54.28 -53.83 48.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.329 -0.851 . . . . 65.430000000000007 112.189 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 72' ' ' ASP . 29.0 mt-30 -55.76 -38.18 69.52 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.855 0.359 . . . . 64.219999999999999 111.748 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.7 -35.63 80.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.456 -0.338 . . . . 75.109999999999999 111.297 176.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 88.4 mt -65.15 -45.84 83.35 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.207 0.527 . . . . 75.430000000000007 110.88 174.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -56.71 -31.06 64.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.082 -0.508 . . . . 73.329999999999998 110.784 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.19 -29.98 65.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.347 -0.388 . . . . 64.349999999999994 111.425 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 12.8 mm-40 -80.58 -20.86 42.38 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 111.083 175.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.39 23.07 10.63 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.97 -0.559 . . . . 70.400000000000006 112.92 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 62.2 mt -97.53 136.19 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 112.112 0.412 . . . . 74.150000000000006 112.112 -175.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -75.7 135.4 40.39 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.442 -0.345 . . . . 75.310000000000002 111.385 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.72 117.18 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.832 0.349 . . . . 73.340000000000003 111.829 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.648 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 25.9 t -68.8 144.37 54.33 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.629 -0.26 . . . . 72.239999999999995 110.623 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -54.15 -28.72 41.88 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.764 0.653 . . . . 64.310000000000002 112.764 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.9 pt -80.91 10.39 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.896 0.379 . . . . 74.140000000000001 111.776 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.7 51.92 7.65 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 116.282 -0.417 . . . . 74.540000000000006 112.528 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 29.4 ttpp -125.96 129.09 48.57 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.608 -0.348 . . . . 72.109999999999999 111.727 -176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.6 HD12 HD13 ' A' ' 58' ' ' ILE . 46.2 mt -118.95 147.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 122.835 0.454 . . . . 75.540000000000006 111.545 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.97 92.96 9.32 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.056 0.455 . . . . 61.43 111.919 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.717 HD21 HD11 ' A' ' 58' ' ' ILE . 88.9 mt -62.31 -41.87 98.9 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.436 0.532 . . . . 71.450000000000003 112.436 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -56.27 -30.38 62.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.1 0.778 . . . . 71.230000000000004 113.1 -171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -99.11 -32.58 11.18 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.281 0.474 . . . . 64.519999999999996 112.281 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -88.4 12.07 15.2 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 111.899 0.333 . . . . 71.129999999999995 111.899 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -64.55 125.59 25.2 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.345 0.498 . . . . 73.129999999999995 112.345 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -84.7 136.81 33.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.525 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -120.89 98.97 47.35 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.103 0.409 . . . . 74.230000000000004 112.103 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.14 -24.61 79.56 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.258 1.972 . . . . 73.200000000000003 111.175 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 101' ' ' LEU . 5.4 mp -88.65 31.26 0.85 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.279 -0.873 . . . . 75.329999999999998 110.594 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.253 1.274 0 N-CA-C 113.181 0.808 . . . . 63.420000000000002 113.181 -176.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.629 -0.137 . . . . 52.329999999999998 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -62.9 128.27 35.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.785 0.326 . . . . 74.530000000000001 111.8 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.523 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 30.2 mm-40 -52.98 -44.46 67.21 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -45.0 -52.22 9.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.957 0.408 . . . . 74.129999999999995 111.691 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.19 -45.52 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.359 -0.382 . . . . 71.209999999999994 111.202 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.44 -38.56 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.027 0.442 . . . . 55.5 111.552 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.2 mm-40 -69.0 -52.88 24.18 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.401 -0.363 . . . . 71.450000000000003 111.774 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.8 pt -62.34 -39.56 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 111.715 0.265 . . . . 74.510000000000005 111.715 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.28 -43.08 92.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.496 0.189 . . . . 71.219999999999999 111.278 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.07 -41.36 71.42 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.133 0.492 . . . . 50.119999999999997 111.269 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.18 -43.8 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.165 -0.471 . . . . 70.530000000000001 111.21 175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.5 mt -64.14 -36.08 75.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 116.347 -0.388 . . . . 60.450000000000003 111.806 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -64.06 -21.64 66.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.806 0.336 . . . . 52.420000000000002 111.849 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -97.61 8.47 44.59 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.392 0.515 . . . . 72.329999999999998 112.392 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 39.2 mm -69.8 124.3 90.35 Favored Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 122.159 -0.338 . . . . 73.150000000000006 110.681 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.46 144.11 97.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.467 2.111 . . . . 74.510000000000005 113.138 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -55.23 111.68 0.92 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.122 -0.49 . . . . 73.5 111.76 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.0 9.86 56.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.045 -0.597 . . . . 71.319999999999993 113.753 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -111.64 152.25 27.88 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.251 -0.558 . . . . 64.439999999999998 111.315 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.83 166.06 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.283 0.563 . . . . 65.549999999999997 112.077 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.7 t -152.51 -178.63 6.96 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.794 -0.639 . . . . 73.430000000000007 110.472 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' OG1' ' HG2' ' A' ' 25' ' ' GLU . 34.2 p -117.71 153.68 32.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.767 0.318 . . . . 55.329999999999998 111.552 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -54.29 -35.91 63.12 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 111.252 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.04 -54.11 32.61 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.858 -0.61 . . . . 53.030000000000001 112.979 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' HG2' ' OG1' ' A' ' 22' ' ' THR . 59.3 mm-40 -63.76 -36.32 83.48 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.864 0.32 . . . . 74.030000000000001 111.864 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mm -58.26 -52.27 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.913 0.387 . . . . 62.420000000000002 111.038 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.23 -42.34 95.03 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.036 0.446 . . . . 44.229999999999997 111.274 177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -58.01 -46.0 85.96 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.317 -0.401 . . . . 75.319999999999993 111.838 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 72.7 mtm -72.23 -26.5 62.05 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.865 0.364 . . . . 63.329999999999998 111.469 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.17 -21.06 59.02 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.903 0.382 . . . . 64.219999999999999 111.331 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.61 12.84 34.12 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.37 -0.443 . . . . 65.129999999999995 113.701 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 78.3 m-85 -123.13 88.39 51.1 Favored Pre-proline 0 CA--C 1.544 0.718 0 O-C-N 122.382 -0.481 . . . . 70.129999999999995 111.573 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.63 139.34 25.19 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.150000000000006 113.008 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.16 -15.55 59.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.196 -0.526 . . . . 72.430000000000007 114.054 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -92.62 16.16 12.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.294 -0.533 . . . . 71.239999999999995 112.164 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.05 67.68 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.085 0.402 . . . . 75.430000000000007 112.085 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -53.8 -37.28 63.34 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.308 -0.405 . . . . 74.010000000000005 111.717 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -74.09 -27.93 61.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.428 -0.351 . . . . 75.150000000000006 111.593 -178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.2 t -60.92 -48.9 86.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.024 0.44 . . . . 65.040000000000006 109.865 173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.56 -33.53 87.48 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.178 -0.534 . . . . 71.340000000000003 112.716 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -58.34 -46.8 85.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.012 0.434 . . . . 74.409999999999997 111.273 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -54.11 15.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.168 -0.469 . . . . 41.229999999999997 111.883 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 66.2 mt -62.08 -37.55 85.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.904 0.383 . . . . 64.120000000000005 111.882 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.41 -2.16 40.45 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.341 -0.457 . . . . 72.310000000000002 113.677 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -97.76 -22.76 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.173 0.511 . . . . 54.509999999999998 110.765 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 52' ' ' LEU . 82.0 mt -70.98 153.74 94.55 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 116.047 -0.524 . . . . 74.129999999999995 112.36 -175.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.21 159.02 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.549 2.166 . . . . 74.439999999999998 112.136 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -66.39 -25.07 66.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 111.91 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -101.82 78.53 0.37 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.435 -0.412 . . . . 75.409999999999997 112.266 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.6 t -127.52 170.15 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.005 0.431 . . . . 61.43 111.595 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -84.83 -18.92 33.38 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.144 0.497 . . . . 62.240000000000002 110.455 176.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 46' ' ' LEU . 66.8 tp -97.83 111.36 58.8 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.966 -0.561 . . . . 63.039999999999999 110.597 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.81 94.94 1.0 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 121.505 1.47 . . . . 75.200000000000003 112.345 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 61.8 p-90 -85.71 -23.6 27.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.181 -0.463 . . . . 74.019999999999996 112.088 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -60.26 -24.39 64.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.865 0.691 . . . . 74.530000000000001 112.865 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -71.75 -3.91 24.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.239 0.459 . . . . 73.120000000000005 112.239 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 t -113.17 115.55 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.15 0.5 . . . . 61.009999999999998 111.752 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.591 HD11 HD21 ' A' ' 93' ' ' LEU . 16.8 pt -118.38 -168.89 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 116.288 -0.415 . . . . 73.299999999999997 111.24 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -88.91 171.44 9.9 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.496 0.554 . . . . 64.400000000000006 112.496 -176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.8 t -66.85 -16.92 64.62 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 62.240000000000002 112.498 -177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -76.58 -17.42 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.91 0.386 . . . . 74.430000000000007 111.205 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.6 20.85 46.16 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.283 -0.484 . . . . 32.109999999999999 112.184 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 82.8 tttt -120.17 161.13 21.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.045 0.45 . . . . 53.530000000000001 111.217 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' A' ' 74' ' ' GLN . 68.8 mt -67.44 125.64 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.334 -0.393 . . . . 72.109999999999999 110.705 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.9 p -67.14 -36.63 82.27 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.062 0.458 . . . . 73.219999999999999 111.768 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD13 ' HB3' ' A' ' 70' ' ' ASP . 80.4 mt -73.01 169.96 15.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.071 -0.513 . . . . 63.310000000000002 111.886 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -127.52 151.82 48.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 74.219999999999999 112.582 -174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 44.16 -109.54 0.27 Allowed Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.569 -0.742 . . . . 45.140000000000001 114.906 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -54.92 -45.24 74.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.173 0.511 . . . . 62.0 110.98 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.603 ' HB3' HD13 ' A' ' 66' ' ' LEU . 11.0 m-20 -79.32 -20.44 47.91 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.149 -0.478 . . . . 71.340000000000003 111.888 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 tt -70.86 -48.21 55.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.678 -0.49 . . . . 74.450000000000003 109.678 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 15.8 m-20 -59.54 -47.08 86.92 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 53.439999999999998 110.681 173.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 70' ' ' ASP . 22.7 ttm180 -48.47 -51.53 26.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.213 0.53 . . . . 64.219999999999999 111.106 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HB3' HD13 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -55.74 -57.98 9.74 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 111.014 176.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.66 -37.73 71.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.158 -0.473 . . . . 75.430000000000007 112.084 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 84.6 mm-40 -56.83 -46.55 81.61 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.034 0.445 . . . . 62.119999999999997 110.994 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.86 -41.56 82.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.287 -0.415 . . . . 61.219999999999999 111.571 178.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 91' ' ' ILE . 74.5 mt -62.37 -58.34 8.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.148 0.499 . . . . 75.140000000000001 111.844 178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -53.21 -30.5 38.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.28 -0.418 . . . . 61.009999999999998 111.639 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -59.53 -38.33 80.75 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.9 0.333 . . . . 43.119999999999997 111.9 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -87.25 3.19 47.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.912 0.386 . . . . 74.329999999999998 111.72 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.65 12.24 67.1 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.396 -0.43 . . . . 74.549999999999997 113.109 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 65.4 mt -75.89 125.01 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.047 0.451 . . . . 62.109999999999999 111.111 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.51 102.05 5.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 111.809 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.5 t -102.12 110.52 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.848 0.356 . . . . 62.140000000000001 111.379 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.3 t -54.55 149.29 10.83 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.301 -0.409 . . . . 63.340000000000003 111.876 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -47.47 -31.47 4.24 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.823 1.046 . . . . 71.530000000000001 113.823 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -82.71 7.86 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.076 0.398 . . . . 75.299999999999997 112.076 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.95 42.62 15.89 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.488 -0.387 . . . . 73.25 112.702 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -127.96 136.34 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.034 0.383 . . . . 73.430000000000007 112.034 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.742 HD11 HD13 ' A' ' 78' ' ' LEU . 59.9 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 120.926 0.393 . . . . 72.150000000000006 111.719 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.98 95.12 3.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.056 0.455 . . . . 71.150000000000006 110.945 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 58' ' ' ILE . 92.3 mt -56.17 -43.58 78.49 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.848 0.356 . . . . 75.030000000000001 111.501 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -61.39 -18.0 56.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.916 0.339 . . . . 74.319999999999993 111.916 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 96' ' ' TYR . 23.0 ttmm -88.99 -46.03 9.19 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.914 0.388 . . . . 64.099999999999994 111.278 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 95' ' ' LYS . 87.3 m-85 -104.2 15.16 28.97 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.697 0.628 . . . . 73.409999999999997 112.697 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -54.24 119.62 5.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.098 0.475 . . . . 61.32 112.246 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 28.9 t90 -100.43 134.84 42.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.31 0.576 . . . . 71.239999999999995 111.741 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -122.11 122.3 27.63 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.621 -0.718 . . . . 63.009999999999998 110.506 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.13 -22.96 72.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.64 2.226 . . . . 63.32 112.993 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -122.63 -171.57 2.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 122.546 0.338 . . . . 63.119999999999997 110.721 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.153 0 N-CA-C 112.069 0.396 . . . . 74.209999999999994 112.069 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.81 0.338 . . . . 73.209999999999994 110.956 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.05 155.62 40.34 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 111.529 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -57.23 -25.32 58.93 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.381 -0.372 . . . . 75.140000000000001 111.938 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -54.75 -55.19 32.58 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.129 0.49 . . . . 72.010000000000005 110.707 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.16 -43.44 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 111.251 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.46 -47.36 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.149 -0.478 . . . . 75.349999999999994 111.928 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -72.54 -49.14 34.72 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.694 0.627 . . . . 72.319999999999993 112.694 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -58.75 -41.21 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.122 -0.361 . . . . 62.229999999999997 111.747 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -65.9 -39.98 91.11 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.964 0.412 . . . . 63.009999999999998 110.95 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.53 83.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.299 -0.41 . . . . 73.209999999999994 111.689 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.9 t -63.63 -43.36 98.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.045 0.45 . . . . 73.140000000000001 110.823 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt -59.87 -42.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.945 -0.57 . . . . 73.219999999999999 111.924 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -62.89 -16.11 57.65 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.427 0.529 . . . . 74.439999999999998 112.427 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -105.54 12.02 31.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.314 0.487 . . . . 72.019999999999996 112.314 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.1 mt -74.71 129.62 83.19 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 120.568 0.223 . . . . 72.200000000000003 111.132 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 9.2 Cg_exo -73.27 -176.19 2.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.133 2.555 . . . . 75.329999999999998 113.314 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -80.7 119.88 23.88 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 62.119999999999997 111.275 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.68 10.23 86.0 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 114.47 0.548 . . . . 64.140000000000001 114.47 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -119.89 99.84 6.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.491 0.646 . . . . 53.210000000000001 111.086 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -91.92 176.13 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.433 0.635 . . . . 74.209999999999994 112.345 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.0 t -147.03 -179.83 7.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.239 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 32.6 p -116.04 154.59 29.63 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.481 -0.327 . . . . 73.340000000000003 111.543 -176.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -52.83 -45.39 67.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.053 0.39 . . . . 70.349999999999994 112.053 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.05 -41.06 97.37 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.921 -0.657 . . . . 62.549999999999997 112.856 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.01 -41.58 90.81 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.822 0.344 . . . . 41.32 111.328 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.9 mm -59.42 -49.62 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.859 0.361 . . . . 63.539999999999999 110.997 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -55.69 -46.72 77.56 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.38 -0.373 . . . . 54.509999999999998 111.473 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -58.21 -52.88 63.74 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.447 -0.342 . . . . 74.299999999999997 111.485 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.545 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 71.5 mtm -64.55 -29.6 70.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.978 0.362 . . . . 73.510000000000005 111.978 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.64 -16.01 59.67 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.901 0.334 . . . . 62.310000000000002 111.901 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.53 32.78 6.77 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.167 -0.539 . . . . 71.319999999999993 113.204 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.9 m-85 -139.48 53.41 4.8 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 122.311 -0.523 . . . . 72.549999999999997 111.543 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 27.9 Cg_exo -62.1 103.58 0.3 Allowed 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.317 2.012 . . . . 74.239999999999995 112.586 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.91 -24.03 2.88 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.162 -0.472 . . . . 61.200000000000003 112.642 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.46 26.02 2.78 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.535 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.09 -48.03 61.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.455 0.539 . . . . 40.350000000000001 112.455 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -64.66 -35.32 80.64 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.47 -0.332 . . . . 75.129999999999995 111.368 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -63.31 -38.34 90.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.705 0.288 . . . . 75.349999999999994 110.995 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 27' ' ' ALA . 31.3 t -59.68 -47.62 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.128 0.489 . . . . 74.129999999999995 110.582 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.48 -42.31 99.71 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.195 -0.526 . . . . 25.010000000000002 112.927 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -60.97 -47.19 87.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.93 0.395 . . . . 71.019999999999996 111.276 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.09 -52.13 60.73 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.226 -0.443 . . . . 53.32 112.004 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.4 mt -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.129 0.418 . . . . 73.120000000000005 112.129 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 -22.1 63.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.01 -0.614 . . . . 73.519999999999996 113.526 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -88.42 -7.88 55.89 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 122.514 -0.403 . . . . 72.230000000000004 111.553 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.5 mt -68.46 147.68 98.13 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 120.898 0.38 . . . . 74.200000000000003 111.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.67 163.17 29.46 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.589 2.193 . . . . 43.310000000000002 112.819 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HA ' ' HZ2' ' A' ' 54' ' ' TRP . 26.9 mp0 -59.46 -58.19 9.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.946 0.403 . . . . 72.299999999999997 111.833 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.6 65.13 3.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.298 -0.477 . . . . 71.25 113.781 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.9 t -109.24 152.15 25.58 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.415 -0.462 . . . . 64.230000000000004 111.624 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -76.18 -9.89 58.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.165 0.507 . . . . 71.349999999999994 111.055 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.522 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -97.11 120.5 61.18 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 110.379 175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 52' ' ' LEU . 62.0 Cg_endo -74.03 94.84 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.307 1.338 . . . . 72.519999999999996 112.556 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.527 ' HZ3' ' HB2' ' A' ' 74' ' ' GLN . 45.1 p-90 -84.06 -22.95 31.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.137 0.494 . . . . 74.319999999999993 111.884 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' O ' HD21 ' A' ' 78' ' ' LEU . 35.9 p90 -62.15 -23.41 66.56 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.704 0.631 . . . . 73.409999999999997 112.704 -178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -75.37 -9.65 58.76 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.791 0.663 . . . . 72.230000000000004 112.791 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.32 113.02 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.942 0.401 . . . . 73.519999999999996 111.151 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 34.9 pt -122.37 -172.02 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 121.227 0.537 . . . . 73.010000000000005 111.919 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.487 HD22 ' HB2' ' A' ' 61' ' ' GLN . 1.9 p-10 -88.6 145.45 25.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.981 0.419 . . . . 53.420000000000002 111.51 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.1 m -53.65 -16.19 1.51 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.683 0.994 . . . . 73.430000000000007 113.683 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB2' HD22 ' A' ' 59' ' ' ASN . 93.6 mt-30 -63.66 -11.62 27.13 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.115 0.413 . . . . 53.439999999999998 112.115 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.87 37.68 33.02 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.81 -0.709 . . . . 52.149999999999999 111.641 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 80.6 tttt -140.66 155.79 46.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 122.665 0.386 . . . . 75.530000000000001 110.903 -175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.578 HG23 ' OE1' ' A' ' 74' ' ' GLN . 45.8 mt -68.02 131.79 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.884 0.373 . . . . 73.019999999999996 111.321 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.0 p -70.66 -43.7 68.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.153 0.501 . . . . 70.329999999999998 111.305 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 70' ' ' ASP . 70.9 mt -69.9 159.66 33.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.898 -0.592 . . . . 71.540000000000006 111.532 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 53.5 pttt -147.17 130.18 16.33 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 112.053 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.63 -138.94 14.2 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 112.489 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -58.97 -40.63 85.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.959 0.409 . . . . 74.420000000000002 111.689 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.584 ' HB2' HD13 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -64.67 -34.11 77.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.815 178.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 8.7 tt -57.3 -43.91 83.63 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.073 0.463 . . . . 73.219999999999999 110.064 174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 63.5 m-20 -60.74 -41.81 96.12 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.079 -0.509 . . . . 72.129999999999995 111.37 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -60.96 -49.21 78.35 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.839 0.352 . . . . 72.319999999999993 110.962 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' OE1' HG23 ' A' ' 64' ' ' ILE . 38.2 tt0 -62.61 -44.59 95.91 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.312 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.32 -53.95 52.28 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.754 0.279 . . . . 75.340000000000003 111.754 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 87.2 mm-40 -58.01 -38.86 76.96 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.813 0.34 . . . . 53.350000000000001 111.781 -178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 80' ' ' ALA . 73.4 mmtt -63.19 -44.48 95.27 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.751 0.31 . . . . 75.319999999999993 111.315 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 91' ' ' ILE . 81.5 mt -64.81 -39.71 94.04 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.037 0.446 . . . . 73.109999999999999 111.408 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -67.52 -20.67 65.46 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 75.140000000000001 111.254 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 77' ' ' LYS . . . -64.24 -30.78 71.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.163 0.506 . . . . 73.340000000000003 110.75 173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.39 9.88 19.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.059 -0.519 . . . . 71.140000000000001 111.06 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.4 30.21 73.29 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.39 -0.433 . . . . 32.5 113.328 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.1 mt -84.41 129.31 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.996 0.427 . . . . 74.319999999999993 111.411 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.64 92.03 0.31 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 73.510000000000005 111.255 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.1 t -103.35 121.34 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.159 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.7 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 30.3 m -66.66 147.24 53.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 110.098 -0.334 . . . . 62.009999999999998 110.098 173.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' H ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -49.52 -33.71 15.38 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.612 1.338 . . . . 54.310000000000002 114.612 -172.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.2 pt -85.13 18.87 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 121.838 -0.539 . . . . 71.219999999999999 112.214 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 53.0 7.74 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.247 -0.501 . . . . 72.310000000000002 113.79 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -115.88 137.4 52.14 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.172 0.511 . . . . 64.329999999999998 112.297 176.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 78' ' ' LEU . 66.8 mt -130.85 137.22 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.106 -0.497 . . . . 75.109999999999999 111.168 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.89 92.77 5.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.985 0.421 . . . . 71.420000000000002 111.24 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 87.6 mt -58.4 -27.47 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.056 0.455 . . . . 73.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -47.48 -39.25 15.48 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.781 -0.645 . . . . 70.120000000000005 112.197 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -112.59 -15.21 13.08 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.294 0.479 . . . . 74.140000000000001 112.294 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -102.28 10.06 39.5 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.272 0.471 . . . . 64.530000000000001 112.272 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -69.67 130.25 41.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 74.019999999999996 111.842 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -87.0 132.39 33.8 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.243 0.544 . . . . 73.239999999999995 111.826 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.87 99.45 51.13 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.998 -0.546 . . . . 74.319999999999993 110.606 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 27.6 Cg_endo -62.5 -29.13 78.33 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.497 2.132 . . . . 51.140000000000001 112.318 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.1 mt -84.73 92.51 8.22 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.957 -0.565 . . . . 73.040000000000006 110.639 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.812 -0.613 . . . . 72.099999999999994 111.256 178.328 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.769 0.319 . . . . 71.299999999999997 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 6' ' ' VAL . 7.5 m-20 -83.41 173.5 11.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.194 0.813 . . . . 71.230000000000004 113.194 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.8 mp0 -47.73 -54.86 10.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.541 0.941 . . . . 72.310000000000002 113.541 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -45.8 -57.59 4.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.014 0.376 . . . . 73.129999999999995 112.014 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.95 -42.34 90.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.33 -0.395 . . . . 53.219999999999999 111.46 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 2' ' ' ASP . 66.3 t -56.02 -41.7 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.847 0.355 . . . . 72.329999999999998 111.941 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 24.6 mm-40 -70.94 -57.44 4.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.385 -0.371 . . . . 73.030000000000001 111.585 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 9' ' ' PHE . 29.8 pt -59.34 -41.95 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 111.763 0.283 . . . . 64.230000000000004 111.763 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' HG13 ' A' ' 8' ' ' ILE . 8.1 m-30 -61.49 -47.86 83.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.797 0.332 . . . . 70.340000000000003 111.04 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.97 65.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.946 0.403 . . . . 51.350000000000001 112.003 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.86 -47.18 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.343 -0.389 . . . . 64.450000000000003 111.409 178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 52' ' ' LEU . 74.4 mt -63.9 -35.01 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.199 0.444 . . . . 65.209999999999994 112.199 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -59.36 -18.04 35.09 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.078 -0.389 . . . . 53.420000000000002 111.942 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.67 12.43 32.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.24 0.83 . . . . 64.230000000000004 113.24 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' ILE . 41.5 mm -69.62 119.68 72.52 Favored Pre-proline 0 CA--C 1.546 0.801 0 O-C-N 122.07 -0.394 . . . . 74.530000000000001 110.592 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 63.2 Cg_endo -71.02 159.84 51.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.717 2.278 . . . . 71.019999999999996 113.66 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HA ' HH22 ' A' ' 56' ' ' ARG . 13.8 tmtt? -64.1 137.97 58.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.004 -0.544 . . . . 63.450000000000003 111.424 -177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.52 -15.51 18.5 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.349 -0.453 . . . . 63.200000000000003 114.04 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 46.0 mmtm -108.59 154.01 22.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.313 -0.522 . . . . 54.119999999999997 112.009 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.48 178.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.717 -0.674 . . . . 72.219999999999999 110.637 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -149.79 -177.21 5.76 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.082 0.468 . . . . 65.400000000000006 111.498 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -121.08 152.23 38.91 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.366 -0.379 . . . . 71.510000000000005 111.62 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -54.51 -37.19 65.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.056 0.391 . . . . 73.230000000000004 112.056 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.34 -48.8 84.35 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.254 -0.498 . . . . 71.409999999999997 112.719 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.2 -41.64 94.33 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 122.735 -0.273 . . . . 72.319999999999993 111.564 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.97 -47.26 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.047 0.451 . . . . 61.439999999999998 110.77 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -59.58 -46.32 89.29 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.062 -0.517 . . . . 34.520000000000003 111.604 177.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 68.2 mttm -57.81 -44.87 86.66 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.058 0.456 . . . . 74.150000000000006 111.772 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.513 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 75.9 mtm -72.65 -30.37 64.23 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.41 -0.359 . . . . 73.319999999999993 111.894 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.54 -19.3 49.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.969 0.359 . . . . 74.349999999999994 111.969 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.38 21.89 28.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.339 -0.458 . . . . 75.049999999999997 113.394 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 76.6 m-85 -128.87 66.88 76.77 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.479 -0.424 . . . . 71.409999999999997 110.811 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -54.83 -33.28 80.85 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.374 2.716 . . . . 73.450000000000003 114.543 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.1 -5.43 70.46 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.837 -0.697 . . . . 74.219999999999999 114.006 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 84.9 m-85 -98.51 20.83 12.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.643 0.609 . . . . 75.349999999999994 112.643 -175.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.94 43.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.652 0.612 . . . . 61.310000000000002 112.652 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.08 -34.91 77.3 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.924 0.392 . . . . 73.129999999999995 111.674 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.453 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 36.7 m80 -59.31 -38.9 81.43 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.749 0.309 . . . . 75.329999999999998 111.697 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 35' ' ' TYR . 63.8 t -58.87 -54.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.023 0.44 . . . . 64.239999999999995 110.953 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.37 97.53 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.208 -0.52 . . . . 50.350000000000001 113.101 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -62.03 -32.65 73.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.947 0.403 . . . . 73.439999999999998 111.082 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.44 -44.31 65.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.283 -0.417 . . . . 62.130000000000003 111.592 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.5 -19.67 57.66 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.305 0.483 . . . . 74.340000000000003 112.305 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.42 12.53 1.31 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 121.339 -0.458 . . . . 71.209999999999994 114.094 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -106.99 -1.85 21.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.109 0.48 . . . . 73.430000000000007 111.064 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 HD23 ' A' ' 52' ' ' LEU . 81.2 mt -88.95 144.77 33.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 112.001 0.371 . . . . 63.539999999999999 112.001 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.84 175.23 11.45 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.797 2.332 . . . . 64.230000000000004 113.317 176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -33.12 73.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.1 0.407 . . . . 62.439999999999998 112.1 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.44 47.61 1.03 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 121.21 -0.519 . . . . 72.530000000000001 113.026 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 p -79.44 154.16 29.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.002 0.43 . . . . 74.239999999999995 111.903 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.24 -43.31 78.2 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.31 0.576 . . . . 74.099999999999994 110.265 174.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.8 tp -76.62 109.67 9.37 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.594 -0.73 . . . . 63.210000000000001 110.51 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 73.7 Cg_endo -77.32 95.26 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.581 1.521 . . . . 72.129999999999995 113.336 -175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.424 ' HB3' HD12 ' A' ' 46' ' ' LEU . 53.6 p-90 -73.51 -29.71 62.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.856 -0.611 . . . . 65.25 111.824 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.522 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 52.8 p90 -64.23 -4.33 3.6 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.965 0.728 . . . . 55.020000000000003 112.965 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.531 HH22 ' HA ' ' A' ' 17' ' ' LYS . 27.1 mtp85 -100.15 -3.4 31.8 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.883 0.327 . . . . 73.010000000000005 111.883 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.78 107.82 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.187 0.518 . . . . 53.539999999999999 111.458 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.667 HD11 HD21 ' A' ' 93' ' ' LEU . 30.1 pt -107.38 -170.3 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 111.661 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -86.52 158.32 19.57 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.961 -0.462 . . . . 63.210000000000001 111.682 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.2 m -52.81 -28.09 21.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.898 1.073 . . . . 74.209999999999994 113.898 -171.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -89.13 18.9 4.59 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.078 0.77 . . . . 73.140000000000001 113.078 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.33 49.29 62.0 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 114.579 0.592 . . . . 64.239999999999995 114.579 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 97.6 mttt -143.53 160.34 40.8 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.253 -0.557 . . . . 74.120000000000005 110.75 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.6 mt -71.57 114.66 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.282 0.563 . . . . 73.519999999999996 110.917 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 p -67.46 -62.61 1.34 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.929 -0.578 . . . . 73.140000000000001 111.091 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.32 105.95 1.92 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.174 0.511 . . . . 71.120000000000005 110.614 177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 2.1 ptpp? -114.1 170.45 8.27 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.231 0.539 . . . . 54.229999999999997 112.274 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.7 -133.85 11.51 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.013 -0.835 . . . . 45.030000000000001 111.013 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.76 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -67.54 -29.45 68.85 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 117.561 0.681 . . . . 62.310000000000002 110.404 172.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.9 -32.78 73.19 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.673 -0.694 . . . . 71.439999999999998 111.129 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -62.58 -58.78 6.34 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.296 -0.411 . . . . 52.210000000000001 111.013 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -66.98 -33.32 75.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.586 0.232 . . . . 44.219999999999999 111.619 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 73' ' ' ARG . 1.2 tpm_? -58.24 -52.04 67.23 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.004 0.43 . . . . 70.319999999999993 110.591 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.522 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.7 tt0 -64.16 -40.27 95.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.178 -0.465 . . . . 45.549999999999997 110.812 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -53.9 -50.2 66.89 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.153 -0.476 . . . . 54.25 111.393 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.47 -34.56 75.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.898 0.38 . . . . 72.519999999999996 111.605 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -63.44 -44.29 94.94 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.122 0.487 . . . . 72.25 111.078 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.1 mt -67.67 -36.96 81.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 72.510000000000005 111.284 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.6 -37.05 80.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.928 0.394 . . . . 71.439999999999998 110.958 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.77 -30.4 70.77 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.229 0.538 . . . . 71.420000000000002 111.218 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -83.62 -13.11 55.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.034 -0.53 . . . . 62.329999999999998 111.517 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.41 32.61 30.59 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.243 -0.503 . . . . 53.43 112.954 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 68.9 mt -94.7 127.84 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.128 0.489 . . . . 74.230000000000004 112.187 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.17 95.92 0.6 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.152 0.501 . . . . 74.129999999999995 111.439 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.68 116.29 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.109 -0.496 . . . . 61.229999999999997 110.882 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 47.7 t -64.07 138.8 58.63 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.687 -0.233 . . . . 72.329999999999998 111.284 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -43.05 -41.27 3.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.94 0.896 . . . . 70.209999999999994 113.364 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.3 pt -80.17 16.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.773 0.657 . . . . 75.140000000000001 112.773 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.12 41.79 30.91 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.171 -0.538 . . . . 61.310000000000002 113.092 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.3 ttpt -122.48 143.43 49.71 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.752 -0.263 . . . . 75.099999999999994 111.128 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 58' ' ' ILE . 68.3 mt -119.84 135.73 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.983 0.42 . . . . 62.450000000000003 111.416 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 93.82 6.86 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.228 0.537 . . . . 72.5 111.551 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD21 HD11 ' A' ' 58' ' ' ILE . 85.5 mt -59.77 -36.17 76.12 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.293 0.479 . . . . 75.450000000000003 112.293 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -52.48 -28.58 20.87 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.256 0.465 . . . . 73.439999999999998 112.256 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.7 ptmt -112.19 -7.94 14.01 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.217 0.451 . . . . 75.299999999999997 112.217 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.463 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 76.3 m-85 -125.45 14.39 8.23 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.283 0.846 . . . . 74.430000000000007 113.283 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -74.24 139.42 44.33 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.358 0.503 . . . . 73.230000000000004 112.358 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -99.24 131.14 45.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.085 0.469 . . . . 55.219999999999999 111.428 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -115.32 99.78 52.8 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 116.076 -0.511 . . . . 73.019999999999996 110.906 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.513 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 38.2 Cg_exo -57.46 -48.23 18.31 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.052 2.501 . . . . 63.219999999999999 112.476 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.5 mt -113.38 102.0 9.92 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.069 -0.514 . . . . 64.450000000000003 109.837 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 119.061 -0.495 . . . . 73.340000000000003 112.272 -177.192 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 15.3 ptt? . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 112.205 0.446 . . . . 73.049999999999997 112.205 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 16.0 t70 -173.99 128.07 0.38 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 110.059 -0.349 . . . . 72.329999999999998 110.059 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -56.68 -41.08 76.69 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.221 0.452 . . . . 63.200000000000003 112.221 -175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 43.2 t80 -57.31 -52.07 66.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.87 0.367 . . . . 75.120000000000005 110.765 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.9 mt -59.2 -47.25 86.03 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 111.526 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' ASP . 85.9 t -55.88 -43.61 75.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 111.958 0.355 . . . . 74.329999999999998 111.958 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -68.6 -52.68 28.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.112 0.412 . . . . 73.310000000000002 112.112 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 39' ' ' VAL . 31.2 pt -59.66 -39.28 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.839 0.352 . . . . 62.200000000000003 111.279 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -64.79 -39.42 93.58 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.664 0.269 . . . . 73.209999999999994 110.95 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -35.08 68.17 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.096 0.474 . . . . 51.340000000000003 111.293 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.0 t -68.79 -39.59 80.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.806 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.2 mt -66.69 -35.12 74.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.064 -0.516 . . . . 54.219999999999999 112.092 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -62.49 -19.01 63.13 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.004 -0.435 . . . . 62.039999999999999 111.355 175.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -91.38 6.19 46.36 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.69 0.626 . . . . 65.329999999999998 112.69 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 12' ' ' ILE . 29.1 mm -78.1 126.81 83.05 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.213 -0.304 . . . . 74.150000000000006 110.65 176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.32 167.22 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.545 2.164 . . . . 63.200000000000003 113.404 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.4 tmtp? -63.31 128.33 35.37 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.831 -0.622 . . . . 74.030000000000001 111.806 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.36 15.54 79.83 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 73.400000000000006 114.145 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.87 154.26 37.31 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.431 -0.453 . . . . 74.230000000000004 111.282 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 91' ' ' ILE . 33.1 m -120.4 170.9 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.283 0.563 . . . . 63.210000000000001 111.724 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.6 p -147.51 170.6 17.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.888 -0.596 . . . . 61.200000000000003 110.657 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 35.7 p -113.74 146.01 40.51 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.691 0.281 . . . . 60.43 111.45 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -53.05 -39.35 63.18 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.954 0.406 . . . . 43.219999999999999 111.218 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.89 99.85 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.001 -0.545 . . . . 41.32 113.643 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.84 -37.87 58.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.283 0.541 . . . . 74.010000000000005 111.741 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mm -56.39 -57.97 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.936 0.398 . . . . 73.510000000000005 111.065 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.33 -45.57 90.99 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.077 0.465 . . . . 43.009999999999998 111.176 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -49.11 -50.35 37.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.814 -0.63 . . . . 55.009999999999998 112.328 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.6 -19.14 46.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 74.329999999999998 112.24 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 -7.58 57.67 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.744 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 16.04 40.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.294 -0.479 . . . . 43.520000000000003 113.122 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 73.4 m-85 -130.51 86.24 53.79 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.547 0.339 . . . . 75.230000000000004 110.698 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.69 -51.92 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 122.233 1.955 . . . . 74.099999999999994 114.338 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.57 56.82 1.0 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.849 -0.691 . . . . 34.340000000000003 114.109 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 32' ' ' TYR . 97.9 m-85 -141.89 21.5 2.13 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.352 0.501 . . . . 73.049999999999997 112.352 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.25 70.08 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.702 0.631 . . . . 42.030000000000001 112.702 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.29 -45.92 92.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.742 0.305 . . . . 73.129999999999995 111.376 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -60.22 -37.33 79.99 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.28 -0.418 . . . . 72.420000000000002 111.222 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG21 ' HB2' ' A' ' 27' ' ' ALA . 59.1 t -59.81 -52.67 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.076 0.465 . . . . 74.099999999999994 110.923 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.44 -41.02 95.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.948 -0.569 . . . . 24.329999999999998 113.232 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -60.95 -41.02 95.47 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.761 0.315 . . . . 73.329999999999998 111.489 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.77 62.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.978 0.418 . . . . 70.239999999999995 111.52 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -61.7 -36.87 82.15 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.219 -0.446 . . . . 63.049999999999997 111.757 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.17 57.53 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.103 -0.57 . . . . 54.299999999999997 113.481 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -94.62 -0.42 54.47 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.531 -0.393 . . . . 73.140000000000001 112.04 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 54' ' ' TRP . 97.0 mt -83.62 147.87 53.45 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 120.601 0.238 . . . . 64.409999999999997 111.347 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.48 157.12 53.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.215 1.943 . . . . 61.329999999999998 111.786 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.51 -58.96 4.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.902 0.382 . . . . 72.209999999999994 111.438 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.96 55.07 5.02 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.111 -0.566 . . . . 62.43 112.863 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.1 t -78.88 161.13 26.94 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.975 0.417 . . . . 61.25 111.704 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -66.02 -28.99 69.28 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.454 0.645 . . . . 75.530000000000001 110.415 173.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.446 HD11 ' HB ' ' A' ' 12' ' ' ILE . 55.6 tp -101.6 118.79 58.98 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.636 -0.711 . . . . 72.430000000000007 110.905 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.01 95.36 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.698 1.599 . . . . 63.520000000000003 111.958 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 46' ' ' LEU . 62.6 p-90 -85.62 -32.3 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.664 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.475 ' O ' HD21 ' A' ' 78' ' ' LEU . 31.2 p90 -54.49 -25.51 25.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.256 0.835 . . . . 64.219999999999999 113.256 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -72.83 -22.21 60.84 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.559 0.578 . . . . 74.120000000000005 112.559 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.13 110.24 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.203 0.525 . . . . 63.310000000000002 111.563 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.57 HD13 HD12 ' A' ' 91' ' ' ILE . 27.2 pt -115.94 -169.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.191 0.519 . . . . 71.150000000000006 111.403 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -80.82 167.39 19.98 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.798 0.332 . . . . 73.450000000000003 111.423 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 t -79.89 11.1 3.51 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.055 0.455 . . . . 62.340000000000003 111.547 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -95.55 -15.34 22.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.35 -0.387 . . . . 64.430000000000007 110.952 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.83 7.67 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.157 -0.544 . . . . 71.329999999999998 113.268 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 84.5 tttt -146.07 154.55 41.97 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 122.504 -0.409 . . . . 72.150000000000006 111.557 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.512 HG21 ' HG ' ' A' ' 71' ' ' LEU . 69.8 mt -57.79 138.52 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.316 -0.402 . . . . 75.140000000000001 111.208 174.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.8 p -79.39 -32.43 43.01 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.398 0.518 . . . . 74.340000000000003 112.398 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.2 mt -72.28 169.75 15.56 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.241 0.543 . . . . 74.040000000000006 112.19 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -143.05 143.75 32.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.277 -0.419 . . . . 70.120000000000005 110.725 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.3 25.76 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.028 -0.606 . . . . 51.520000000000003 112.667 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.55 -24.16 65.5 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.288 -0.537 . . . . 74.319999999999993 111.987 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -65.75 -26.4 67.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.022 0.439 . . . . 72.120000000000005 110.771 175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.512 ' HG ' HG21 ' A' ' 64' ' ' ILE . 9.7 tt -66.31 -41.11 90.16 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.083 -0.508 . . . . 71.239999999999995 109.755 172.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 1.1 m-20 -55.23 -44.39 75.43 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.203 -0.453 . . . . 52.350000000000001 111.191 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 1.0 OUTLIER -52.71 -54.19 37.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.738 0.304 . . . . 75.329999999999998 111.347 176.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -61.04 -45.1 96.14 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.524 -0.307 . . . . 72.200000000000003 110.865 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.7 tttm -53.54 -53.77 46.84 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.084 -0.507 . . . . 75.549999999999997 112.01 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 9.4 mm100 -60.94 -32.57 72.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.417 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.54 -39.64 81.05 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 110.74 175.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD13 HD11 ' A' ' 91' ' ' ILE . 77.0 mt -62.42 -43.06 99.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.057 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.51 -30.36 71.12 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.379 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.04 -23.57 67.23 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.345 0.593 . . . . 35.009999999999998 110.832 172.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -90.16 0.62 57.08 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.928 -0.578 . . . . 64.310000000000002 111.504 173.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.6 15.08 81.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.154 -0.546 . . . . 64.120000000000005 113.12 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.2 mt -80.05 124.06 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.225 0.536 . . . . 72.019999999999996 111.595 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -67.62 92.2 0.32 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.841 -0.618 . . . . 64.409999999999997 111.354 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 75' ' ' LYS . 41.3 t -80.97 105.81 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.189 -0.46 . . . . 61.240000000000002 110.47 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 48.8 m -59.87 144.26 49.18 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.482 -0.326 . . . . 62.140000000000001 111.147 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -35.6 -49.98 0.59 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.562 1.319 . . . . 64.420000000000002 114.562 -171.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.2 pt -86.45 25.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.929 0.714 . . . . 54.210000000000001 112.929 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.89 28.24 57.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.391 -0.433 . . . . 74.230000000000004 113.812 177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 86' ' ' SER . 89.5 mttt -98.74 150.42 21.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.37 0.605 . . . . 74.349999999999994 112.181 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 78' ' ' LEU . 63.5 mt -126.89 114.48 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 115.72 -0.673 . . . . 73.349999999999994 110.2 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.63 94.65 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.131 0.491 . . . . 72.030000000000001 111.526 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD21 HD11 ' A' ' 58' ' ' ILE . 99.0 mt -54.92 -39.01 68.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 112.071 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -55.99 -22.55 27.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.757 0.651 . . . . 55.0 112.757 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.466 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 22.4 ptmt -112.99 -15.35 12.87 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.504 0.557 . . . . 72.439999999999998 112.504 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.466 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 68.9 m-85 -117.86 3.27 12.22 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.858 1.058 . . . . 73.099999999999994 113.858 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -65.63 137.5 57.38 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.265 0.555 . . . . 53.420000000000002 111.691 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -80.34 123.01 27.63 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 111.718 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -100.49 102.32 18.4 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.917 -0.583 . . . . 75.299999999999997 110.406 175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.21 6.12 5.28 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.716 2.277 . . . . 74.549999999999997 113.552 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.66 91.9 2.09 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.325 0.583 . . . . 74.120000000000005 111.784 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.363 -0.827 . . . . 64.040000000000006 112.138 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG3' ' HB2' ' A' ' 5' ' ' LEU . 16.8 ttt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.066 -0.346 . . . . 65.549999999999997 110.066 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 54.63 33.25 18.82 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.226 0.824 . . . . 72.430000000000007 113.226 166.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 68.8 -30.03 0.18 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.545 0.943 . . . . 70.530000000000001 113.545 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -48.44 -57.46 6.06 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.044 0.449 . . . . 70.109999999999999 111.494 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 92.9 mt -62.01 -37.95 86.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.04 -0.527 . . . . 53.109999999999999 111.289 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.25 -48.76 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.912 0.387 . . . . 44.329999999999998 111.68 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -65.89 -52.22 52.0 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.399 -0.364 . . . . 74.019999999999996 111.896 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 31.3 pt -59.82 -39.2 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 111.876 0.325 . . . . 72.409999999999997 111.876 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.47 -41.74 93.03 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.928 0.394 . . . . 73.430000000000007 111.261 177.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.04 -33.11 66.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.944 0.402 . . . . 54.240000000000002 111.38 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' HA ' HE21 ' A' ' 14' ' ' GLN . 61.1 t -72.3 -40.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.19 -0.459 . . . . 52.130000000000003 111.592 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' ILE . 72.3 mt -60.37 -37.36 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.454 0.538 . . . . 63.43 112.454 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -65.69 -10.05 33.03 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.463 0.542 . . . . 63.310000000000002 112.463 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' A' ' 11' ' ' VAL . 50.3 mt-30 -100.31 11.7 38.81 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.066 0.765 . . . . 65.420000000000002 113.066 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 12' ' ' ILE . 26.3 mm -83.71 117.63 69.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 O-C-N 122.039 -0.413 . . . . 71.400000000000006 111.232 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.31 156.44 25.59 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.099 2.532 . . . . 73.120000000000005 113.619 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.901 ' HA ' HH22 ' A' ' 56' ' ' ARG . 0.1 OUTLIER -69.94 128.22 35.61 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.997 -0.439 . . . . 71.140000000000001 111.498 -176.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.96 1.67 69.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.164 -0.541 . . . . 31.039999999999999 113.457 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -123.42 154.07 39.54 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.921 0.391 . . . . 71.129999999999995 111.44 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.0 m -128.02 175.44 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.036 0.446 . . . . 74.200000000000003 111.858 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -145.86 178.97 7.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.399 -0.364 . . . . 42.549999999999997 110.986 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 22.3 p -112.26 159.48 18.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.824 0.345 . . . . 64.040000000000006 111.726 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -56.17 -35.92 67.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.013 0.435 . . . . 74.140000000000001 110.932 176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -68.6 -53.97 17.82 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.946 -0.57 . . . . 61.210000000000001 113.007 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.36 -42.2 77.41 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.765 0.283 . . . . 74.0 111.765 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.98 -47.86 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.971 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.51 -45.05 95.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.763 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.2 mttt -57.39 -51.98 67.2 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.53 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 74.6 mtm -66.18 -20.72 66.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.269 -0.423 . . . . 70.519999999999996 111.903 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.21 -21.2 33.51 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.872 0.368 . . . . 74.450000000000003 111.366 174.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.47 17.4 26.63 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.299 -0.477 . . . . 61.5 113.484 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.52 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 98.0 m-85 -122.4 86.61 48.37 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 120.988 0.423 . . . . 75.120000000000005 111.115 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.32 134.0 18.45 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.717 2.278 . . . . 64.230000000000004 113.164 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.89 -10.76 73.8 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.053 -0.594 . . . . 70.129999999999995 113.745 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HA ' ' ND1' ' A' ' 38' ' ' HIS . 65.1 m-85 -82.33 23.2 0.77 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.628 0.603 . . . . 74.230000000000004 112.628 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.37 68.54 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.094 0.473 . . . . 71.219999999999999 111.614 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -60.44 -38.75 85.13 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 120.841 0.353 . . . . 73.140000000000001 111.598 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.533 ' ND1' ' HA ' ' A' ' 35' ' ' TYR . 56.5 m80 -63.46 -48.79 76.23 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.41 -0.359 . . . . 60.420000000000002 111.404 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 35' ' ' TYR . 97.8 t -57.71 -43.54 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.827 0.346 . . . . 71.400000000000006 111.117 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.91 -46.73 93.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.103 -0.57 . . . . 70.540000000000006 113.026 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -65.62 -35.65 81.43 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.979 0.418 . . . . 70.230000000000004 111.329 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.41 -48.41 67.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.341 -0.39 . . . . 62.020000000000003 111.866 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.49 -33.26 75.19 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.859 0.361 . . . . 74.099999999999994 111.259 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.28 -4.12 21.77 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 121.248 -0.501 . . . . 65.219999999999999 113.595 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -85.02 -16.38 40.95 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.045 0.45 . . . . 65.329999999999998 110.83 176.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.5 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.2 mt -79.75 156.07 75.36 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 120.956 0.407 . . . . 45.0 112.005 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.89 -165.32 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.993 2.462 . . . . 74.209999999999994 113.523 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -45.28 -59.76 2.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.788 0.662 . . . . 71.209999999999994 112.788 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.93 77.19 0.2 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.831 -0.699 . . . . 73.219999999999999 113.245 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -72.47 176.37 5.44 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.891 0.377 . . . . 71.239999999999995 111.288 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -61.8 -22.69 65.68 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.888 0.375 . . . . 71.219999999999999 111.376 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 53' ' ' PRO . 56.7 tp -90.61 114.46 61.32 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 110.541 173.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.2 Cg_endo -74.73 95.92 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 121.998 1.798 . . . . 53.340000000000003 112.869 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.604 ' HZ3' HD11 ' A' ' 66' ' ' LEU . 62.2 p-90 -86.13 -22.82 26.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.184 0.516 . . . . 63.210000000000001 111.854 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.419 ' HB2' ' HG3' ' A' ' 74' ' ' GLN . 46.6 p90 -62.42 -12.22 20.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.117 0.784 . . . . 64.230000000000004 113.117 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.901 HH22 ' HA ' ' A' ' 17' ' ' LYS . 31.6 mtt-85 -87.46 1.38 53.62 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.589 0.589 . . . . 72.140000000000001 112.589 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 t -118.63 112.96 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.333 0.587 . . . . 64.450000000000003 111.982 -175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.571 HD11 HD21 ' A' ' 93' ' ' LEU . 20.8 pt -111.84 -174.72 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 111.533 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.553 HD22 ' HB2' ' A' ' 65' ' ' SER . 10.6 p30 -92.83 175.03 6.95 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.901 -0.499 . . . . 72.230000000000004 111.816 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.4 p -59.73 -29.96 68.49 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.829 0.677 . . . . 71.430000000000007 112.829 -175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -67.71 -20.27 65.25 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.848 0.356 . . . . 73.519999999999996 111.774 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.67 45.52 5.46 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.953 -0.459 . . . . 53.439999999999998 111.953 -173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 87.4 tttt -145.43 159.58 42.86 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.263 0.554 . . . . 65.519999999999996 111.666 -176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 63' ' ' LYS . 69.2 mt -75.57 112.97 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.105 -0.498 . . . . 71.310000000000002 110.535 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.553 ' HB2' HD22 ' A' ' 59' ' ' ASN . 24.7 t -84.84 51.96 2.29 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 65.340000000000003 111.732 -176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 93.4 mt -131.24 -167.66 1.88 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 111.961 -175.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -97.89 172.04 7.9 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.81 -0.632 . . . . 64.420000000000002 110.709 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.29 56.58 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 113.89 0.316 . . . . 64.150000000000006 113.89 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 73' ' ' ARG . 68.5 mtt85 -60.3 -57.69 11.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.533 0.682 . . . . 63.439999999999998 110.936 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.3 m-20 -65.29 -24.66 67.35 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.474 -0.785 . . . . 75.109999999999999 111.929 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.56 -55.27 25.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.438 -0.346 . . . . 63.210000000000001 110.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.41 -33.31 72.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.757 -0.202 . . . . 70.420000000000002 111.505 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 69' ' ' ARG . 9.5 mpt_? -53.71 -63.49 1.13 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.096 0.474 . . . . 64.319999999999993 110.879 172.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 55' ' ' PHE . 53.6 tt0 -59.45 -44.99 92.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.798 -0.637 . . . . 75.439999999999998 111.395 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 58.7 tttm -57.16 -49.76 74.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 112.042 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -58.73 -38.97 79.53 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.073 0.464 . . . . 71.340000000000003 111.575 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.743 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.4 mmpt? -66.93 -34.83 78.63 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.978 0.418 . . . . 75.209999999999994 111.166 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD13 HD11 ' A' ' 91' ' ' ILE . 95.9 mt -74.07 -42.11 60.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.052 0.454 . . . . 74.109999999999999 111.624 177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 44.9 mt-10 -66.32 -27.86 68.23 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.153 -0.342 . . . . 73.0 110.753 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.18 -24.93 67.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.274 0.559 . . . . 64.129999999999995 110.998 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.79 3.16 55.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.848 -0.614 . . . . 61.420000000000002 111.588 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.01 46.15 37.88 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.247 -0.501 . . . . 52.149999999999999 113.073 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.96 131.5 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.018 0.437 . . . . 51.039999999999999 111.847 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -71.28 106.21 3.76 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.919 -0.582 . . . . 73.230000000000004 111.312 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.96 120.73 62.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.948 0.404 . . . . 70.049999999999997 111.159 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 40.5 t -65.87 150.6 48.34 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.56 -0.291 . . . . 54.340000000000003 111.713 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' HG3' HG23 ' A' ' 88' ' ' ILE . 11.7 pt-20 -44.22 -41.06 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.053 0.941 . . . . 74.409999999999997 113.538 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 87' ' ' GLU . 38.5 pt -83.96 20.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 112.018 0.377 . . . . 72.400000000000006 112.018 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.16 41.99 91.81 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.567 -0.349 . . . . 62.130000000000003 112.86 -177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 38.2 ttpt -114.75 131.8 56.66 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.484 -0.421 . . . . 74.099999999999994 111.556 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.658 HD11 HD13 ' A' ' 78' ' ' LEU . 61.1 mt -115.31 129.42 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.862 0.363 . . . . 73.099999999999994 111.046 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 99.11 2.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.998 0.428 . . . . 75.319999999999993 111.189 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.571 HD21 HD11 ' A' ' 58' ' ' ILE . 90.7 mt -55.7 -36.5 67.25 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.556 -0.293 . . . . 72.420000000000002 111.588 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 10.7 mmt180 -52.88 -19.98 2.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.072 0.768 . . . . 71.109999999999999 113.072 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.403 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 19.4 ptpt -112.44 -42.74 3.61 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.287 0.477 . . . . 71.430000000000007 112.287 176.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 57.3 m-85 -95.08 9.25 40.24 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.726 1.01 . . . . 73.409999999999997 113.726 -175.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -66.46 138.4 57.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.021 0.438 . . . . 73.140000000000001 111.498 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.429 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 23.8 t90 -90.49 142.6 27.57 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 111.646 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -106.38 96.47 13.78 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 111.059 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 37.6 Cg_exo -61.59 -42.42 33.11 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.546 2.164 . . . . 55.450000000000003 112.74 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.8 mt -131.47 -66.55 0.72 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.372 -0.376 . . . . 75.209999999999994 111.089 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 119.044 -0.503 . . . . 61.219999999999999 111.978 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.774 0.321 . . . . 63.420000000000002 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -65.47 150.74 47.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.208 0.447 . . . . 71.239999999999995 112.208 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 79.8 mm-40 -55.0 -30.73 60.08 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.43 0.53 . . . . 63.229999999999997 112.43 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -51.94 -49.8 62.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.126 0.488 . . . . 62.340000000000003 110.568 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.9 mt -68.32 -46.14 71.01 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.843 -0.617 . . . . 63.310000000000002 111.094 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -55.8 -42.43 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.416 -0.356 . . . . 63.310000000000002 111.913 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 11' ' ' VAL . 31.2 mm-40 -68.88 -49.49 57.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.103 0.408 . . . . 60.32 112.103 -177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.633 HG13 ' HD1' ' A' ' 9' ' ' PHE . 33.6 pt -62.9 -40.38 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 O-C-N 122.118 -0.364 . . . . 73.239999999999995 111.422 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' HD1' HG13 ' A' ' 8' ' ' ILE . 2.9 m-85 -59.46 -48.86 80.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.876 0.369 . . . . 70.010000000000005 110.905 174.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 -38.9 67.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.279 -0.418 . . . . 72.519999999999996 112.085 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 7' ' ' GLN . 47.1 t -61.57 -46.21 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 111.058 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.573 ' HB ' HD11 ' A' ' 52' ' ' LEU . 64.8 mt -66.44 -38.31 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 115.989 -0.551 . . . . 72.140000000000001 112.225 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -58.91 -25.5 63.48 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 122.194 -0.316 . . . . 54.109999999999999 111.707 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -85.45 -3.78 58.96 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.915 0.709 . . . . 71.109999999999999 112.915 -176.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -71.17 127.1 91.86 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 122.096 -0.378 . . . . 73.400000000000006 111.43 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.69 166.82 24.97 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.734 2.29 . . . . 73.099999999999994 114.041 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 81' ' ' GLU . 1.7 tmtp? -60.0 121.73 12.56 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.846 -0.616 . . . . 72.239999999999995 112.305 -177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.61 17.75 47.71 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.244 -0.503 . . . . 33.229999999999997 113.839 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -122.4 143.78 49.45 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.225 0.536 . . . . 71.319999999999993 112.073 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 83' ' ' ILE . 34.6 m -124.88 164.2 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 116.143 -0.48 . . . . 73.040000000000006 111.14 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -148.44 170.18 18.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.924 0.392 . . . . 53.5 111.33 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.3 p -109.47 160.38 16.26 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.951 0.405 . . . . 43.340000000000003 111.524 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -53.33 -38.72 63.49 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.468 0.544 . . . . 63.32 112.468 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.23 -42.36 99.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.02 -0.61 . . . . 54.530000000000001 113.075 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.6 -52.69 56.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.836 0.35 . . . . 73.540000000000006 111.071 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.8 mm -51.62 -45.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.109 0.48 . . . . 72.030000000000001 111.382 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 39' ' ' VAL . . . -59.73 -39.32 84.34 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.046 -0.525 . . . . 41.530000000000001 112.037 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.59 -48.19 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.155 0.428 . . . . 63.340000000000003 112.155 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -72.66 -12.71 61.14 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.972 0.415 . . . . 74.040000000000006 111.536 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.68 -25.81 32.68 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.893 0.377 . . . . 63.109999999999999 111.507 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 21.46 11.01 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.42 -0.419 . . . . 52.43 112.956 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -140.28 58.09 10.01 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.727 0.411 . . . . 71.209999999999994 110.706 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.34 -30.46 81.08 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.032 2.488 . . . . 73.450000000000003 114.605 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.38 -14.55 61.75 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.932 -0.651 . . . . 54.439999999999998 114.181 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -93.64 26.07 3.24 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.462 0.541 . . . . 73.530000000000001 112.462 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.67 -36.73 62.46 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.182 0.438 . . . . 74.230000000000004 112.182 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' HD2' HH11 ' A' ' 37' ' ' ARG . 12.9 ptm85 -59.43 -43.17 93.13 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.848 0.356 . . . . 71.310000000000002 111.437 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -67.39 -36.6 81.65 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.016 0.436 . . . . 64.230000000000004 110.812 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 27' ' ' ALA . 60.2 t -60.12 -41.05 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.169 -0.469 . . . . 71.120000000000005 110.81 174.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.71 -42.71 99.79 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.399 -0.429 . . . . 45.350000000000001 113.206 177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -66.41 -39.84 89.23 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.91 0.386 . . . . 75.310000000000002 111.151 176.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -54.34 34.26 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.216 -0.447 . . . . 45.200000000000003 111.72 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -65.75 -36.6 84.03 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.505 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.7 -19.73 58.64 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.098 -0.572 . . . . 73.0 113.23 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -86.24 -2.73 58.64 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.004 0.43 . . . . 73.209999999999994 111.503 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.13 136.78 49.79 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 111.749 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.43 156.21 28.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.566 2.178 . . . . 61.409999999999997 112.333 174.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.68 -32.82 53.19 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.84 0.352 . . . . 72.319999999999993 111.688 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.23 31.06 5.26 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 121.044 -0.598 . . . . 43.130000000000003 113.577 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.8 t -77.16 147.83 36.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.082 0.468 . . . . 73.120000000000005 111.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' NZ ' ' A' ' 51' ' ' LYS . 4.8 ttmp? -64.59 -38.24 90.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.077 -0.51 . . . . 74.519999999999996 110.934 177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.573 HD11 ' HB ' ' A' ' 12' ' ' ILE . 27.1 tp -73.2 129.78 85.58 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 111.181 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 52' ' ' LEU . 33.0 Cg_endo -65.13 95.51 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.43 1.42 . . . . 63.039999999999999 111.585 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -79.47 -31.41 42.4 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.729 -0.669 . . . . 74.209999999999994 112.376 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -61.21 -19.1 61.23 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.222 0.823 . . . . 75.540000000000006 113.222 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.75 -5.76 51.74 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.842 0.682 . . . . 62.439999999999998 112.842 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 t -118.74 123.58 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.019 0.438 . . . . 75.230000000000004 111.717 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.635 HG21 HD12 ' A' ' 91' ' ' ILE . 32.4 pt -129.48 -175.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 112.021 -178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 61' ' ' GLN . 6.6 p-10 -88.5 164.46 15.43 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.07 0.462 . . . . 75.25 111.946 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 63.2 m -61.43 -19.22 61.73 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.578 0.955 . . . . 64.409999999999997 113.578 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 54.0 mt-30 -79.45 0.98 27.2 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.079 0.4 . . . . 64.430000000000007 112.079 177.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.7 59.27 7.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.09 -0.576 . . . . 35.450000000000003 112.668 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -144.06 154.62 43.41 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.706 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.542 HG21 HD22 ' A' ' 71' ' ' LEU . 66.5 mt -60.05 130.9 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.143 0.497 . . . . 74.400000000000006 111.567 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.8 t -70.89 -42.71 69.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.85 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 70.3 mt -81.9 156.06 24.99 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.046 0.45 . . . . 70.239999999999995 111.988 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -127.34 168.47 14.76 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.942 0.401 . . . . 73.010000000000005 111.681 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 73.22 -134.57 19.92 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.218 -0.515 . . . . 71.340000000000003 112.784 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -70.51 -26.67 63.69 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.131 -0.629 . . . . 70.430000000000007 110.819 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 4.5 m-20 -66.15 -22.01 66.36 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.344 -0.389 . . . . 71.420000000000002 111.261 175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 64' ' ' ILE . 3.5 tm? -57.93 -63.32 1.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.383 0.611 . . . . 75.349999999999994 110.166 174.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -63.02 -27.81 69.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.744 -0.662 . . . . 63.219999999999999 111.94 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.596 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 32.6 ttp180 -70.13 -45.0 67.76 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 111.366 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -63.48 -39.27 94.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.779 -0.576 . . . . 72.409999999999997 109.97 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.489 ' HG3' HG21 ' A' ' 85' ' ' VAL . 27.7 ttpp -64.7 -43.13 94.48 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.841 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 3.7 pt20 -61.24 -35.94 78.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.845 0.355 . . . . 62.420000000000002 110.889 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.47 -47.38 79.2 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.292 -0.413 . . . . 72.209999999999994 110.821 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 75' ' ' LYS . 57.2 mt -58.31 -47.99 81.93 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.35 0.595 . . . . 74.219999999999999 111.385 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.86 -27.29 69.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.903 -0.59 . . . . 71.219999999999999 111.744 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.15 -34.28 73.34 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.135 0.493 . . . . 72.540000000000006 110.849 174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' ' HE3' ' A' ' 17' ' ' LYS . 56.1 mt-10 -92.9 10.37 31.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 111.725 175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.17 73.74 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.321 -0.466 . . . . 63.549999999999997 114.127 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 20' ' ' VAL . 70.2 mt -84.04 119.12 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 117.12 0.46 . . . . 50.439999999999998 111.445 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -78.38 127.09 31.7 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.962 0.411 . . . . 61.520000000000003 111.681 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG21 ' HG3' ' A' ' 75' ' ' LYS . 46.5 t -115.01 128.35 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 110.809 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 22.2 t -73.71 165.5 24.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.966 0.358 . . . . 74.150000000000006 111.966 -178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.0 -44.75 64.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.745 1.017 . . . . 74.030000000000001 113.745 -167.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.9 pt -79.28 18.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.318 0.488 . . . . 64.409999999999997 112.318 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.45 37.18 41.87 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.071 -0.585 . . . . 51.020000000000003 112.161 -177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.681 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 83.6 tttt -102.4 129.84 48.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.261 0.467 . . . . 72.299999999999997 112.261 -173.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.635 HD12 HG21 ' A' ' 58' ' ' ILE . 59.1 mt -109.21 116.21 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.857 0.361 . . . . 74.420000000000002 110.655 175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.02 92.83 0.54 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.282 0.563 . . . . 72.400000000000006 111.807 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD21 HD11 ' A' ' 58' ' ' ILE . 98.1 mt -56.06 -34.24 65.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.993 -0.549 . . . . 73.420000000000002 112.018 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -55.73 -33.86 64.63 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.912 0.387 . . . . 74.439999999999998 111.921 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -113.61 -3.56 13.59 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.775 0.657 . . . . 75.540000000000006 112.775 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 20' ' ' VAL . 61.3 m-85 -125.28 -0.13 7.71 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.18 1.178 . . . . 72.420000000000002 114.18 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.15 133.25 50.3 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.753 0.706 . . . . 72.329999999999998 111.982 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -69.72 136.43 51.0 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.679 -0.691 . . . . 65.140000000000001 111.586 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -136.44 90.48 17.42 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 115.988 -0.551 . . . . 75.329999999999998 111.49 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.26 -25.22 26.54 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.348 2.032 . . . . 65.349999999999994 112.594 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 pp -163.28 -175.56 4.33 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.132 -0.485 . . . . 70.209999999999994 110.922 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.306 0 CA-C-O 118.689 -0.672 . . . . 74.430000000000007 111.121 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.71 0.291 . . . . 62.219999999999999 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 109.65 1.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.763 0.316 . . . . 44.119999999999997 111.198 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 6.3 tp60 -55.47 -36.79 66.97 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.691 -177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -52.95 -50.66 63.61 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 110.863 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.7 mt -64.24 -46.65 82.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.119 -0.491 . . . . 72.549999999999997 110.996 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.5 t -53.34 -47.08 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 116.143 -0.481 . . . . 74.010000000000005 111.703 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.0 mm-40 -70.53 -51.45 28.63 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.225 0.454 . . . . 74.519999999999996 112.225 -176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.8 pt -60.7 -42.56 92.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.13 -0.356 . . . . 71.040000000000006 111.416 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -64.19 -41.19 97.2 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.686 0.279 . . . . 75.430000000000007 111.094 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.16 -38.42 70.86 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.943 0.402 . . . . 52.200000000000003 111.515 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' HA ' HE21 ' A' ' 14' ' ' GLN . 46.9 t -70.42 -41.17 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.264 -0.426 . . . . 74.109999999999999 111.15 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.477 ' O ' HG12 ' A' ' 15' ' ' ILE . 82.0 mt -63.88 -33.23 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -61.89 -16.45 50.68 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.041 -0.412 . . . . 75.319999999999993 111.768 175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' A' ' 11' ' ' VAL . 44.6 mt-30 -90.69 2.35 56.02 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.482 0.549 . . . . 74.129999999999995 112.482 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 56' ' ' ARG . 25.6 mm -75.76 122.45 87.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 122.186 -0.322 . . . . 54.119999999999997 110.511 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -88.98 -162.73 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.044 2.496 . . . . 73.239999999999995 113.919 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.5 tmtt? -79.57 124.8 28.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.764 -0.653 . . . . 72.040000000000006 111.381 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -48.79 2.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.301 -0.476 . . . . 75.200000000000003 114.113 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 75.6 mmtt -79.32 128.49 33.4 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.093 0.446 . . . . 70.549999999999997 111.951 -178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -111.01 158.39 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 122.634 0.374 . . . . 72.120000000000005 111.364 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -124.35 176.62 6.34 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.948 0.404 . . . . 42.350000000000001 111.903 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 30.9 p -119.83 153.08 36.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.886 0.374 . . . . 65.209999999999994 111.712 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -53.56 -39.53 64.83 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.235 0.457 . . . . 62.310000000000002 112.235 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 36' ' ' ALA . . . -61.87 -39.09 97.05 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.445 -0.407 . . . . 71.219999999999999 113.454 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.47 -38.96 62.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.95 0.405 . . . . 73.409999999999997 111.212 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mm -60.5 -54.73 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.975 0.417 . . . . 74.519999999999996 110.878 175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.57 75.28 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.536 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -51.65 -62.47 1.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.161 -0.472 . . . . 71.239999999999995 111.435 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 67.4 mtm -74.42 -19.0 60.57 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.366 0.506 . . . . 74.150000000000006 112.366 -177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.03 -11.56 60.82 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 111.835 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.17 11.97 50.64 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.157 -0.544 . . . . 75.5 113.249 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -134.51 63.42 59.87 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 120.895 0.379 . . . . 74.310000000000002 110.579 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.79 -27.97 74.14 Favored 'Trans proline' 0 N--CA 1.481 0.765 0 C-N-CA 123.07 2.513 . . . . 53.229999999999997 114.675 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.78 8.67 61.67 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 120.608 -0.806 . . . . 71.219999999999999 114.385 -175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -114.75 33.18 5.52 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.38 0.59 . . . . 73.239999999999995 112.375 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -54.18 -41.72 68.87 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.753 0.649 . . . . 14.41 112.753 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -56.82 -34.88 68.16 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.342 0.497 . . . . 75.439999999999998 112.342 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -69.66 -32.49 71.16 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.48 -0.327 . . . . 74.230000000000004 111.569 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -59.85 -46.58 93.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.86 0.362 . . . . 60.340000000000003 110.844 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -62.45 -38.7 96.74 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.98 -0.629 . . . . 75.530000000000001 112.54 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -60.63 -41.52 95.04 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.873 0.368 . . . . 61.049999999999997 111.408 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.21 -43.9 80.9 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.327 -0.397 . . . . 61.030000000000001 112.006 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 54' ' ' TRP . 78.3 mt -68.71 -29.53 67.97 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.925 0.343 . . . . 32.049999999999997 111.925 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.86 38.62 1.3 Allowed Glycine 0 CA--C 1.533 1.183 0 C-N-CA 120.972 -0.632 . . . . 61.409999999999997 113.344 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.62 14.17 0.75 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.548 0.689 . . . . 64.5 110.281 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HD23 ' A' ' 52' ' ' LEU . 69.0 mt -121.09 141.13 32.24 Favored Pre-proline 0 N--CA 1.471 0.583 0 CA-C-N 116.003 -0.544 . . . . 74.129999999999995 111.585 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.05 143.08 22.5 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.43 2.087 . . . . 71.140000000000001 112.678 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.02 -19.79 64.7 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.659 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.82 -3.55 80.2 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.25 -0.5 . . . . 62.030000000000001 113.699 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.3 t -71.4 160.64 32.4 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.395 0.517 . . . . 75.010000000000005 112.395 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -73.35 -19.34 61.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.976 0.417 . . . . 55.409999999999997 110.861 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.481 HD23 HD13 ' A' ' 46' ' ' LEU . 65.5 tp -92.57 105.88 16.23 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 64.510000000000005 110.16 174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 85.5 Cg_endo -82.82 96.69 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.012 1.808 . . . . 74.349999999999994 114.005 -173.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 43' ' ' LEU . 69.9 p-90 -66.75 -25.82 66.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.332 0.587 . . . . 74.540000000000006 110.698 171.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.457 ' HA ' HE21 ' A' ' 74' ' ' GLN . 34.4 p90 -73.65 16.61 0.19 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.647 0.61 . . . . 74.430000000000007 112.647 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.619 ' HB3' HG21 ' A' ' 15' ' ' ILE . 25.2 mmt180 -115.11 -5.48 12.45 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.173 -0.329 . . . . 74.420000000000002 111.746 176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.4 t -127.7 122.07 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.147 0.498 . . . . 60.130000000000003 112.304 -174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 93' ' ' LEU . 37.5 pt -123.27 -169.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 116.09 -0.504 . . . . 72.120000000000005 110.997 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.475 HD22 ' HG2' ' A' ' 61' ' ' GLN . 0.4 OUTLIER -96.34 155.83 16.6 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.785 -0.572 . . . . 72.109999999999999 111.833 177.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.2 p -53.81 -28.66 36.69 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.46 1.282 . . . . 54.409999999999997 114.46 -170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' HG2' HD22 ' A' ' 59' ' ' ASN . 10.0 pt20 -69.71 -4.2 18.61 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.78 -0.575 . . . . 71.409999999999997 112.443 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.66 11.79 76.49 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 73.319999999999993 113.615 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 5.0 ttmp? -108.28 140.06 42.07 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.657 -0.32 . . . . 75.310000000000002 111.068 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.4 mt -66.35 124.85 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.694 0.283 . . . . 62.420000000000002 111.036 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -60.72 -59.74 4.91 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.927 0.394 . . . . 72.450000000000003 111.775 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 83.1 mt -71.43 130.94 42.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 110.707 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 45.8 mttp -111.54 173.37 6.38 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.66 0.615 . . . . 75.420000000000002 112.66 -169.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.74 -111.08 2.98 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 116.042 -0.526 . . . . 61.340000000000003 113.689 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 73' ' ' ARG . 91.2 mtt180 -56.83 -60.89 2.9 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.068 0.461 . . . . 64.230000000000004 111.793 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.565 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 15.5 m-20 -61.12 -30.81 70.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.841 -0.618 . . . . 53.32 111.794 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 7.5 tt -58.85 -51.85 68.25 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.259 0.552 . . . . 74.329999999999998 110.235 176.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -66.23 -39.61 89.69 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.127 -0.488 . . . . 52.520000000000003 110.973 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 69' ' ' ARG . 25.3 mmm180 -59.26 -50.2 74.91 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.409 -0.359 . . . . 72.099999999999994 111.294 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.457 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 35.4 tt0 -57.75 -47.59 82.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.909 0.385 . . . . 74.430000000000007 110.218 175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -50.97 -46.81 61.35 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.054 -0.521 . . . . 72.209999999999994 111.691 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 13.2 mm-40 -61.52 -40.85 96.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 111.478 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 42.5 mmtm -74.46 -13.26 60.68 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.11 0.411 . . . . 64.219999999999999 112.11 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 83.5 mt -91.37 -39.53 11.96 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.537 0.684 . . . . 71.129999999999995 110.633 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.75 -22.52 66.63 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.558 -0.746 . . . . 73.140000000000001 111.202 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.39 -41.5 72.73 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.36 -0.382 . . . . 71.519999999999996 111.461 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 20.9 mp0 -90.68 -26.28 19.66 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.964 0.411 . . . . 63.100000000000001 111.463 175.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.01 66.36 0.8 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 116.207 -0.451 . . . . 62.130000000000003 112.424 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 64.5 mt -116.84 148.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 O-C-N 122.697 -0.296 . . . . 74.25 110.68 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -80.58 114.22 19.32 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.701 0.63 . . . . 73.230000000000004 112.701 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 t -118.67 100.45 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.416 -0.357 . . . . 63.340000000000003 110.303 172.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 90' ' ' LYS . 57.9 p -76.37 169.12 18.83 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.251 -0.281 . . . . 73.209999999999994 111.694 -175.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.543 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.98 -50.32 3.3 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.055 1.502 . . . . 75.409999999999997 115.055 -168.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' HG2' ' A' ' 87' ' ' GLU . 32.5 pt -83.18 14.64 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.93 -0.481 . . . . 62.25 112.226 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.36 54.82 5.94 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 121.117 -0.563 . . . . 60.409999999999997 112.149 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 24.9 ttpp -120.92 128.54 52.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.133 0.492 . . . . 71.439999999999998 112.219 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.602 HD12 HD13 ' A' ' 58' ' ' ILE . 56.1 mt -107.24 139.6 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 116.023 -0.535 . . . . 74.120000000000005 111.431 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.44 92.48 2.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.153 0.501 . . . . 71.439999999999998 110.971 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 58' ' ' ILE . 56.4 mt -68.16 -44.45 75.94 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.015 0.746 . . . . 74.129999999999995 113.015 -176.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -49.33 -31.1 8.55 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 112.48 0.548 . . . . 72.219999999999999 112.48 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -98.77 -42.66 7.1 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.326 0.491 . . . . 63.509999999999998 112.326 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -88.16 7.28 32.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.036 0.754 . . . . 65.530000000000001 113.036 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -61.37 132.43 53.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.063 0.458 . . . . 74.510000000000005 111.604 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.499 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 25.9 t90 -63.24 133.85 54.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.23 0.538 . . . . 75.219999999999999 111.473 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -135.4 98.56 12.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.982 -0.554 . . . . 74.150000000000006 111.175 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.86 -43.15 21.27 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.258 1.972 . . . . 63.32 111.378 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 101' ' ' LEU . 2.3 pt? -145.05 154.04 42.08 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.549 -0.75 . . . . 72.400000000000006 109.798 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 C--O 1.252 1.216 0 N-CA-C 113.129 0.789 . . . . 71.150000000000006 113.129 -173.009 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.738 0.304 . . . . 72.219999999999999 110.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 6' ' ' VAL . 17.1 m-20 -69.99 129.55 39.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.165 0.432 . . . . 73.400000000000006 112.165 -175.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 16.5 mm100 -53.72 -32.89 53.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.021 -0.536 . . . . 61.210000000000001 112.308 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.3 -53.45 55.91 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.98 0.419 . . . . 73.319999999999993 110.767 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.4 -42.3 83.53 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.075 -0.511 . . . . 74.030000000000001 111.398 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 2' ' ' ASP . 98.7 t -55.93 -46.98 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.442 -0.344 . . . . 71.209999999999994 111.899 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 28.4 mm-40 -69.94 -52.48 24.12 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.14 0.422 . . . . 42.439999999999998 112.14 -177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' O ' HG13 ' A' ' 12' ' ' ILE . 36.7 pt -59.62 -44.52 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 122.288 -0.258 . . . . 73.239999999999995 111.651 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' ILE . 20.6 m-30 -64.86 -41.97 95.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.791 0.329 . . . . 75.430000000000007 111.243 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.23 -32.87 64.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.024 0.44 . . . . 73.0 111.617 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 HG11 ' HE3' ' A' ' 29' ' ' MET . 59.4 t -76.17 -37.92 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.349 -0.387 . . . . 53.210000000000001 111.132 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 8' ' ' ILE . 79.1 mt -65.63 -35.27 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.009 0.374 . . . . 75.209999999999994 112.009 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.96 -10.4 28.97 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.99 -0.444 . . . . 61.229999999999997 111.819 174.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -96.25 1.69 52.31 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.903 0.335 . . . . 74.510000000000005 111.903 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 51.1 mm -70.52 116.96 50.62 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 120.664 0.268 . . . . 64.239999999999995 111.29 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 39.5 Cg_exo -61.01 142.6 97.95 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.076 2.517 . . . . 62.439999999999998 113.252 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -63.73 85.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.229 0.538 . . . . 74.439999999999998 111.363 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' HG2' ' A' ' 81' ' ' GLU . . . 147.69 -34.99 1.22 Allowed Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.957 -0.565 . . . . 62.329999999999998 112.744 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -87.37 168.27 13.29 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.294 0.479 . . . . 65.430000000000007 112.294 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.4 m -133.2 157.54 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.759 -0.655 . . . . 64.420000000000002 110.727 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -128.77 179.61 5.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.803 0.335 . . . . 73.040000000000006 111.245 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 67.3 p -128.0 152.49 47.86 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.043 0.386 . . . . 71.140000000000001 112.043 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -57.98 -59.1 5.78 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.539 0.94 . . . . 75.310000000000002 113.539 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -54.48 -31.58 51.88 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 120.803 -0.713 . . . . 41.420000000000002 112.702 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.64 -49.59 52.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.263 0.625 . . . . 74.450000000000003 111.437 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.41 ' HA ' ' HE2' ' A' ' 29' ' ' MET . 41.3 mm -57.53 -49.13 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.795 0.331 . . . . 60.509999999999998 110.899 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -57.23 -46.0 83.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.954 0.407 . . . . 73.310000000000002 111.477 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -58.49 -47.0 85.53 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.373 -0.376 . . . . 73.349999999999994 111.497 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.696 ' SD ' ' HG3' ' A' ' 100' ' ' PRO . 72.1 mtm -69.03 -35.47 76.66 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 74.239999999999995 111.953 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.77 -21.85 65.23 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.935 0.398 . . . . 63.32 111.906 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.34 26.09 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.335 -0.46 . . . . 73.430000000000007 113.202 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 40.8 m-85 -125.38 73.09 67.31 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 122.532 -0.393 . . . . 74.109999999999999 110.953 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.88 119.03 6.03 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.419 2.079 . . . . 74.010000000000005 113.168 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.79 -22.43 12.82 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.289 -0.481 . . . . 63.299999999999997 113.619 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -79.01 36.01 0.27 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.649 0.611 . . . . 75.0 112.649 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.69 67.54 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 111.952 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -55.73 -47.69 76.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.315 -0.402 . . . . 73.299999999999997 111.993 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -56.74 -39.26 73.64 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.856 0.317 . . . . 74.120000000000005 111.856 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.23 -50.56 79.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.923 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.7 -34.26 88.36 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.172 -0.537 . . . . 73.409999999999997 112.897 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -62.07 -38.03 87.28 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.984 0.421 . . . . 63.0 110.85 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.53 -48.93 36.42 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.559 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.13 -33.35 74.32 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.87 0.322 . . . . 62.43 111.87 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.12 -5.29 33.06 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.192 -0.527 . . . . 70.129999999999995 113.615 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.12 -10.45 35.91 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.105 0.479 . . . . 71.120000000000005 111.178 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.451 HD11 HD23 ' A' ' 52' ' ' LEU . 78.9 mt -89.61 145.55 33.87 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 73.430000000000007 112.234 -174.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -85.9 167.84 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.752 2.301 . . . . 45.130000000000003 112.147 171.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' HE3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -68.43 -39.89 81.39 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.907 0.384 . . . . 62.210000000000001 111.081 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.64 71.51 2.32 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.195 -0.526 . . . . 61.43 112.779 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.1 p -143.51 173.02 12.01 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 110.992 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.42 -22.75 23.56 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.48 0.548 . . . . 73.129999999999995 112.48 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.451 HD23 HD11 ' A' ' 46' ' ' LEU . 60.4 tp -94.04 112.01 55.46 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.848 -0.16 . . . . 75.409999999999997 111.175 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 62.0 Cg_endo -73.52 95.31 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 121.505 1.47 . . . . 63.329999999999998 112.764 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -78.74 -34.27 45.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.81 -0.632 . . . . 73.420000000000002 111.521 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -62.46 -10.81 12.83 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.594 0.961 . . . . 75.430000000000007 113.594 -175.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.617 ' HG3' ' HB2' ' A' ' 53' ' ' PRO . 16.7 mtp85 -88.17 -9.56 52.7 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.991 0.367 . . . . 75.200000000000003 111.991 -177.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -106.55 108.99 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.177 0.513 . . . . 73.409999999999997 111.328 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 93' ' ' LEU . 23.4 pt -109.82 -169.81 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.036 0.446 . . . . 71.030000000000001 111.931 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.6 HD21 ' HB2' ' A' ' 61' ' ' GLN . 2.8 p-10 -85.54 159.94 19.78 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.958 -0.464 . . . . 74.099999999999994 110.711 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.2 m -62.5 -6.08 3.1 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.29 1.218 . . . . 74.439999999999998 114.29 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.6 ' HB2' HD21 ' A' ' 59' ' ' ASN . 85.6 mt-30 -100.61 -12.96 18.79 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.995 -0.441 . . . . 63.140000000000001 111.865 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.84 59.55 1.33 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.688 -0.768 . . . . 55.329999999999998 113.336 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 40.3 ttmt -150.32 157.05 42.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.549 0.339 . . . . 75.340000000000003 110.417 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 71' ' ' LEU . 66.8 mt -66.06 124.61 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.191 0.52 . . . . 72.409999999999997 111.236 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 p -69.57 -50.32 45.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.127 -0.488 . . . . 61.450000000000003 111.697 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.5 131.32 43.12 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.987 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' NZ ' ' HB2' ' A' ' 67' ' ' LYS . 9.8 mtmp? -109.42 -174.51 2.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.145 0.498 . . . . 74.5 111.815 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.95 -118.31 8.74 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.253 -0.499 . . . . 75.120000000000005 112.969 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -90.15 -35.68 15.25 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.468 -0.43 . . . . 63.439999999999998 111.248 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -55.77 -32.47 63.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 111.48 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HA ' HG21 ' A' ' 64' ' ' ILE . 8.9 tt -53.37 -48.38 68.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.212 0.529 . . . . 74.200000000000003 111.064 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.33 -42.43 88.19 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.193 -0.458 . . . . 64.310000000000002 110.649 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 47.4 ttp180 -62.64 -39.51 94.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.382 -0.372 . . . . 64.420000000000002 111.712 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.28 -42.67 88.07 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.021 -0.424 . . . . 74.340000000000003 110.578 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HG3' HG21 ' A' ' 85' ' ' VAL . 29.5 ttpp -61.56 -46.85 88.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.388 -0.369 . . . . 65.010000000000005 111.914 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 12.6 pt20 -59.61 -37.81 79.62 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.053 0.454 . . . . 73.150000000000006 110.736 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.585 ' HE3' ' HB2' ' A' ' 48' ' ' GLU . 72.4 mmtt -65.31 -27.3 68.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.331 -0.395 . . . . 75.430000000000007 111.643 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.19 -34.33 29.05 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.203 0.525 . . . . 63.399999999999999 111.108 173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -62.89 -18.53 63.13 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.155 -0.341 . . . . 75.310000000000002 111.009 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.58 -35.21 63.08 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.399 -0.364 . . . . 73.349999999999994 111.747 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.413 ' HG2' ' HA2' ' A' ' 18' ' ' GLY . 7.9 mp0 -90.09 -7.97 52.52 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.962 0.411 . . . . 74.409999999999997 111.098 174.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.51 32.57 24.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.304 -0.474 . . . . 70.540000000000006 112.703 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.5 mt -75.03 132.74 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.261 0.553 . . . . 65.030000000000001 112.15 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.42 113.86 12.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.599 -0.728 . . . . 71.0 111.344 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 75' ' ' LYS . 18.7 t -124.28 119.11 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.705 0.288 . . . . 70.129999999999995 110.94 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 31.0 t -63.4 151.26 41.5 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.699 -0.228 . . . . 73.129999999999995 111.516 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -45.83 -33.54 3.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.010000000000005 112.884 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.625 HG13 ' HB2' ' A' ' 90' ' ' LYS . 30.5 pt -84.0 19.91 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.428 -0.351 . . . . 75.400000000000006 111.912 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.99 36.58 92.2 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.331 -0.462 . . . . 53.299999999999997 112.713 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HB2' HG13 ' A' ' 88' ' ' ILE . 5.9 tmtm? -104.63 132.05 51.32 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.644 -0.327 . . . . 71.530000000000001 110.82 -175.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 ' N ' ' HD3' ' A' ' 90' ' ' LYS . 66.1 mt -115.21 135.67 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 120.832 0.348 . . . . 64.25 111.582 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.77 93.81 5.66 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.116 0.484 . . . . 70.349999999999994 111.689 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 58' ' ' ILE . 87.4 mt -60.12 -36.54 77.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.472 0.545 . . . . 72.219999999999999 112.472 -177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -47.72 -24.33 0.92 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.946 1.091 . . . . 75.219999999999999 113.946 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -37.91 4.8 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.963 -0.461 . . . . 51.140000000000001 112.179 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -87.36 5.25 39.56 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.314 0.487 . . . . 71.219999999999999 112.314 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -60.51 142.08 55.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.21 0.528 . . . . 74.140000000000001 112.095 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -109.17 123.18 48.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.079 0.466 . . . . 71.530000000000001 110.889 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -98.61 97.51 4.89 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 111.188 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.696 ' HG3' ' SD ' ' A' ' 29' ' ' MET . 44.4 Cg_endo -66.39 -9.24 23.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.531 2.154 . . . . 63.420000000000002 112.355 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.56 5.2 32.62 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.925 -0.579 . . . . 70.200000000000003 111.601 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.256 1.426 0 CA-C-O 118.984 -0.531 . . . . 63.399999999999999 111.226 175.129 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.886 0.374 . . . . 73.109999999999999 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 6' ' ' VAL . 36.7 m-20 -68.78 152.34 45.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.933 0.716 . . . . 75.519999999999996 112.933 -176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.74 -34.74 71.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.057 -0.52 . . . . 62.520000000000003 111.451 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -55.01 -51.66 65.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.082 0.468 . . . . 74.109999999999999 110.788 173.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.63 -45.99 91.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.855 -0.612 . . . . 61.240000000000002 111.339 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 2' ' ' ASP . 91.9 t -52.47 -49.5 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.335 -0.393 . . . . 74.030000000000001 111.875 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.09 -49.59 55.84 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.637 0.606 . . . . 73.140000000000001 112.637 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 12' ' ' ILE . 42.8 pt -61.92 -42.89 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 120.873 -0.331 . . . . 71.230000000000004 111.716 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -65.9 -38.3 88.39 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.62 0.247 . . . . 74.299999999999997 111.14 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.65 -37.08 65.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.143 0.497 . . . . 62.530000000000001 111.317 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.409 ' HA ' HE21 ' A' ' 14' ' ' GLN . 60.1 t -72.91 -44.41 57.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 111.103 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 8' ' ' ILE . 84.7 mt -61.33 -37.48 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.586 0.587 . . . . 73.319999999999993 112.586 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -63.66 -15.65 58.9 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.961 -0.462 . . . . 74.049999999999997 111.874 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 11' ' ' VAL . 48.3 mt-30 -93.27 0.97 57.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.415 0.524 . . . . 65.099999999999994 112.415 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 12' ' ' ILE . 15.9 mm -77.92 119.74 78.58 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 122.188 -0.32 . . . . 55.340000000000003 110.18 176.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 174.16 12.96 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.905 2.403 . . . . 71.409999999999997 113.869 -174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 81' ' ' GLU . 14.3 tmtt? -72.47 124.76 25.85 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 74.409999999999997 110.936 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.26 -10.61 58.23 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.848 -0.691 . . . . 71.209999999999994 113.945 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -118.21 156.9 27.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.167 0.508 . . . . 50.539999999999999 111.765 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 173.51 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.882 -0.599 . . . . 65.109999999999999 111.285 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.9 t -151.94 167.27 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.886 0.374 . . . . 74.340000000000003 111.002 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -100.77 156.37 17.38 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.281 0.562 . . . . 70.439999999999998 112.173 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HE1' HD12 ' A' ' 43' ' ' LEU . 87.1 m-85 -56.6 -34.61 67.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.082 -0.508 . . . . 55.229999999999997 111.554 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.83 -51.21 60.02 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.271 -0.49 . . . . 45.340000000000003 112.844 176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -56.91 -48.24 78.7 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.836 0.35 . . . . 73.450000000000003 111.329 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.9 mm -55.71 -49.97 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.173 -0.467 . . . . 72.209999999999994 111.268 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -60.07 -47.07 87.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.129 -0.487 . . . . 54.119999999999997 112.085 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 29.7 mtpp -55.7 -59.31 5.04 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.855 0.36 . . . . 64.200000000000003 111.66 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 69.0 mtm -65.98 -28.35 68.82 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.305 0.483 . . . . 64.439999999999998 112.305 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.64 -28.07 66.57 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.813 0.339 . . . . 73.310000000000002 111.586 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.65 19.6 9.63 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.316 -0.469 . . . . 72.230000000000004 113.083 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 85.1 m-85 -131.4 82.7 61.32 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 122.581 -0.364 . . . . 54.43 111.185 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 136.11 34.46 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.256 1.971 . . . . 73.409999999999997 112.559 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.86 20.36 76.28 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.999 -0.619 . . . . 63.229999999999997 113.519 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 39' ' ' VAL . 38.8 m-85 -110.27 9.77 23.68 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.24 0.459 . . . . 72.209999999999994 112.24 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.62 -39.66 65.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.265 0.555 . . . . 74.450000000000003 111.051 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -51.03 -47.11 61.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.406 -0.816 . . . . 73.319999999999993 111.904 173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -74.4 -35.65 63.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.422 -0.354 . . . . 74.319999999999993 111.734 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 35' ' ' TYR . 42.8 t -60.08 -42.08 88.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.112 0.482 . . . . 62.350000000000001 110.684 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 23' ' ' TYR . . . -63.8 -37.54 94.83 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.231 -0.509 . . . . 42.100000000000001 112.623 174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -65.43 -30.76 71.59 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.977 0.418 . . . . 61.509999999999998 111.191 176.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.0 -57.93 3.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.374 -0.376 . . . . 65.219999999999999 111.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.415 HD12 ' HE1' ' A' ' 23' ' ' TYR . 74.1 mt -63.69 -31.83 73.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.118 0.414 . . . . 72.439999999999998 112.118 -178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.66 -10.38 54.38 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.952 -0.642 . . . . 73.219999999999999 113.216 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 13.56 32.69 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.995 0.426 . . . . 74.340000000000003 110.848 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 82.1 mt -96.19 151.58 38.28 Favored Pre-proline 0 N--CA 1.472 0.671 0 N-CA-C 112.217 0.451 . . . . 73.319999999999993 112.217 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -85.9 -179.58 3.35 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.792 2.328 . . . . 74.140000000000001 113.485 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -79.23 -33.03 44.05 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.49 0.552 . . . . 70.010000000000005 112.49 -177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.44 27.98 9.77 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.948 -0.644 . . . . 53.43 113.792 -176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.0 p -82.79 139.77 33.36 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.37 -0.488 . . . . 74.400000000000006 111.17 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -77.06 -24.22 51.96 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.019 0.438 . . . . 63.409999999999997 110.788 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 53' ' ' PRO . 55.0 tp -69.97 115.94 38.97 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.048 -0.524 . . . . 75.430000000000007 110.37 170.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 77.6 Cg_endo -77.04 95.92 1.09 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 121.93 1.753 . . . . 63.109999999999999 113.117 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -83.45 -20.73 33.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.056 0.455 . . . . 74.310000000000002 111.537 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.509 ' O ' HD21 ' A' ' 78' ' ' LEU . 33.2 p90 -67.47 -11.5 58.04 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.15 0.796 . . . . 72.340000000000003 113.15 -176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.448 HH22 ' CD ' ' A' ' 81' ' ' GLU . 50.4 mtt-85 -89.34 -5.35 57.58 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.474 0.546 . . . . 64.140000000000001 112.474 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 20.5 t -111.05 119.17 59.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 111.886 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 93' ' ' LEU . 30.0 pt -124.32 -179.88 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 111.735 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' LYS . 3.0 p-10 -88.4 168.56 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.591 0.589 . . . . 61.32 112.591 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.4 t -56.42 -28.74 60.3 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.113 1.153 . . . . 60.219999999999999 114.113 -169.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -70.58 -5.96 33.08 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.72 0.637 . . . . 61.439999999999998 112.72 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.81 49.93 15.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.474 -0.87 . . . . 72.400000000000006 110.97 -171.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 84.5 tttt -142.51 152.26 42.49 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.405 -0.397 . . . . 64.510000000000005 110.651 -172.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.54 HD11 HG11 ' A' ' 85' ' ' VAL . 55.8 mt -64.07 122.29 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.97 0.414 . . . . 74.040000000000006 111.248 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 82.8 p -64.62 -49.27 71.73 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 111.698 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 70' ' ' ASP . 86.2 mt -63.0 162.44 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.253 -0.43 . . . . 73.329999999999998 111.4 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' NZ ' ' O ' ' A' ' 64' ' ' ILE . 38.2 mmtm -136.38 -174.79 3.79 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.876 0.369 . . . . 63.130000000000003 111.535 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.91 -129.23 43.77 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.915 -0.66 . . . . 43.030000000000001 112.117 -176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -90.32 -17.27 27.67 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.409 -0.465 . . . . 73.129999999999995 111.317 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 73' ' ' ARG . 2.5 m-20 -64.41 -28.08 69.44 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.043 0.449 . . . . 65.319999999999993 110.423 173.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 tt -58.13 -50.47 73.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.869 -0.605 . . . . 73.329999999999998 109.81 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.538 ' HB3' ' NE2' ' A' ' 76' ' ' GLN . 12.9 m-20 -64.88 -32.32 73.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.781 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -55.61 -55.54 30.8 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.607 0.241 . . . . 73.519999999999996 111.255 175.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.428 ' OE1' HG23 ' A' ' 64' ' ' ILE . 34.4 tt0 -59.14 -48.85 80.08 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.749 0.309 . . . . 74.019999999999996 111.206 177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 38.2 ttpt -56.61 -47.29 79.95 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.253 0.464 . . . . 75.219999999999999 112.253 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.538 ' NE2' ' HB3' ' A' ' 72' ' ' ASP . 2.1 mp0 -66.44 -29.2 69.29 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.796 0.295 . . . . 74.400000000000006 111.796 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -66.45 -42.67 87.28 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.199 0.523 . . . . 75.310000000000002 110.432 172.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 69.8 mt -68.01 -54.15 20.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.771 -0.65 . . . . 74.409999999999997 111.852 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -58.7 -29.15 66.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.112 -0.494 . . . . 63.439999999999998 112.007 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.34 76.82 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.933 0.397 . . . . 52.450000000000003 111.703 177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 17' ' ' LYS . 51.6 mt-10 -87.61 -26.89 22.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.846 0.355 . . . . 74.010000000000005 111.432 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.67 44.08 0.47 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.974 -0.631 . . . . 74.430000000000007 113.678 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 74.9 mt -113.46 110.84 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 110.124 -0.324 . . . . 62.32 110.124 174.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.52 108.71 5.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.278 0.561 . . . . 54.43 111.919 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 18.9 t -98.68 124.37 51.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 73.409999999999997 110.757 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.7 m -56.5 134.23 53.93 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.363 -0.606 . . . . 70.019999999999996 109.363 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.73 -33.55 55.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.144 0.794 . . . . 64.340000000000003 113.144 -169.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 pt -70.8 -5.79 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-O 121.067 0.461 . . . . 75.340000000000003 112.219 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 63' ' ' LYS . . . 100.23 43.69 2.33 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 113.785 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HB3' ' NZ ' ' A' ' 90' ' ' LYS . 9.3 mtpm? -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.648 0.724 . . . . 75.420000000000002 112.582 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HD13 ' A' ' 58' ' ' ILE . 68.2 mt -125.49 130.51 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.669 -0.696 . . . . 74.329999999999998 110.368 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.02 93.92 2.79 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.962 0.411 . . . . 74.019999999999996 111.793 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 58' ' ' ILE . 93.2 mt -59.35 -30.34 68.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.457 0.54 . . . . 63.43 112.457 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -55.05 -33.35 62.64 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 111.99 0.367 . . . . 70.209999999999994 111.99 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -106.91 -40.46 5.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.921 0.341 . . . . 70.409999999999997 111.921 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -83.78 13.91 4.4 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.699 0.629 . . . . 75.430000000000007 112.699 -177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.52 139.36 58.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.317 0.579 . . . . 75.140000000000001 112.005 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 23.4 t90 -84.48 124.78 31.74 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.915 -0.584 . . . . 73.120000000000005 111.296 176.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -113.97 98.84 49.06 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.418 -0.356 . . . . 71.140000000000001 111.167 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 58.3 Cg_endo -92.94 174.5 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.976 2.451 . . . . 70.209999999999994 113.266 177.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 101' ' ' LEU . 6.1 mp -80.14 79.13 6.74 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.239 0.542 . . . . 71.540000000000006 110.048 174.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.603 -0.713 . . . . 72.209999999999994 112.257 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.558 0.218 . . . . 72.329999999999998 110.577 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -58.73 152.49 18.77 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.299 0.571 . . . . 62.140000000000001 112.411 -175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -58.75 -25.8 63.35 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.734 -0.667 . . . . 70.310000000000002 111.961 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.67 -58.14 9.04 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.841 0.353 . . . . 72.200000000000003 111.054 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.65 -42.55 99.67 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.144 -0.48 . . . . 62.350000000000001 111.064 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.5 t -53.24 -48.67 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.844 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' HG23 ' A' ' 11' ' ' VAL . 26.2 mm-40 -71.13 -55.94 7.14 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.622 0.601 . . . . 73.120000000000005 112.622 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 39.3 pt -54.72 -44.41 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 111.929 0.344 . . . . 61.32 111.929 -176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 23.0 m-30 -66.5 -43.32 85.67 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.846 0.355 . . . . 75.310000000000002 111.034 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.49 78.53 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.455 -0.339 . . . . 63.43 111.658 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 7' ' ' GLN . 67.4 t -61.42 -41.33 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.321 -0.4 . . . . 65.230000000000004 111.047 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.9 mt -62.9 -37.1 78.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.886 0.375 . . . . 71.319999999999993 111.648 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -63.92 -20.9 66.2 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.144 -0.347 . . . . 74.019999999999996 111.845 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -85.81 -8.19 58.26 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 61.229999999999997 112.207 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HB ' HH11 ' A' ' 56' ' ' ARG . 42.1 mm -67.99 127.57 93.32 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 111.772 0.286 . . . . 74.0 111.772 -178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -62.67 151.36 84.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.778 2.319 . . . . 63.539999999999999 112.682 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.497 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -69.83 123.18 20.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 110.934 -175.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.78 59.86 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.233 -0.508 . . . . 62.530000000000001 113.904 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -96.07 141.99 28.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.244 0.522 . . . . 65.519999999999996 111.156 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.18 164.23 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.249 0.547 . . . . 71.230000000000004 112.16 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -151.83 -179.21 7.26 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.886 -0.597 . . . . 63.329999999999998 110.809 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.486 HG21 ' HA ' ' A' ' 60' ' ' SER . 32.0 p -107.96 159.18 16.75 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.201 0.524 . . . . 72.030000000000001 112.304 -177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -52.54 -45.01 66.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.823 -0.626 . . . . 73.25 112.021 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.33 -42.51 99.8 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.19 -0.528 . . . . 72.439999999999998 113.167 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.82 -47.06 82.3 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 122.634 -0.333 . . . . 64.239999999999995 111.377 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.1 mm -54.61 -42.19 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.06 0.457 . . . . 72.150000000000006 110.597 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.84 76.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.881 -0.6 . . . . 51.439999999999998 111.722 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.42 -58.24 9.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.686 0.279 . . . . 73.25 111.533 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -65.4 -31.5 72.64 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.235 -0.291 . . . . 62.340000000000003 111.458 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.68 -30.45 69.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.825 0.345 . . . . 74.5 111.719 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.92 30.46 8.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.38 -0.438 . . . . 52.549999999999997 113.371 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 57.7 m-85 -137.77 56.98 12.33 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.404 0.52 . . . . 62.149999999999999 112.404 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 32' ' ' TYR . 38.0 Cg_exo -58.12 131.28 42.43 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.156 1.904 . . . . 73.239999999999995 112.503 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.85 -8.97 61.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.354 -0.45 . . . . 73.439999999999998 113.226 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -101.32 19.9 16.85 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.414 -0.462 . . . . 74.109999999999999 111.596 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.38 -48.83 68.29 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.49 0.552 . . . . 61.310000000000002 112.49 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -62.91 -33.34 75.12 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.552 0.215 . . . . 71.040000000000006 111.481 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -66.68 -42.4 86.58 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.843 0.354 . . . . 74.239999999999995 110.71 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 58.6 t -56.88 -52.46 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.092 0.473 . . . . 72.430000000000007 110.372 174.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.01 -36.54 92.44 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.967 -0.56 . . . . 72.420000000000002 113.086 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -61.89 -43.97 97.75 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 122.602 -0.352 . . . . 73.010000000000005 110.922 177.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.88 -45.47 92.42 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 111.393 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 85.0 mt -61.01 -36.1 78.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.146 0.498 . . . . 73.319999999999993 111.19 177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.69 0.79 33.58 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.045 -0.525 . . . . 71.319999999999993 113.881 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 17.5 m120 -117.77 2.4 12.24 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.266 0.533 . . . . 71.209999999999994 111.812 176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 54' ' ' TRP . 83.5 mt -71.18 149.89 94.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.746 0.308 . . . . 62.009999999999998 111.804 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 45.6 Cg_endo -66.3 168.61 15.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.762 2.308 . . . . 71.340000000000003 113.823 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -64.21 -44.22 92.61 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.792 -0.64 . . . . 74.019999999999996 112.001 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.12 64.55 0.27 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.312 -0.47 . . . . 62.409999999999997 113.331 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 75.7 p -95.68 136.81 35.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.623 -0.34 . . . . 50.43 111.336 177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.05 -28.88 69.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.116 0.484 . . . . 73.310000000000002 110.773 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HD2' ' A' ' 53' ' ' PRO . 60.5 tp -70.46 114.93 30.01 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.905 -0.589 . . . . 63.399999999999999 110.981 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.503 ' HD2' HD12 ' A' ' 52' ' ' LEU . 97.4 Cg_endo -80.41 95.48 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.762 1.641 . . . . 73.219999999999999 113.053 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HB3' HD12 ' A' ' 46' ' ' LEU . 37.7 p-90 -79.9 -25.0 40.75 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.125 0.488 . . . . 61.100000000000001 111.652 178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 32.3 p90 -61.28 -21.99 64.44 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.411 0.893 . . . . 61.149999999999999 113.411 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 99.3 mtt180 -73.63 -15.25 61.26 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.872 0.693 . . . . 63.009999999999998 112.872 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 t -104.83 108.15 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 71.219999999999999 111.944 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 93' ' ' LEU . 19.5 pt -115.23 -170.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.944 0.402 . . . . 73.010000000000005 111.566 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -82.3 168.7 17.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.118 0.485 . . . . 74.140000000000001 111.937 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.486 ' HA ' HG21 ' A' ' 22' ' ' THR . 49.1 m -76.28 12.89 1.05 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.054 0.39 . . . . 55.109999999999999 112.054 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -109.1 2.53 21.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.701 0.286 . . . . 75.109999999999999 111.48 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.44 60.83 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.952 -0.642 . . . . 72.540000000000006 112.639 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 89' ' ' GLY . 63.3 tttp -150.1 147.47 27.81 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.042 0.449 . . . . 63.219999999999999 111.323 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 71' ' ' LEU . 76.8 mt -65.6 129.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.706 0.289 . . . . 74.049999999999997 110.74 173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -82.33 -21.84 35.84 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.722 0.638 . . . . 61.310000000000002 112.722 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . 92.6 mt -73.26 169.04 17.92 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.366 0.506 . . . . 73.409999999999997 112.366 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -74.56 169.94 16.75 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.404 -0.362 . . . . 74.219999999999999 111.749 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.75 -51.51 10.32 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.018 0.767 . . . . 61.219999999999999 115.018 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -59.44 -50.46 73.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.206 0.527 . . . . 62.32 111.774 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 66' ' ' LEU . 4.7 m-20 -71.9 -23.26 61.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 75.239999999999995 111.03 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HA ' HG21 ' A' ' 64' ' ' ILE . 9.1 tt -68.46 -48.34 64.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.92 -0.582 . . . . 72.409999999999997 110.145 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 76' ' ' GLN . 35.7 t70 -60.66 -46.77 89.07 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.929 0.395 . . . . 71.219999999999999 110.741 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 ttp-105 -55.64 -50.66 69.59 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.221 0.534 . . . . 74.219999999999999 111.346 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.423 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.8 tt0 -61.9 -41.11 97.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.142 0.496 . . . . 73.209999999999994 110.653 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -59.7 -43.96 93.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.755 -0.657 . . . . 61.219999999999999 111.856 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.594 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 81.7 mm-40 -58.0 -45.99 85.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.189 0.519 . . . . 74.019999999999996 110.822 177.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -65.68 -38.37 89.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.89 -0.596 . . . . 71.230000000000004 111.998 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 91' ' ' ILE . 82.9 mt -64.48 -45.87 85.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 111.188 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.1 -29.77 70.66 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.757 0.313 . . . . 65.430000000000007 111.082 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.39 74.15 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.978 0.418 . . . . 52.009999999999998 111.05 173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -67.14 -21.55 65.82 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.095 -0.502 . . . . 75.439999999999998 111.148 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.46 14.93 14.79 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.16 -0.473 . . . . 64.420000000000002 112.831 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.9 mt -91.13 131.97 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.911 0.386 . . . . 75.510000000000005 112.0 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.41 92.4 7.02 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.974 0.416 . . . . 62.229999999999997 110.983 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.66 133.05 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.537 -0.301 . . . . 64.329999999999998 111.373 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 32.9 t -82.42 158.71 23.17 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.67 0.272 . . . . 64.230000000000004 111.056 176.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 88' ' ' ILE . 12.8 pt-20 -44.71 -44.36 9.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.032 1.123 . . . . 75.510000000000005 114.032 -170.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 HG23 ' HG3' ' A' ' 87' ' ' GLU . 48.2 pt -81.49 21.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.281 0.474 . . . . 74.109999999999999 112.281 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' LYS . . . 70.71 33.05 66.79 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.786 -0.721 . . . . 54.109999999999999 112.408 -177.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.936 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 0.0 OUTLIER -84.32 114.08 21.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.875 0.47 . . . . 70.510000000000005 111.288 -178.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 78' ' ' LEU . 61.2 mt -121.19 140.67 44.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.946 -0.57 . . . . 72.400000000000006 110.694 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.93 98.61 11.48 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.846 0.355 . . . . 73.420000000000002 111.262 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 58' ' ' ILE . 90.9 mt -59.89 -35.46 74.9 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.81 0.338 . . . . 71.120000000000005 111.362 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.1 ptt-85 -54.19 -12.49 0.64 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.623 0.601 . . . . 72.140000000000001 112.623 175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -109.91 -44.19 3.85 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.79 0.329 . . . . 71.120000000000005 111.661 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -105.76 13.7 29.3 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.217 0.821 . . . . 62.210000000000001 113.217 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.73 120.19 10.17 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.034 0.445 . . . . 64.310000000000002 111.802 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -70.0 133.96 47.8 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.123 -0.36 . . . . 72.209999999999994 110.537 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 102' ' ' GLU . 39.1 mt-30 -106.13 96.31 12.95 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.457 -0.338 . . . . 64.430000000000007 111.341 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.44 -10.94 30.38 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.334 2.023 . . . . 74.219999999999999 112.826 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.2 mt -97.41 -0.36 46.39 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 111.903 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 99' ' ' GLN . 7.9 mm-40 . . . . . 0 C--O 1.253 1.268 0 CA-C-O 119.066 -0.492 . . . . 55.43 112.205 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.782 0.325 . . . . 64.310000000000002 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.33 156.16 37.42 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.467 0.543 . . . . 71.299999999999997 112.467 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 58.1 mm-40 -57.16 -35.69 69.85 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.283 -0.417 . . . . 63.530000000000001 110.905 172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 8' ' ' ILE . 64.3 t80 -50.42 -51.91 42.34 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.022 0.439 . . . . 64.420000000000002 110.674 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.6 -45.88 92.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.921 -0.581 . . . . 64.319999999999993 110.933 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -57.1 -47.98 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.403 -0.362 . . . . 65.200000000000003 111.772 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 11' ' ' VAL . 29.9 mm-40 -66.36 -55.82 14.07 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.064 0.394 . . . . 74.420000000000002 112.064 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 4' ' ' PHE . 38.0 pt -59.24 -42.04 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 111.796 0.295 . . . . 71.019999999999996 111.796 -177.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -65.82 -45.68 81.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.491 0.186 . . . . 71.239999999999995 111.111 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.79 -36.38 64.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 71.450000000000003 111.654 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 7' ' ' GLN . 66.4 t -68.35 -46.12 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 116.306 -0.407 . . . . 63.229999999999997 110.979 175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.545 ' HB ' HD11 ' A' ' 52' ' ' LEU . 78.0 mt -64.52 -34.15 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 112.157 0.429 . . . . 64.120000000000005 112.157 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -57.6 -25.19 59.69 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.895 0.378 . . . . 73.540000000000006 111.593 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -89.14 -0.78 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.862 0.69 . . . . 64.109999999999999 112.862 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.3 mt -76.93 118.6 72.92 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 120.714 0.292 . . . . 72.319999999999993 111.242 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.82 -172.17 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.913 2.408 . . . . 62.439999999999998 113.956 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' NH2' ' A' ' 56' ' ' ARG . 37.5 ttmt -72.74 140.6 47.89 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.984 -0.553 . . . . 72.409999999999997 112.141 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.91 15.49 76.16 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.228 -0.511 . . . . 62.140000000000001 113.797 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -129.52 143.74 50.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.151 0.5 . . . . 71.439999999999998 112.105 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -132.44 167.71 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 115.736 -0.665 . . . . 75.340000000000003 110.732 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.3 p -139.45 -179.58 5.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.904 0.383 . . . . 63.399999999999999 111.269 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 43.3 p -119.64 150.24 40.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.042 0.449 . . . . 64.310000000000002 111.521 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 42.8 m-85 -54.21 -38.85 66.13 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 111.844 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.41 -43.59 86.99 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.249 -0.501 . . . . 73.319999999999993 113.816 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.09 -37.59 64.14 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 117.139 0.469 . . . . 71.209999999999994 111.305 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -55.96 -53.02 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.003 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.53 -45.04 81.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.796 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -60.85 -49.21 78.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 111.512 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.4 ' HE3' HG11 ' A' ' 11' ' ' VAL . 69.1 mtm -65.45 -39.41 92.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.807 0.337 . . . . 74.200000000000003 111.623 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.6 -23.55 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.963 0.411 . . . . 71.340000000000003 111.943 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.43 22.38 9.78 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.355 -0.45 . . . . 72.420000000000002 113.335 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -132.6 72.77 77.41 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 120.937 0.398 . . . . 71.439999999999998 110.972 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.16 122.49 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.485 2.123 . . . . 71.140000000000001 112.774 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.08 -21.39 29.39 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.346 -0.454 . . . . 61.509999999999998 112.986 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -82.71 29.4 0.45 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.543 -0.386 . . . . 71.310000000000002 111.82 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' TYR . . . -52.63 -61.22 2.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.987 0.736 . . . . 70.150000000000006 112.987 -175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 12.8 ptp180 -63.63 -30.37 71.49 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.196 0.443 . . . . 72.420000000000002 112.196 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -60.13 -32.0 70.6 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.873 0.368 . . . . 73.439999999999998 111.12 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.5 t -64.1 -45.12 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.046 0.451 . . . . 72.200000000000003 110.558 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.36 -44.38 97.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.069 -0.514 . . . . 70.209999999999994 113.413 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 37' ' ' ARG . 4.7 mptp? -65.2 -39.93 93.51 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.506 -0.408 . . . . 72.120000000000005 111.074 177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.29 -44.67 92.47 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.851 0.357 . . . . 74.409999999999997 111.203 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.08 -37.21 86.79 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.39 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.98 -16.22 63.8 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.366 -0.445 . . . . 54.329999999999998 113.659 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -97.48 4.73 50.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.388 -0.478 . . . . 55.310000000000002 112.073 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 54' ' ' TRP . 95.1 mt -73.66 131.65 81.88 Favored Pre-proline 0 N--CA 1.471 0.593 0 N-CA-C 112.037 0.384 . . . . 73.120000000000005 112.037 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.04 155.27 17.29 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.532 2.155 . . . . 53.509999999999998 112.341 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -29.29 63.5 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.267 0.469 . . . . 64.230000000000004 112.267 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.52 -21.17 64.43 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.336 -0.459 . . . . 62.5 113.46 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.9 m -76.29 130.49 38.22 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.095 0.474 . . . . 62.329999999999998 111.401 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -83.62 8.54 13.98 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD11 ' HB ' ' A' ' 12' ' ' ILE . 57.0 tp -82.36 117.11 67.27 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.693 -0.231 . . . . 72.120000000000005 111.232 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD2' HD12 ' A' ' 52' ' ' LEU . 74.5 Cg_endo -74.81 95.91 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 121.775 1.65 . . . . 71.219999999999999 113.214 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' HB3' HD12 ' A' ' 46' ' ' LEU . 48.2 p-90 -72.23 -31.09 65.53 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.043 -0.526 . . . . 62.409999999999997 111.885 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -63.64 -10.27 17.99 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.162 0.801 . . . . 73.120000000000005 113.162 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 17' ' ' LYS . 35.6 mtt85 -86.28 -13.63 46.14 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.91 0.708 . . . . 73.319999999999993 112.91 -178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 t -111.5 116.74 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.932 -0.48 . . . . 41.149999999999999 111.765 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 91' ' ' ILE . 42.8 pt -125.18 -169.7 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.214 0.53 . . . . 71.439999999999998 111.776 -178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.55 156.17 20.87 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.987 0.422 . . . . 64.349999999999994 111.856 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.0 m -68.17 -3.25 9.94 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.754 0.65 . . . . 70.109999999999999 112.754 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -79.75 -7.36 58.59 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.346 0.499 . . . . 65.549999999999997 112.346 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.72 31.91 43.03 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.286 -0.483 . . . . 65.319999999999993 113.684 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.2 165.76 22.64 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.891 0.377 . . . . 61.130000000000003 111.657 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 ' OE1' ' A' ' 74' ' ' GLN . 55.1 mt -75.78 115.23 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.07 -0.514 . . . . 63.25 110.399 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -68.57 -20.91 64.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.468 0.544 . . . . 74.239999999999995 112.468 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 89.2 mt -93.62 140.89 29.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.687 0.28 . . . . 73.010000000000005 111.449 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.71 ' HD2' HD12 ' A' ' 71' ' ' LEU . 20.8 tptm -125.88 157.55 37.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.973 0.416 . . . . 73.140000000000001 111.401 -178.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.15 -137.03 18.61 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.219 -0.515 . . . . 54.219999999999999 112.552 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -60.26 -31.69 70.46 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.479 0.657 . . . . 64.209999999999994 110.951 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 m-20 -69.18 -19.31 63.99 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.781 -0.645 . . . . 71.450000000000003 111.798 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.71 HD12 ' HD2' ' A' ' 67' ' ' LYS . 6.1 tt -75.96 -56.65 4.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.598 0.237 . . . . 72.209999999999994 110.488 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.77 -42.2 97.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.005 0.372 . . . . 62.030000000000001 112.005 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 3.9 ptp180 -59.07 -47.83 83.82 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 120.966 -0.293 . . . . 74.510000000000005 111.265 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.435 ' OE1' HG23 ' A' ' 64' ' ' ILE . 48.5 tt0 -64.55 -41.68 96.18 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 65.340000000000003 111.175 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 61.0 tttm -58.09 -54.18 49.86 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.468 -0.333 . . . . 73.209999999999994 111.56 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -62.1 -31.99 72.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.261 0.467 . . . . 71.420000000000002 112.261 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 11.3 mmpt? -60.19 -46.01 91.17 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.155 0.502 . . . . 64.129999999999995 110.154 174.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 75.2 mt -66.57 -42.96 86.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.633 -0.712 . . . . 63.43 111.117 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 76.3 mm-40 -53.3 -41.32 65.5 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.697 175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.0 88.28 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.222 -0.445 . . . . 64.140000000000001 111.426 176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -69.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.146 0.498 . . . . 74.530000000000001 111.097 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 98.46 23.32 12.62 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.108 -0.496 . . . . 42.210000000000001 112.58 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 67.7 mt -92.28 127.15 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.175 0.512 . . . . 63.450000000000003 111.657 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -74.17 95.88 2.66 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.098 0.475 . . . . 64.329999999999998 111.784 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.7 t -87.56 117.94 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.541 -0.3 . . . . 74.519999999999996 110.544 174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 59.6 m -79.47 166.77 21.64 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -40.3 -56.11 2.04 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.877 1.436 . . . . 71.310000000000002 114.877 -170.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.552 HG23 ' HG2' ' A' ' 87' ' ' GLU . 35.8 pt -85.75 26.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.986 -0.446 . . . . 72.340000000000003 112.016 -175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.79 36.22 74.37 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.843 -0.694 . . . . 54.299999999999997 111.565 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 7.7 ttpm? -99.11 121.42 40.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.959 0.409 . . . . 53.229999999999997 111.045 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.656 HD12 HD13 ' A' ' 58' ' ' ILE . 67.6 mt -103.86 128.1 57.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.939 0.4 . . . . 73.430000000000007 111.423 -177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.25 93.44 1.47 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 111.294 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD21 HD11 ' A' ' 58' ' ' ILE . 80.6 mt -64.12 -42.4 96.86 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.885 0.698 . . . . 75.439999999999998 112.885 -173.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.3 mtm-85 -51.35 -40.48 59.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.637 0.606 . . . . 73.439999999999998 112.637 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 58.7 pttt -92.86 -25.36 18.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.37 0.508 . . . . 75.420000000000002 112.37 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 58.8 m-85 -101.03 2.91 40.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.164 0.801 . . . . 74.109999999999999 113.164 -178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -68.92 131.93 45.9 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.925 -0.484 . . . . 73.5 111.8 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 100' ' ' PRO . 25.5 t90 -77.35 149.31 35.26 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.942 -0.572 . . . . 75.409999999999997 110.531 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -150.97 87.7 4.63 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 120.937 0.398 . . . . 75.109999999999999 111.034 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 98' ' ' TRP . 84.0 Cg_endo -79.57 -7.56 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.811 2.341 . . . . 74.400000000000006 113.747 -176.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt -63.04 101.26 0.26 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.465 0.543 . . . . 73.219999999999999 112.465 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.253 1.289 0 CA-C-O 119.396 -0.335 . . . . 73.140000000000001 111.406 174.792 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.868 0.366 . . . . 71.310000000000002 110.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -70.57 148.42 48.19 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.416 0.524 . . . . 72.540000000000006 112.416 -174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -50.68 -36.03 33.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.923 -0.58 . . . . 74.349999999999994 112.181 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -49.76 -56.25 10.99 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.806 0.336 . . . . 73.019999999999996 111.401 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.6 -43.84 92.52 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 111.069 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.9 t -55.25 -48.01 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.211 -0.45 . . . . 62.25 111.723 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -70.24 -52.07 25.91 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.328 0.492 . . . . 72.25 112.328 -176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.2 pt -58.7 -41.41 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 120.948 -0.301 . . . . 74.239999999999995 111.53 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -70.41 -35.86 73.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.642 0.258 . . . . 62.340000000000003 111.205 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.14 76.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.069 0.461 . . . . 43.100000000000001 111.346 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -66.33 -44.05 91.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.031 0.443 . . . . 62.439999999999998 110.747 175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.561 ' HB ' HD11 ' A' ' 52' ' ' LEU . 70.7 mt -64.72 -30.3 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 116.132 -0.486 . . . . 61.109999999999999 111.837 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -63.33 -12.55 30.72 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 62.020000000000003 112.151 175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -101.63 3.69 40.1 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.316 0.487 . . . . 72.439999999999998 112.316 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.506 HG21 ' HB3' ' A' ' 56' ' ' ARG . 39.7 mm -70.01 129.18 91.1 Favored Pre-proline 0 N--CA 1.474 0.729 0 O-C-N 122.399 -0.188 . . . . 72.439999999999998 110.923 177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HB2' ' A' ' 19' ' ' LYS . 64.5 Cg_endo -89.02 -171.34 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.088 2.525 . . . . 73.010000000000005 113.418 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 17' ' ' LYS . 1.1 tmtp? -65.61 127.43 31.86 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.256 -0.429 . . . . 72.450000000000003 111.264 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.07 -47.44 3.14 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 114.698 0.639 . . . . 75.340000000000003 114.698 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 98' ' ' TRP . 48.2 mmtm -65.56 99.05 0.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 112.027 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.27 157.9 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.452 0.644 . . . . 71.299999999999997 111.83 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.9 p -125.98 167.67 14.98 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 53.420000000000002 111.791 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 59.4 p -105.89 150.97 25.14 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.929 0.395 . . . . 71.150000000000006 111.647 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -51.77 -36.79 48.83 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.243 -0.435 . . . . 71.230000000000004 112.098 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -62.0 -48.69 81.69 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.261 -0.495 . . . . 53.219999999999999 113.101 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.46 -50.61 73.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.032 0.444 . . . . 73.299999999999997 110.873 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.4 mm -52.36 -47.79 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.869 -0.605 . . . . 73.25 111.347 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -61.46 -37.04 82.13 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.213 -0.448 . . . . 75.319999999999993 112.141 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 96.2 mttt -63.17 -59.07 5.26 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.172 0.434 . . . . 73.319999999999993 112.172 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -63.62 -24.04 67.63 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.739 0.304 . . . . 71.319999999999993 111.713 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.8 -27.56 63.99 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.563 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.54 11.91 34.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.316 -0.469 . . . . 60.119999999999997 113.447 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' HB3' ' HD2' ' A' ' 35' ' ' TYR . 49.6 m-85 -128.99 69.84 81.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 120.8 0.333 . . . . 74.5 111.165 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.45 30.99 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.844 2.363 . . . . 53.210000000000001 113.931 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.35 4.01 3.07 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.165 -0.54 . . . . 63.149999999999999 113.008 177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' HD2' ' HB3' ' A' ' 32' ' ' TYR . 64.7 m-85 -121.98 28.16 7.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 122.353 -0.498 . . . . 54.329999999999998 112.06 -176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.57 -37.25 72.85 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.136 0.493 . . . . 65.040000000000006 111.835 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.56 -36.39 84.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.509 0.671 . . . . 71.540000000000006 110.613 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -73.06 -34.09 66.07 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.527 -0.76 . . . . 75.040000000000006 111.068 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -56.86 -45.04 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.106 0.479 . . . . 44.350000000000001 110.661 174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.58 -42.39 99.17 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.245 -0.503 . . . . 72.230000000000004 112.762 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -59.67 -46.79 87.99 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.991 0.424 . . . . 72.439999999999998 110.557 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.64 -51.22 70.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.319 -0.4 . . . . 52.020000000000003 111.543 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.7 mt -60.79 -39.74 89.98 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.832 0.348 . . . . 73.219999999999999 111.477 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.62 -12.67 70.57 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.149 -0.548 . . . . 61.43 113.314 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -96.04 -16.12 21.82 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 122.424 -0.457 . . . . 65.040000000000006 111.268 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.46 148.98 92.87 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 111.926 0.343 . . . . 55.140000000000001 111.926 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 68.6 Cg_endo -72.49 -165.92 0.25 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.461 2.108 . . . . 60.310000000000002 112.952 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -63.43 -68.72 0.32 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.989 0.423 . . . . 64.040000000000006 111.697 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -119.38 96.22 0.64 Allowed Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.221 -0.514 . . . . 73.439999999999998 112.705 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 79.7 p -107.88 28.16 8.5 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 122.63 -0.335 . . . . 72.310000000000002 111.311 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 50' ' ' SER . 4.8 tppp? 74.57 -47.91 0.64 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 53.340000000000003 111.205 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.561 HD11 ' HB ' ' A' ' 12' ' ' ILE . 35.9 tp -67.74 127.42 93.37 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 122.854 0.461 . . . . 72.239999999999995 111.778 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 52' ' ' LEU . 73.2 Cg_endo -77.17 95.55 1.07 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 121.665 1.576 . . . . 74.329999999999998 112.201 173.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -76.98 -31.0 56.21 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.076 -0.511 . . . . 75.430000000000007 111.93 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.489 ' O ' HD21 ' A' ' 78' ' ' LEU . 26.8 p90 -64.04 -16.59 62.02 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.325 0.861 . . . . 73.329999999999998 113.325 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.9 mtt180 -85.46 9.72 14.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.75 130.69 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.224 0.535 . . . . 71.209999999999994 111.898 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' THR . 14.1 pt -134.35 -174.65 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 116.261 -0.427 . . . . 62.119999999999997 111.738 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 63' ' ' LYS . 11.1 p30 -95.01 -179.75 4.93 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.917 -0.489 . . . . 54.030000000000001 112.085 -178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 t -57.84 -35.46 70.94 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.724 0.639 . . . . 63.439999999999998 112.724 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.27 3.7 8.42 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.03 0.382 . . . . 72.420000000000002 112.03 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 58' ' ' ILE . . . 61.91 50.98 60.37 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.855 -0.688 . . . . 70.209999999999994 112.129 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' HD21 ' A' ' 59' ' ' ASN . 40.0 ttmt -138.65 150.35 46.15 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.145 0.497 . . . . 74.200000000000003 112.048 -175.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.494 HG21 ' HA ' ' A' ' 71' ' ' LEU . 72.4 mt -70.24 119.84 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.973 -0.558 . . . . 71.040000000000006 111.159 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.7 t -88.11 30.22 0.88 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.151 0.426 . . . . 62.219999999999999 112.151 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 64' ' ' ILE . 95.5 mt -112.98 177.48 4.61 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.809 0.337 . . . . 63.43 111.401 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.1 171.3 5.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.446 -0.343 . . . . 73.340000000000003 111.515 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.52 -40.04 86.05 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.45 -0.405 . . . . 41.210000000000001 113.85 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -79.37 -45.71 19.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.435 -0.45 . . . . 75.129999999999995 111.741 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.47 -23.24 64.31 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.956 0.408 . . . . 74.25 111.378 175.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 64' ' ' ILE . 7.6 tt -59.39 -58.19 9.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.271 -0.422 . . . . 43.450000000000003 110.52 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.18 -34.37 73.51 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.667 0.27 . . . . 73.239999999999995 111.347 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 73' ' ' ARG . 21.3 ttt180 -57.43 -51.94 67.4 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.989 0.423 . . . . 64.310000000000002 111.546 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' OE1' HG23 ' A' ' 64' ' ' ILE . 53.6 tt0 -65.91 -43.82 87.04 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.049 0.452 . . . . 74.519999999999996 110.589 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.72 -41.04 73.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.8 -0.636 . . . . 75.450000000000003 111.598 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -62.03 -44.96 95.59 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.771 0.32 . . . . 63.539999999999999 111.417 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.712 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 10.6 mmpt? -60.5 -34.47 74.12 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.976 0.417 . . . . 75.400000000000006 111.46 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.632 HD13 HD11 ' A' ' 91' ' ' ILE . 91.8 mt -74.66 -46.53 37.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.104 0.478 . . . . 71.409999999999997 111.864 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -67.35 -18.37 65.13 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.134 -0.354 . . . . 64.310000000000002 111.412 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.75 -29.54 70.76 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.018 0.437 . . . . 73.030000000000001 111.105 172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 51.2 mt-10 -89.31 -18.92 26.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 110.847 171.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.07 2.57 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.948 -0.569 . . . . 72.230000000000004 112.591 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.3 mt -99.83 132.27 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.613 -0.345 . . . . 75.340000000000003 111.053 178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 96' ' ' TYR . 43.1 tt0 -67.17 91.95 0.25 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.387 0.613 . . . . 71.140000000000001 111.092 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 91' ' ' ILE . 39.7 t -109.77 120.62 61.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.961 -0.563 . . . . 75.310000000000002 110.96 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 41.9 t -63.36 148.79 47.44 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.738 -0.21 . . . . 72.329999999999998 110.462 174.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -49.74 -38.6 34.35 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.72 0.637 . . . . 74.120000000000005 112.72 -172.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.58 17.73 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.169 0.433 . . . . 62.329999999999998 112.169 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.23 44.73 42.61 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 72.239999999999995 113.355 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 27.7 ttpp -118.67 112.67 20.1 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.952 0.406 . . . . 72.040000000000006 111.805 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 78' ' ' LEU . 54.7 mt -98.53 141.82 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.059 -0.518 . . . . 54.130000000000003 111.554 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.91 93.13 4.99 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.01 0.434 . . . . 70.530000000000001 111.571 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 58' ' ' ILE . 90.3 mt -55.21 -32.32 62.15 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.374 -0.375 . . . . 64.329999999999998 111.963 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 94' ' ' ARG . 24.2 mtp180 -54.85 -33.45 61.78 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.46 ' HG3' ' CD2' ' A' ' 96' ' ' TYR . 9.5 ptpp? -110.24 -10.13 14.64 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.483 0.549 . . . . 44.439999999999998 112.483 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.46 ' CD2' ' HG3' ' A' ' 95' ' ' LYS . 66.6 m-85 -118.9 11.12 12.48 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.335 0.865 . . . . 71.430000000000007 113.335 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 18.2 ptpt -63.7 133.16 53.09 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.981 0.419 . . . . 70.219999999999999 111.66 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' LYS . 21.8 t90 -66.43 117.18 8.3 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.186 0.517 . . . . 75.219999999999999 111.63 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.25 91.82 12.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.859 -0.61 . . . . 62.25 111.092 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 9.0 Cg_exo -73.37 -49.3 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.815 2.343 . . . . 74.430000000000007 113.081 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.21 97.98 5.7 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 111.847 0.314 . . . . 64.140000000000001 111.847 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 114.282 1.216 . . . . 55.509999999999998 114.282 176.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.543 0.211 . . . . 63.200000000000003 111.267 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.2 150.9 16.68 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.357 0.599 . . . . 73.120000000000005 112.526 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.0 mm-40 -59.3 -44.41 92.54 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.697 -0.683 . . . . 74.109999999999999 112.343 -173.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -48.58 -49.03 38.39 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.97 0.414 . . . . 75.340000000000003 111.37 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.54 -43.6 98.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.98 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.73 -40.74 80.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.313 -0.403 . . . . 71.150000000000006 111.477 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 26.7 mm-40 -65.79 -62.75 1.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.499 -0.318 . . . . 70.530000000000001 111.653 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG13 ' CD1' ' A' ' 9' ' ' PHE . 28.3 pt -56.43 -40.39 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 111.997 0.369 . . . . 74.310000000000002 111.997 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.462 ' CD1' HG13 ' A' ' 8' ' ' ILE . 5.9 m-30 -64.43 -41.26 96.67 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.811 0.339 . . . . 75.349999999999994 111.203 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -61.94 -34.73 76.63 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.957 0.408 . . . . 73.230000000000004 111.373 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 7' ' ' GLN . 59.4 t -68.84 -37.66 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 111.137 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 8' ' ' ILE . 74.4 mt -63.54 -36.12 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.069 0.462 . . . . 63.25 111.471 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -69.74 -9.66 55.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 122.054 -0.404 . . . . 72.430000000000007 111.819 175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 25.3 mt-30 -89.86 -4.18 57.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 111.738 0.273 . . . . 73.230000000000004 111.738 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.611 ' HB ' HH11 ' A' ' 56' ' ' ARG . 38.3 mm -76.86 125.02 87.57 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.849 -0.159 . . . . 53.420000000000002 111.106 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 17.4 Cg_exo -68.76 158.91 55.91 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.902 2.401 . . . . 63.420000000000002 113.085 175.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -65.46 122.28 16.81 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.052 -0.522 . . . . 73.340000000000003 110.918 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.85 -1.21 68.0 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.195 -0.526 . . . . 42.130000000000003 114.198 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -104.4 141.1 36.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.307 0.553 . . . . 64.400000000000006 111.458 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -108.37 157.88 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.285 0.564 . . . . 74.340000000000003 111.651 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -136.02 176.84 8.32 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.883 -0.599 . . . . 60.5 110.968 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 39.2 p -122.6 149.01 44.56 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.972 0.36 . . . . 75.209999999999994 111.972 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -50.89 -62.33 1.67 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.074 0.768 . . . . 72.409999999999997 113.074 -173.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.72 -29.4 64.28 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.691 -0.766 . . . . 62.219999999999999 112.962 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -68.02 -47.13 69.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.968 0.507 . . . . 53.340000000000003 111.544 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 45.5 mm -57.19 -49.25 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 53.219999999999999 110.679 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -58.37 -43.02 88.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.069 -0.514 . . . . 54.200000000000003 111.258 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -54.16 -51.32 64.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.296 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 68.4 mtm -70.07 -22.91 63.01 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.368 -0.378 . . . . 45.119999999999997 111.805 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.14 -5.53 54.37 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.95 0.405 . . . . 73.030000000000001 111.773 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.73 10.0 60.64 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.324 -0.465 . . . . 32.140000000000001 113.492 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 89.9 m-85 -130.96 76.58 76.77 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.818 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.71 145.88 71.01 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.497 2.132 . . . . 55.240000000000002 113.219 -176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.8 -12.44 63.67 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.262 -0.494 . . . . 64.430000000000007 114.234 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -79.01 46.98 0.73 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.325 0.563 . . . . 64.140000000000001 112.499 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.98 83.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.297 0.48 . . . . 35.43 112.297 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -62.38 -40.11 95.38 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.473 -0.33 . . . . 64.230000000000004 111.632 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -63.57 -40.3 96.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.718 0.294 . . . . 71.319999999999993 111.55 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.3 t -64.79 -52.5 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 111.092 176.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.8 -33.27 84.71 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.133 -0.556 . . . . 61.140000000000001 112.895 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.08 -48.93 76.5 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.743 0.417 . . . . 74.049999999999997 111.078 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.18 -49.19 73.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.119 -0.491 . . . . 62.009999999999998 111.588 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.99 -40.4 97.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.912 0.387 . . . . 73.140000000000001 111.15 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.22 4.43 18.48 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.214 -0.517 . . . . 71.439999999999998 113.26 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -111.45 0.38 16.53 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.096 0.474 . . . . 75.439999999999998 110.684 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.57 149.52 46.59 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.289 -0.414 . . . . 64.549999999999997 111.35 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 50' ' ' SER . 55.3 Cg_endo -69.34 164.72 33.05 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.516 2.144 . . . . 71.439999999999998 112.933 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.0 -23.01 65.06 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.564 0.579 . . . . 74.239999999999995 112.564 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.75 64.36 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.902 -0.666 . . . . 73.299999999999997 112.956 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 47' ' ' PRO . 90.6 p -82.82 177.56 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.958 0.409 . . . . 64.120000000000005 111.335 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -80.58 7.34 10.25 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.084 0.469 . . . . 54.329999999999998 111.274 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' HD2' ' A' ' 53' ' ' PRO . 38.9 tp -126.63 121.85 23.47 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.099 0.56 . . . . 63.299999999999997 110.338 177.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 52' ' ' LEU . 57.5 Cg_endo -71.29 95.84 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.702 1.601 . . . . 75.329999999999998 112.163 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -78.84 -16.61 56.87 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.898 0.333 . . . . 75.439999999999998 111.898 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.478 ' O ' HD21 ' A' ' 78' ' ' LEU . 47.1 p90 -69.62 1.88 3.73 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.537 0.569 . . . . 64.120000000000005 112.537 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.611 HH11 ' HB ' ' A' ' 15' ' ' ILE . 29.3 mmt85 -83.78 -13.94 52.64 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.244 0.461 . . . . 52.329999999999998 112.244 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.54 138.38 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.697 0.629 . . . . 71.219999999999999 112.697 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD11 HD21 ' A' ' 93' ' ' LEU . 39.7 pt -135.84 -174.81 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 116.118 -0.492 . . . . 74.239999999999995 110.865 174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -87.7 149.62 24.12 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.143 0.497 . . . . 54.399999999999999 111.31 176.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 45.9 m -65.18 4.48 0.48 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.405 0.891 . . . . 73.319999999999993 113.405 -171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -87.98 -9.55 53.16 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.18 -0.325 . . . . 71.519999999999996 111.01 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.06 36.91 6.94 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.314 -0.47 . . . . 52.329999999999998 113.095 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -150.98 155.74 39.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.275 0.559 . . . . 74.140000000000001 112.357 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 62.0 mt -84.63 117.96 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 115.84 -0.618 . . . . 74.219999999999999 109.973 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.9 t -77.08 -12.56 59.96 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.236 0.458 . . . . 71.450000000000003 112.236 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.12 139.54 57.52 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 54.210000000000001 111.741 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.31 171.55 7.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.24 -0.436 . . . . 73.310000000000002 111.579 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.49 -156.41 52.04 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.872 -0.68 . . . . 61.5 112.636 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -19.1 65.7 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 117.409 0.605 . . . . 75.299999999999997 110.985 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.38 -36.12 68.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.858 -0.61 . . . . 70.310000000000002 111.531 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.28 -52.65 63.82 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.418 -0.355 . . . . 64.510000000000005 110.144 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 1.1 m-20 -64.08 -28.32 69.7 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.131 0.419 . . . . 71.209999999999994 112.131 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -54.62 44.49 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.389 -0.596 . . . . 73.400000000000006 109.389 175.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' HG3' ' CB ' ' A' ' 55' ' ' PHE . 53.4 tt0 -65.98 -45.45 81.63 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.896 -0.593 . . . . 44.329999999999998 111.041 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 72' ' ' ASP . 85.7 tttt -49.84 -56.51 10.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.587 -0.733 . . . . 54.020000000000003 112.28 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 72' ' ' ASP . 20.2 mm-40 -60.78 -41.54 95.76 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.501 -0.318 . . . . 64.319999999999993 111.44 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.644 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 6.4 mmpt? -55.2 -50.71 68.69 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.953 0.406 . . . . 72.430000000000007 111.11 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD21 ' O ' ' A' ' 55' ' ' PHE . 91.5 mt -63.95 -50.79 67.24 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.274 -0.421 . . . . 72.430000000000007 111.88 -178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.41 -20.76 66.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 111.328 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.92 60.93 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.053 0.454 . . . . 62.039999999999999 111.033 171.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 77' ' ' LYS . 21.1 mm-40 -74.05 -25.55 59.91 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.868 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.86 24.2 4.04 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.353 -0.451 . . . . 72.219999999999999 113.045 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.453 HD12 HD22 ' A' ' 78' ' ' LEU . 66.6 mt -103.06 122.52 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 111.638 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.63 102.03 1.41 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.964 0.412 . . . . 55.109999999999999 111.508 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.34 137.87 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.895 0.379 . . . . 75.329999999999998 111.185 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.73 ' HB3' ' HB3' ' A' ' 90' ' ' LYS . 48.2 t -92.02 158.22 16.36 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.681 -0.236 . . . . 61.140000000000001 111.264 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -45.29 -49.73 12.43 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.77 1.026 . . . . 65.510000000000005 113.77 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.7 pt -78.26 18.49 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.503 0.556 . . . . 73.230000000000004 112.503 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.8 59.05 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.533 -0.365 . . . . 25.399999999999999 112.461 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 86' ' ' SER . 44.0 tttm -93.45 120.1 33.33 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.03 0.443 . . . . 75.530000000000001 111.909 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.663 HD12 HD13 ' A' ' 58' ' ' ILE . 62.5 mt -110.88 134.27 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.344 -0.389 . . . . 71.120000000000005 111.601 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.64 93.56 3.64 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.363 0.601 . . . . 63.100000000000001 111.836 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.748 HD21 HD11 ' A' ' 58' ' ' ILE . 91.1 mt -64.85 -32.07 73.6 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.551 0.574 . . . . 74.439999999999998 112.551 -176.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -60.11 -29.12 68.39 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.704 0.631 . . . . 72.120000000000005 112.704 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.415 ' HE3' ' CE2' ' A' ' 96' ' ' TYR . 60.3 pttt -108.33 -24.02 11.65 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.464 0.542 . . . . 72.040000000000006 112.464 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 95' ' ' LYS . 65.1 m-85 -100.21 9.42 42.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.908 -0.495 . . . . 71.019999999999996 112.119 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.647 ' HD3' HE21 ' A' ' 99' ' ' GLN . 18.8 ptpt -56.88 132.51 52.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.84 0.352 . . . . 72.129999999999995 111.598 175.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -84.13 120.41 26.14 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.157 0.503 . . . . 73.049999999999997 111.276 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.647 HE21 ' HD3' ' A' ' 97' ' ' LYS . 85.9 mm-40 -108.78 98.99 32.16 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.926 -0.579 . . . . 52.310000000000002 111.031 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 11.05 1.04 Allowed 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.577 2.184 . . . . 60.439999999999998 112.705 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 78.5 mt -94.57 -10.28 32.55 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.349 -0.387 . . . . 74.329999999999998 111.604 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 112.206 0.447 . . . . 72.439999999999998 112.206 -175.788 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.832 0.349 . . . . 45.210000000000001 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.36 153.47 35.77 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 120.871 0.367 . . . . 64.209999999999994 111.187 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 28.5 mt-30 -62.15 -21.07 64.76 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.548 -0.296 . . . . 73.519999999999996 111.588 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -49.69 -48.81 49.48 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.144 0.497 . . . . 65.340000000000003 110.654 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 42' ' ' ALA . 51.5 mt -65.9 -43.57 87.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.004 -0.544 . . . . 62.140000000000001 111.026 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.1 t -57.97 -41.55 80.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.419 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 29.4 mm-40 -64.53 -49.16 72.36 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.173 0.435 . . . . 71.420000000000002 112.173 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 pt -64.88 -42.69 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 120.67 0.272 . . . . 54.140000000000001 111.513 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CZ ' ' HB1' ' A' ' 42' ' ' ALA . 22.7 m-30 -62.37 -38.68 90.49 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.984 0.421 . . . . 71.239999999999995 110.875 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 -47.03 73.12 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.376 -0.375 . . . . 34.439999999999998 111.224 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.15 -41.48 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.141 0.495 . . . . 63.509999999999998 111.249 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HB ' HD11 ' A' ' 52' ' ' LEU . 61.2 mt -61.93 -35.69 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 N-CA-C 112.406 0.521 . . . . 70.120000000000005 112.406 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' HD13 ' A' ' 52' ' ' LEU . 91.3 m-70 -64.53 -27.21 68.81 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 111.859 0.318 . . . . 62.5 111.859 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -23.81 62.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.446 0.535 . . . . 74.209999999999994 112.446 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.663 ' HB ' HH11 ' A' ' 56' ' ' ARG . 17.8 mt -59.92 126.19 82.7 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 122.496 -0.128 . . . . 74.349999999999994 111.221 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 155.12 67.31 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.301 2.001 . . . . 62.009999999999998 113.035 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.5 tptt -61.26 111.99 1.96 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.077 -0.51 . . . . 73.010000000000005 111.368 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.73 7.67 29.25 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.913 -0.661 . . . . 51.109999999999999 114.144 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -120.22 153.1 36.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.272 0.536 . . . . 70.549999999999997 111.603 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 83' ' ' ILE . 35.9 m -121.65 171.91 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.962 0.411 . . . . 70.310000000000002 111.134 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.6 t -150.87 177.59 9.97 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.863 0.363 . . . . 70.140000000000001 111.118 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 73.0 p -117.09 157.29 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.935 0.398 . . . . 71.010000000000005 111.922 -177.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 97.7 m-85 -50.73 -43.99 58.16 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.022 -0.535 . . . . 74.420000000000002 112.404 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . . . -60.05 -48.15 87.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.213 -0.518 . . . . 62.549999999999997 113.222 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -59.05 -51.81 68.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.694 0.283 . . . . 65.329999999999998 111.448 -179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -50.52 -45.75 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.088 0.471 . . . . 72.319999999999993 111.16 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 32' ' ' TYR . . . -64.71 -37.9 89.15 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 65.200000000000003 111.946 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 98.3 mttt -60.34 -53.98 51.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.873 0.323 . . . . 72.140000000000001 111.873 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -64.47 -34.97 79.44 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.133 -0.355 . . . . 72.0 111.553 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.73 -22.5 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.933 0.346 . . . . 54.310000000000002 111.933 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.98 19.23 37.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.35 -0.453 . . . . 63.210000000000001 113.529 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 44.7 m-85 -136.16 68.75 63.03 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.955 0.377 . . . . 72.040000000000006 111.15 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.37 138.24 42.08 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.459 2.106 . . . . 74.140000000000001 113.246 -177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.84 -28.39 16.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.415 -0.422 . . . . 53.200000000000003 113.641 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -83.52 36.88 0.55 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.111 0.481 . . . . 73.109999999999999 112.19 -176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 23' ' ' TYR . . . -57.72 -39.28 76.9 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.108 -0.496 . . . . 61.200000000000003 112.097 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 17.6 tpp180 -60.36 -45.29 94.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.481 -0.327 . . . . 75.340000000000003 111.424 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -62.05 -37.7 85.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.923 0.392 . . . . 74.25 110.976 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 61.4 t -59.62 -45.51 94.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.058 0.456 . . . . 64.420000000000002 110.485 172.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.91 -37.5 93.87 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 113.08 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' ARG . 31.5 mmmt -63.51 -38.12 89.91 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.949 0.405 . . . . 63.399999999999999 111.024 176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 5' ' ' LEU . . . -68.34 -49.96 56.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.137 -0.483 . . . . 54.32 111.407 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 89.0 mt -57.54 -41.64 81.37 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.131 -0.486 . . . . 60.32 111.54 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.83 -7.3 28.52 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.279 -0.486 . . . . 54.509999999999998 113.661 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -106.44 -7.93 17.36 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.711 0.291 . . . . 74.400000000000006 111.456 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.1 mt -70.21 142.67 90.15 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 112.477 0.547 . . . . 71.150000000000006 112.477 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 50' ' ' SER . 37.5 Cg_endo -67.67 138.51 45.51 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 113.237 177.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -50.48 -44.78 55.94 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.703 -0.681 . . . . 74.129999999999995 112.782 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.82 37.38 3.44 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.274 -0.488 . . . . 75.409999999999997 113.289 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' A' ' 47' ' ' PRO . 37.5 t -77.94 146.33 35.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.076 0.465 . . . . 75.109999999999999 111.473 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -74.48 -13.92 60.76 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.085 0.469 . . . . 75.209999999999994 110.425 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.54 HD11 ' HB ' ' A' ' 12' ' ' ILE . 51.1 tp -82.83 114.07 49.74 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.61 -0.723 . . . . 52.219999999999999 110.32 173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.23 94.61 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.784 1.656 . . . . 71.019999999999996 112.977 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -76.99 -18.84 57.95 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.444 0.64 . . . . 72.510000000000005 111.094 175.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -80.88 -7.69 59.53 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.48 0.919 . . . . 60.329999999999998 113.48 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.663 HH11 ' HB ' ' A' ' 15' ' ' ILE . 96.4 mtt180 -86.37 -18.74 31.07 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.923 0.712 . . . . 73.430000000000007 112.923 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.84 106.12 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.196 0.522 . . . . 62.310000000000002 111.957 -173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD11 HD21 ' A' ' 93' ' ' LEU . 26.8 pt -118.18 -174.47 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.968 -0.56 . . . . 74.010000000000005 111.373 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.477 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -88.9 166.77 13.74 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.928 -0.482 . . . . 61.100000000000001 111.956 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.1 m -55.98 -30.36 61.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.778 0.659 . . . . 70.530000000000001 112.778 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -65.43 -5.41 7.6 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.911 0.708 . . . . 74.340000000000003 112.911 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.06 51.34 28.91 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.827 -0.701 . . . . 71.5 112.202 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' HB3' HD21 ' A' ' 59' ' ' ASN . 87.2 tttt -148.81 146.43 28.0 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.58 0.229 . . . . 73.049999999999997 110.93 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.3 127.54 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.981 0.42 . . . . 74.140000000000001 111.432 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 p -75.93 -30.95 58.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.857 0.36 . . . . 73.420000000000002 111.644 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -76.95 152.71 35.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.737 0.303 . . . . 72.129999999999995 111.137 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 26.3 mtpp -131.62 -176.07 3.92 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.969 0.414 . . . . 72.040000000000006 111.694 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.0 -149.68 51.72 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.141 -0.552 . . . . 51.109999999999999 112.417 -176.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -62.79 -28.2 69.83 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.511 -0.405 . . . . 70.439999999999998 111.539 178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.6 -35.77 72.97 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.749 0.309 . . . . 63.539999999999999 111.753 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 67' ' ' LYS . 6.5 tt -66.65 -52.8 40.89 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.456 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -58.12 -40.3 80.87 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.386 0.612 . . . . 74.430000000000007 110.972 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -62.87 -47.7 82.19 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.766 -0.652 . . . . 62.530000000000001 111.217 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.29 -38.57 87.27 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.137 0.494 . . . . 44.530000000000001 110.415 175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG3' ' HB ' ' A' ' 85' ' ' VAL . 83.1 tttt -55.85 -53.19 59.77 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.937 -0.574 . . . . 73.340000000000003 111.173 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -53.91 -38.16 64.54 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.866 0.365 . . . . 74.549999999999997 111.632 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 7.4 mmpt? -59.33 -49.86 76.18 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 111.077 174.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 74.3 mt -66.42 -45.9 78.36 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.244 -0.434 . . . . 62.210000000000001 111.957 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -53.54 -32.0 48.81 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.676 0.391 . . . . 74.209999999999994 111.109 175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.01 -30.56 71.55 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.355 -0.384 . . . . 75.200000000000003 111.676 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.03 -2.29 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.572 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.69 13.45 56.78 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.32 -0.467 . . . . 70.310000000000002 112.944 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 60.3 mt -91.91 106.75 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.702 0.286 . . . . 64.349999999999994 111.166 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -73.11 113.52 10.25 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.135 0.493 . . . . 71.5 111.784 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' A' ' 75' ' ' LYS . 41.7 t -101.42 121.16 51.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.261 -0.427 . . . . 53.439999999999998 111.229 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.694 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 20.2 m -66.71 142.68 57.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.41 -0.359 . . . . 71.349999999999994 110.718 178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.36 -23.0 8.37 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.345 0.869 . . . . 63.130000000000003 113.345 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.6 pt -80.62 7.76 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 112.091 0.404 . . . . 73.519999999999996 112.091 176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.86 26.32 49.95 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 116.364 -0.38 . . . . 43.539999999999999 113.321 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.694 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 26.7 ttpp -97.74 134.61 40.68 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 58' ' ' ILE . 63.1 mt -124.04 110.25 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.004 -0.543 . . . . 74.150000000000006 110.416 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.62 95.96 0.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.455 0.539 . . . . 71.430000000000007 112.455 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 HD11 ' A' ' 58' ' ' ILE . 80.8 mt -60.34 -32.97 71.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.364 -0.38 . . . . 73.329999999999998 111.844 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -51.97 -31.11 27.7 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.265 0.468 . . . . 74.420000000000002 112.265 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.73 -20.18 11.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.198 0.444 . . . . 71.109999999999999 112.198 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -109.62 13.88 23.66 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.688 0.625 . . . . 64.030000000000001 112.688 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 63.3 pttt -63.43 134.97 56.59 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.265 0.555 . . . . 64.409999999999997 112.015 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' A' ' 100' ' ' PRO . 18.1 t90 -75.06 142.79 43.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.131 -0.486 . . . . 71.530000000000001 110.665 175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.88 ' HG3' ' HB2' ' A' ' 102' ' ' GLU . 35.6 tt0 -108.75 84.37 2.5 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 120.811 0.339 . . . . 75.409999999999997 111.464 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 98' ' ' TRP . 56.5 Cg_endo -91.5 -16.07 1.34 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.78 2.32 . . . . 71.230000000000004 113.868 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pp -160.19 23.2 0.16 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.577 0.584 . . . . 74.120000000000005 112.577 -177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.88 ' HB2' ' HG3' ' A' ' 99' ' ' GLN . 30.2 mm-40 . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.942 -0.551 . . . . 73.040000000000006 111.176 179.613 . . . . . . . . 1 1 . 1 stop_ save_